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Abstract 
 
The development of regioselective and diastereoselective processes provides chemists 
with versatile synthetic tools to access new synthetic pathways. This thesis focuses on two 
specific areas of regio- and diastereocontrol: hydroboration of olefins and intramolecular 
aglycone deliveries. The first chapter provides background literature containing existing reported 
strategies for regiocontrol using copper catalysts in hydroboration of olefins. This chapter lays 
the groundwork and motivation for investigation into the hydroboration of olefins. Subsequently, 
the second chapter discusses the development of a versatile procedure for the copper-catalyzed 
hydroboration of terminal olefins leading to the synthesis of secondary alkylboranes. This 
procedure provides the reversed regioselectivity compared with widely used hydroboration 
procedures. The newly synthesized secondary alkylboranes can be transformed to the 
corresponding trifluoroborate salts and used in photocatalytic cross-couplings to synthesize new 
carbon-carbon bonds. Furthermore, advances in the regioselective hydroboration of 1,1-
disubstituted and 1,2-disubstituted alkenes are described, with efforts in the former of these areas 
providing the most promising outcomes for future applications.  
The third chapter begins with a discussion of literature methods for intramolecular 
aglycone delivery in the synthesis of 1,2-cis glycosides. Within this context, an overview of 
activating thioglycosides and latent-activation of glycosides for intermolecular glycosylation 
reactions is provided. The fourth chapter the describes the preparation of sugar silanes containing 
an o-(p-methoxyphenylethynyl)phenyl group and their utilization in intramolecular aglycone 
 xxiv 
delivery strategies. Beginning with the new silanes prepared, dehydrogenative silylation with 
menthol was accomplished with tris(pentafluorophenyl) borane catalyst, effectively tethering the 
aglycone. The tethered assemblies were then examined in intramolecular aglycone delivery 
strategies. High levels of diastereocontrol were observed, and future work will focus on 
optimization of the glycosylation yields.  
 
 1 
 Chapter 1 Introduction to Copper-Catalyzed Hydroboration 
 
1.1 General Overview of Thesis 
Of the multitude of topics taught in sophomore organic chemistry, regioselectivity and 
stereoselectivity are key pillars upon which notions of targeted synthesis provide a key 
foundation for strategies in targeted synthesis. From the difunctionalization of olefins to 
electrophilic aromatic substitution and Diels-Alder cycloadditions, notions of regioselectivity 
play a key role in how both students and researchers understand synthetic routes to drug targets, 
complex monomers, and beyond. Within these systems, regioselective outcomes are either 
rationalized via an electronic argument, a steric argument, or a combination of both sterics and 
electronics. These simplistic arguments often lead students to one straightforward result; 
however, in reality there are many other compounding factors contributing to regiocontrol. In the 
chapters that follow, this thesis discusses two projects that provide new methods for regio- and 
diastereocontrol: the synthesis of secondary alkylboranes from alkenes via copper-NHC 
catalysis, and the synthesis of 1,2-cis glycosides selectively via sugar silane intermediates 
1.2 Regioselectivity Explanations for Hydrofunctionalization of Olefins 
Hydrofunctionalization reactions of olefins are a sweeping set of reactions that comprise 
a large portion of topics in organic chemistry. The formal addition of “H-Y” to a terminal olefin 
results in two isomeric products, the branched functionalized product, in which functional group 
Y is added to the internal position of the olefin (1-2) and the linear functionalized product where 
functional group Y is added to the terminal position of the olefin (1-3) (Scheme 1-1 A). 
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One of the first reactions often taught in sophomore organic chemistry is the acid 
catalyzed electrophilic addition of “H-X” to an olefin. The first step of the mechanism proceeds 
with protonation of the olefin to give a carbocation, which is then attacked by the nucleophilic 
“X-” species. The initial carbocation formation is what dictates the regioselectivity of the 
reaction. Two potential carbocations can be formed: secondary carbocation 1-4, and a primary 
carbocation 1-5 (Scheme 1-1 B). The increased stability from hyperconjugation of neighboring 
carbons causes the secondary carbocation to be more stable, resulting in the predominant 
observation of the secondary branched product.  
The analogous linear product can be synthesized but the regioselectivity is governed not 
by carbocation stability but rather radical stability. The Nicewicz group has demonstrated that an 
acrindinium photooxidant can undergo a single electron transfer first adding the “X•” group 
while simultaneously forming a secondary radical. The resulting radical undergoes a hydrogen 
abstraction from a hydrogen donor also present in solution (Scheme 1-1 C).1 Similar arguments 
to carbocation stability apply to radical stability, but this method offers a switch in order of 
addition of the “H” and “X” atoms, thus favoring the formation of the linear functionalized 
product.   
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Scheme 1-1: (A) Two Regioisomeric Product from H-X Addition to an Olefin (B) Carbocation Stability in Acid-Catalyzed 
Hydrofunctionalization (C) Radical Stability in Photoredox Hydrofunctionalization 
1.3 Influence of Herbert C. Brown on Organic Synthesis 
 Another reaction that is typically taught alongside the electrophilic addition of “H-X” 
unit is the hydroboration of olefins. It was first reported in 1948 that heating diborane and 
ethylene together at 100 °C resulted in the synthesis of triethylborane.2 Several years later, it was 
discovered that diborane in ethereal solvents was able to undergo hydroboration with 1-hexene at 
room temperature (Scheme 1-2);3,4 a discovery made by Herbert C. Brown who would later go 
on to win the Nobel Prize in Chemistry for his work to incorporate boron into organic synthesis. 
In addition to research into a fundamental topic of organic chemistry, his work with borane in 
ethereal solvents led to the development and utility of the BH3•THF complex that is 
commercially available today.4 
R
R
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product
H
Y
R Y
H
H Y
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R
RR
H
H
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C
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Scheme 1-2 Brown’s Hydroboration in Ethereal Solvents Discovery 
Brown has been credited with the widely accepted reaction mechanism for the 
hydroboration of alkenes.5 Rather than a two-step mechanism wherein regioselectivity of the 
reaction is dictated via stabilization of an intermediate (Scheme 1-3), this process is proposed to 
proceed through a concerted, one-step mechanism. Initially, the BH3•THF complex exists in 
equilibrium with the non-complexed BH3 and THF molecule. Free BH3 then reacts with an olefin 
via 4-membered transition state 1-10 due to the hydridic nature of the B-H bond, wherein partial 
charges align leading to a one-step formation of both C-H and C-B bonds. This mechanism leads 
to compound 1-11 as the major product.  
 
Scheme 1-3: Mechanism for Brown's Hydroboration 
This proposed mechanism explains the regioselectivity when the carbons of the olefin 
have different substitution patterns; however, sterics become a factor when substitution the olefin 
are of the same degree (Table 1-1).6 When cis-4-methyl-2-pentene (1-12) was subjected to 
hydroboration conditions with BH3•THF, regioisomeric products 1-13 and 1-14 were observed in 
almost equal ratios after subsequent oxidation of the alkylboranes. When more sterically 
hindered disiamylborane (Sia2BH) was used, selectivity shifted towards greater formation of the 
less sterically hindered alcohol 1-13. Lastly, when the bulky 9-borabicylco(3.3.1)nonane (9-
BBN) was employed almost exclusive formation of 1-13 was observed. These results support the 
notion that there is a steric component to the hydroboration reaction between two electronically 
indistinguishable carbons. 
BH3·diglyme
1-hexene
diglyme, rt
B
1-8 1-9
O BH3 O + BH3 R
R
H BH2
∂-
∂-
∂+
∂+ R BH2
H
1-10 1-11
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Table 1-1: Regioselectivity of Sterically Encumbered Alkenes with Various Boranes 
In addition to hydroborations of alkenes, Brown was able to apply this hydroboration 
methodology to a different π-system: alkynes.7 Overall, monohydroboration was observed as the 
major product, as the monocarbonyl was isolated after oxidation. Terminal alkynes behaved in a 
similar manner as terminal alkenes, where boron incorporation occurred predominantly at the 
terminal carbon. Once again, regioselectivity of internal alkynes was dictated by the sterics of the 
alkyne substituents. Brown discovered that an additional electronic effect was seen when one of 
the substituents on the alkyne was a phenyl group, such as observed with phenylacetylene 
substrate 1-15 (Table 1-2). Subjecting this substrate to BH3•THF was resulted in benzylic ketone 
1-16 formation in approximately a 3:1 ratio with homobenzylic aldehyde 1-17. As expected, use 
of the larger borane Sia2BH favored the formation of aldehyde 1-17. However, unlike the trend 
observed with sterics and selectivity in Table 1-1, the electronic contribution of the phenyl group 
resulted in 9-BBN favoring the benzylic ketone 1-16 in approximately a 2:1 ratio. 
1) "Borane"
2) NaOH, H2O2
+
1-12 1-13 1-14
OH HO
Borane 1-13:1-14
BH3·THF 57:43
Sia2BH
9-BBN
97:3
99.8:0.2
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Table 1-2: Regioselectivity Affects on the Electronic of Benzene Groups on the Hydroboration of Alkynes with Various 
Boranes 
Moreover, Brown went on to report the first enantioselective hydroboration reactions 
using monoisopinocampheylborane (ipcBH2, 1-19) as a chiral boron source (Scheme 1-4).8,9 
Brown was then able to improve the synthesis of 1-19 by truncating the mixing time of α-pinene 
(1-18) and BH3•SMe2 to synthesize desired 1-19; however, the ee was not optimal, as it 
resembled the original enantioselectivity of 1-18 (Scheme 1-4 A). A series of cooling and mixing 
1-19 with excess 1-18 increased the enatioselectivity of 1-19 to >99% ee, which was then used in 
subsequent hydroboration reactions (Scheme 1-4 B). Both trans- and cis-alkene 1-20 
successfully were hydroborated but the enatioselectivities differed. The trans-isomer resulted in 
the formation of chiral alcohol 1-21 in 73% ee while the cis-isomer had higher enatioselectivity 
of 98% ee – indicating that trans-isomers are more difficult to react in an enatioselective fashion. 
 
Scheme 1-4: (A) Synthesis of Icp2BH (B) Enantioselective Hydroboration with Icp2BH 
 Brown’s investigation into the hydroboration of olefins and alkynes has provided a useful 
synthetic tool in total synthesis (Scheme 1-5). For example, Weinreb’s total synthesis of the 
1) "Borane"
2) NaOH, H2O2
Borane 1-16:1-17
BH3·THF 74:26
Sia2BH
9-BBN
19:81
65:35
O
O
1-16 1-17
+
1-15
BH3·SMe2+
THF
0 °C, 2h
BH
2
1-18
92% ee
1-19
92% ee
1) 0 °C, 0.5 h
2) 15% excess 1-18
3) 0 °C, 72 h
BH
2
1-19
>99% ee
1) 1-19, 0 °C
2) NaOH, H2O2
OH
1-20 1-21
trans-1-20: 73% ee
cis-1-20: 98% ee
A
B
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antitumor agent agelastatin A, originally isolated from a marine sponge, utilized Brown’s 
hydroboration conditions on internal olefin 1-22, which resulted in the formation of two isomeric 
products, 1-23 and 1-24 (Scheme 1-5 A).10 Optimization efforts to bias selectivity towards the 
formation of desired product 1-24 proved unsuccessful, but selective oxidation allowed for 
separation of the isomers before proceeding forward. Corey also used a hydroboration reaction in 
his second generation total synthesis of gibberellic acid, a hormone found in plants and fungi 
(Scheme 1-5 B).11 The hydroboration of 1-25 to 1-26 installs the functional handle needed to 
synthesize the bridged bicycle. More recently, Sato and Chida demonstrated how the 
hydroboration of 1-27 to 1-28 establishes the core structure of not only madangamine C, but, 
also madangamine E and madangamine A – three additional alkaloids isolated from marine 
sponges (Scheme 1-5 C). 12 
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Scheme 1-5: (A) Weinreb's Total Synthesis of Agelastatin A (B) Corey's Total Synthesis of Gibberellic Acid (C) Sato and 
Chida's Total Synthesis of Madangamine C 
1.4 Copper-Catalyzed Hydroboration 
In 1985, the first report of metal-catalyzed hydroboration of olefins was described by 
Noth.13 He demonstrated that Wilkinsons’s rhodium catalysts [RhCl(PPh3)3] preferred to undergo 
hydroboration of olefins rather than undergo reduction of ketones in the presence of 
catecholborane. Since this initial introduction of metal-catalyzed hydroboration of olefins, the 
field has taken off, and expanded the metal identity to include iridium,14 ruthenium,15 titanium,16 
early transition metals,17 palladium,18 iron,19 cobalt,20 manganese,21 nickel,22 and platinum23 to 
name just a few. Copper not mentioned above, will be covered in greater depth later to be able to 
foster the experimental data discussed in Chapter 2. 
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1.4.1 Initial Proof of Concept for Copper-Catalyzed Hydroboration 
The first introduction of a copper-boron complex was by Sadighi in 2005 (Scheme 1-6).24 
Discrete N-heterocyclic carbene (NHC)-copper(I) tert-butoxide complex 1-29 was subjected to 
ligand exchange conditions with bis(pinacolato)diboron (B2pin2) to form NHCCu-Bpin complex 
1-30 where complex 1-30 successfully reduced CO2 to CO (Scheme 1-6 A). Although this 
reaction is not a hydroboration, discussing it serves to demonstrate the chemical compatibility of 
boron and copper. Follow up investigation revealed the same 1-30 complex could readily react 
with an alkene, and upon alkene insertion between the copper and boron bond form 
stoichiometric isolable copper-boron species 1-32 (Scheme 1-6 B).25  
 
Scheme 1-6: (A) First Report of Copper-Boron Complex (B) First Indication Copper Catalyzed Hydroboration Reactions 
of Olefins 
1.4.2 Initial Copper-Catalyzed Hydroboration  
Three years later drawing inspiration from Sadighi, Hoveyda developed a catalytic method for 
copper-catalyzed hydroboration of olefins (Scheme 1-7).26 The key to successful catalyst 
turnover was the addition of stoichiometric methanol to protonate the copper-carbon species, 
thereby preparing the catalyst for turnover. In this seminal work, it was also determined that the 
formal hydroboration occurs on the same face of the olefin, resulting in diastereoselectivity 
IPrCu O-t-Bu
B2pin2
n-pentane
IPrCu Bpin
1-29 1-30
IPrCu Bpin
1-30
+ CO2
THF-d8
-80 °C- -40 °C
IPrCu OBpin
1-31
1-30
1-31
CO2
COB2pin2
(pinB)2O
IPrCu Bpin
1-30
BpinPh
Ph CuIPr
1-32
A
B
 10 
analogous to the hydroboration methods previously established by Brown (Scheme 1-7 A). 
Lastly, the report demonstrated that by using a chelating chiral NHC ligand, enantioselective 
hydroboration could be achieved (Scheme 1-7 B). 
 
Scheme 1-7: (A) Formal Deuteroboration of Styrene Derivatives with High Diastereoselectivity (B) Enantioselective 
Hydroboration of Styrene Derivatives 
1.4.3 Copper-Catalyzed Hydroboration of Other Olefin Classes 
Expansion of the copper-catalyzed hydroboration reaction methodology to other olefin 
classes besides mono-substituted styrene derivatives followed shortly thereafter. One 
complicated substrate class chosen was 1,1-disubstituted styrene derivatives, which due to the 
increased substitution of the olefin would require the formation of a tertiary-copper complex. 
Two years after his publication, Hoveyda demonstrated that α-methyl styrene 1-36 and its 
derivatives readily undergo enantioselective hydroboration to chiral borylated product 1-37 via a 
copper-NHC complex formed in situ (Scheme 1-8 A).27 Zhang was able to expand the substrate 
scope from simple alkyl and aryl substitution to diaryl-substitution and arrive at analogous 
enantioenriched alkylboranes using a chiral phosphine-copper complex (Scheme 1-8 B).28 
Shortly after this publication, mechanistic considerations by DFT studies indicated that the 
IMesCuCl (0.5 mol %)
NaO-t-Bu (0.5 mol %)
B2pin2 (1.1 equiv)
MeOD (2.0 equiv)
PhMe, rt, 10 min
D
Bpin
1-34
>98% D
>98% yield
>98% dr
1-33
1-33
N N
PhPh iPr
iPr
iPrSO3
CuCl (7.5 mol %), KO-t-Bu (30 mol %)
B2pin2 (1.1 equiv), MeOH (2.0 equiv)
THF, -50 °C, 48 h
(7.5 mol%) Bpin
1-35
99:1 er, 80% yield
A
B
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hydroboration reaction of 1,1-disubstituted styrene derivatives does indeed involve a tertiary 
copper intermediate.29 
 
Scheme 1-8: Hydroboration of 1,1-Disubstituted Styrene Derivatives 
 Another class of terminal olefin that has been explored in copper-catalyzed hydroboration 
are non-conjugated, mono-substituted olefins. While our contributions in this field will be 
discussed further in Chapter 2, there are other notable reports that will be discussed in the pages 
that follow (Scheme 1-9). Ito developed a phosphine-copper catalyzed hydroboration of terminal 
olefins that leads to the formation of the secondary alkylborane over the linear alkylborane 
(Scheme 1-9 A).30 Although regioselectivities for the branched alkylborane were high across 
multiple functionalized olefins, reaction yields were modest. Both the Hong and Shi groups 
recently reported NHC-copper systems that catalyze enantioselective hydroboration reactions for 
the synthesis of enantioenriched secondary alkylboranes (Scheme 1-9 B).31 Using NHCs that 
were designed and synthesized by the late Robert Gawley,32 chirality about the aromatic ring 
system is used to induce enatioselectivity but use of the larger boron source, 
bis(dimethylpentanediol)diboron (B2dmpd2), was necessary to increase enantioselectivity.  
1-36
N N
PhPh
iPrSO3
CuCl (7.5 mol %), KO-t-Bu (80 mol %)
B2pin2 (1.1 equiv), MeOH (2.0 equiv)
THF, -50 °C, 48 h
(7.5 mol %)
Bpin
1-37
95%, 93.5:6.5 er
PPh2PPh2
(5 mol %)
CuCl (5 mol %, NaBArF (5 mol %)
NaO-t-Bu (1.0 equiv), MeOH (2.0 equiv)
rt, 24 h
Bpin
1-38 1-39 86%, 98:2 er
A
B
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Scheme 1-9: Hydroboration of Mono-Substituted, Terminal Olefins 
 A significantly more difficult substrate class for hydroboration reactions is 1,2-
disubstituted olefins. As mentioned previously, although Brown was able to successfully perform 
hydroboration reactions, he faced regioselectivity issues when electronics or sterics were not bias 
enough to significantly differentiate between the two carbon centers. Leveraging differences in 
olefin electronics, Hoveyda demonstrated that diborylation of alkyne 1-43 most likely proceeds 
through a vinylborane species 1-44, indicating vinylboranes successfully undergo hydroboration 
reactions in high regioselectivity and enantioselectivity, as well as synthesizing vicinal diborane 
1-45 using a chelating NHC-copper catalyst (Scheme 1-10 A).33 Hoveyda was then able to 
expand this methodology to the hydroboration of vinylsilanes, thereby synthesizing 
enantioenriched vicinal and geminal borosilanes (Scheme 1-10 B).34 The driving force for vicinal 
versus geminal borosilanes is tuned by based on the properties of the carbon substituent. An 
alkyl substituent with copper and ligand 1-49 leads to the vicinal borosilane 1-47, while an aryl 
substituent with copper and ligand 1-50 leads to the geminal borosilane 1-48 due to the 
difference in the electronics of the olefin.  
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Scheme 1-10: Hoveyda's Hydroboration of 1,2-Disubstituted Olefins 
 As Hoveyda exploited the NHC-copper boron catalyst as the active catalyst for 
hydroboration of olefins with methanol as the proton source, Hartwig pioneered a 
complementary route for the synthesis of alkylboranes. Concurrent with these developments, 
Buchwald group demonstrated that a copper-hydride formed in situ could insert into a symmetric 
internal alkene35 as Hartwig reported a regioselective insertion of an olefin into a copper-hydride 
via a directing group36 to synthesize hydroaminated products.  
With the knowledge that a copper-hydride could insert into an olefin, the concept of 
regioselective hydroboration of internal olefins using a directing group was further explored by 
Hartwig (Scheme 1-11).37 Use of a homoallyl-directing group – such as protected nitrogens, 
ethers, or silyl ethers – achieved successful regioselective hydroboration. The use of chiral 
phosphine ligand, (S)-DTBMP-SEGPHOS, enabled high enantioselectivity in the reaction. After 
N N
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iPr
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R
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NaO-t-Bu (0.8 equiv)
B2pin2 (1.1 equiv), MeOH (2.0 equiv)
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R
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R
Bpin
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or
N N
PhPh
MesBF4
N N
PhPh Ph
SO3
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A
B
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performing DTF calculations, it was determined that hydride insertion is both the 
regiodetermining and enantiodetermining step of the reaction. This demonstrated that a directing 
group was not necessary for the reaction to proceed, although with out one the overall reaction 
yield was low. This methodology was only applied to symmetric olefins (1-55) indicating the 
need for a directing group in order to achieve regioselectivity and enhance reactivity. 
 
Scheme 1-11: Copper-Hydride Hydroboration of Internal Olefins with Select Examples 
1.5 Conclusion  
Even before the isolation of a copper-boron species in 2005, copper catalysis for the 
borylation of π-systems had been widely explored. As discussed in this chapter, the two main 
copper-catalyzed methods for the hydroboration of olefins use either (1) a copper-boron species 
to do alkene insertion followed by protonation by methanol, or (2) a copper-hydride species for 
insertion, followed by borylation by pinacolborane. These main strategies represent only a small 
subset of the copper catalyzed reactions in the presence of boronic starting materials (Scheme 
1-12). With reagent control, alkynes are hydroborated to vinylborane species 1-57 or diborane 
species 1-58.33 Catalyzed by copper, conjugate addition to enone 1-59 leads to β-borylated 
product 1-60.38 Instead of protonating the copper-carbon species with methanol, the copper-
carbon bond also can be alkylated39 or aminated40 forming 1-62 or 1-63, depending on the ligand 
used. Similarly, regioselective hydroboration of allenes for the synthesis of 1-65 or 1-66 are 
divergent outcomes based on small differences in the reaction conditions.41,42 Furthermore, 
R DG + HBpin
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regiocontrol in the hydroboration of 1,3-dienes can be achieved by copper catalysts.42 Overall, 
the use of the first row metal copper has catalyzed a wide variety of borylation reactions of many 
carbon-carbon π-systems. 
 
Scheme 1-12: Copper-Catalyzed Borylations of π-Systems 
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 Chapter 2 Advances in Regioselective Hydroboration of Olefins 
 
2.1 Introduction to Alkylboranes 
 The versatility of organoboranes in synthesis has been of great interest to chemists for 
many years. Suzuki and Miyaura initially discovered the importance of carbon-boron bonds in 
cross-coupling reactions43 while Morken,44 Molander,45–49 and others50–53 have expanded upon 
this valuable functional moiety. Other useful transformations of carbon-boron esters such as 
oxidations,54 aminations,55 cleavage,56 etc.15 as well as inter-conversion among boron identity58–
60 have increased the attractiveness of synthesizing new organoboranes demanding the synthetic 
community to provide facile routes to alkylboranes (Scheme 2-1). 
 
Scheme 2-1: Synthetic Transformation of Alkylboronic Esters 
 With the exception of some metal catalyzed cross-coupling, all of the previously 
mentioned boronic ester transformations are stereoretentive, maintaining the original 
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stereochemical identity of the carbon-boron bond. The mechanism of oxidation for the 
transformation of 2-1 to 2-3 demonstrates a generalizable pathway for the stereoretentive 
transformations (Scheme 2-2). First, a nucleophile is formed (deprotonation of hydrogen 
peroxide) followed by nucleophilic attack on the empty p orbital of the boron atom forming 
boronate species 2-7. Boronate species 2-7 undergoes a 1,2-metallate shift at the boron center 
forming intermediate 2-8. After an SN2 attack at the boron center of 2-8, alkoxy species 2-9 
undergoes protonation, forming the desired oxidized product 2-3 with retention of the original 
stereocenter. 
 
Scheme 2-2: Mechanism for Stereoretentive Oxidation 
2.2 Previous Synthesis of Secondary Alkylboranes and Gap in the Literature 
Due to their synthetic utility, syntheses of secondary alkylboranes have remained of 
interest in methodology development (Scheme 2-3). Variations of the Matteson rearrangement, 
which entails formation of a boronate species from an organolithium reagent that undergoes a 
1,2-metallate shift, have been demonstrated to be desirable methods for the synthesis of 
secondary alkylboranes.61–66 The transmetalation of organolithium or organomagnesium reagents 
to electrophilic boron species has been shown to be effective for synthesizing secondary 
alkylboranes.67 Although both of these methods have shown to be useful, there is a limitation of 
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functional group compatibility as the strongly basic character of the organometallic reagents 
promotes undesirable side reactions. Metal-catalyzed cross-couplings efficiently convert 
secondary alkyl halides to organoboranes without observation of chain walking.68,69 While 
overcoming the challenge of cross-coupling sp3 centers is no small feat, using halides as starting 
materials has its own synthetic drawbacks. Lastly, hydrogenation of vinylboranes has also been 
utilized for the synthesis of alkylboranes.70–72 The synthesis of the vinylborane starting material 
involves hydroboration of alkynes. Although the aforementioned methods have their own niche 
in synthetic chemistry, at the onset of this investigation there were no reports of commercially 
available terminal olefins being directly converted to secondary alkylboranes. This would 
provide a facile method for transforming commodity chemicals and rapidly building up their 
complexity. Furthermore, accessing conditions that tolerate a wide variety of functional groups 
allows for the synthesis of new alkylboranes that can be transformed to other functional groups 
as well as new carbon-carbon bond via a variety of cross-coupling reactions. Additionally, it is 
important to note that the Ito group demonstrated a formal hydroboration of monosubstituted, 
terminal olefins via a copper-phosphine system; however, preparation of phosphine ligands 
provides additional synthetic challenges that may be circumvented using an alternative 
approach.30 
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Scheme 2-3: Previous Approaches to Secondary Alkylboranes and the Gap in the Literature 
2.3 Optimization of the Formal Hydroboration of Terminal Olefins 
2.3.1 Rationale for Initial Optimization Conditions 
 Regioreversal additions of H-X to π-systems has long been an interest of the 
Montgomery group.73–77 In 2013, it was reported that metal identity controls the regioselectivity 
for the hydrosilylation of allenes (Scheme 2-4 A).76 Palladium favors the formation of 
allylsilanes (2-17), while nickel favors vinylsilanes (2-18). A followup investigation indicated 
that the size of the N-heterocyclic carbene (NHC) ligand employed affects the regioselectivity of 
the same addition, with a small ligand favoring 2-17 and a large ligand favoring 2-18 (Scheme 
2-4 B). 
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Scheme 2-4: Examples of Regiocontrol for Hydrosilylation of Allenes (A) Metal Identity (B) Ligand Size 
2.3.2 Optimization Using Pinacolborane  
 Drawing inspiration from the hydrosilylation of allenes, initial attempts for the 
hydroboration of terminal olefin 2-19 to the desired branched alkylborane 2-1 examined metal 
identity and ligand size (Table 2-1). When Pd2(dba)3 was paired with what is typically classified 
as a small ligand, IMes·HCl, and a large ligand, SIPr·HCl, in tetrahydrofuran, decent reactivity 
was observed, 62% and 47%, respectively; unfortunately ~20:80 regioselectivity favoring 
undesirable alkylborane 2-20 was observed (entries 1-2). Similar regioselectivity results were 
observed when using Ni(cod)2 as a pre-catalyst (entries 3-4). Expanding the scope of the metal 
identity to platinum, cobalt, and rhodium did not increase the selectivity, rather exclusive or 
almost exclusive formation of undesired 2-20 was observed (entries 5-7). 
·R' LnNi(0)R3SiH +
SiR3
R'
HLnPd(0)R3Si
H
R'
·R'
LnPd(0)
R3SiH +
SiR3
R'
HLnPd(0)R3Si
H
R'
IMes·HCl IPr*OMe·HBF4
NN
Cl
NN
BF4
Ph Ph Ph
PhPh
Ph
Ph PhMeO OMe
2-17 2-18
2-17 2-18
A
B
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Table 2-1: Initial Investigation into Regioselective Hydroboration of 2-19 
 Without observing regioselectivity favoring the branched alkylborane 2-1, the mechanism 
of the reaction was evaluated (Scheme 2-5). Initially, it was hypothesized that oxidative addition 
into the boron-hydrogen bond leads to the regiodetermining alkene insertion step. The alkene 
insertion between the metal-hydride bond occurs, leading to the linear alkylborane 2-20. Unlike 
the hydrosilylation of allenes (in which pi-insertion into the metal-hydride bond could be 
switched to the metal-silyl bond depending on the metal identity), the insertion between the 
metal-boron bond was not able to be favored – leading to the desired branched alkylborane 2-1. 
Ph conditions
a
Ph Ph
Bpin Bpin+
Entry Catalyst Reagent Solvent 2-1:2-20c (yield)
1
2
3
4
5
6
7
Pd2dba3
Pd2dba3
Ligandb
IMes HBpin THF 17:83 (62)
SIPr HBpin THF 21:79 (47)
Ni(cod)2
Ni(cod)2
IMes
SIPr
HBpin
HBpin
THF
THF
21:79 (14)
13:87 (<5)
PtCl2
CoBr2
Rh(PPh3)3Cl
SIPr
SIPr
SIPr
HBpin
HBpin
HBpin
THF
THF
THF
7:93 (74)
<2:98 (62)
<2:98 (33)
aAll experiments were conducted at rt for 2 h at 0.2 M under nitrogen atmosphere.  bLigand HCl salts 
were used with KO-t-Bu. cNMR yields are shown using 1,3,5-trimethoxybenzene as internal standard. 
Regioselectivity ratios were determined on crude reaction mixtures.
NN
Cl
NN
Cl
IMes·HCl SIPr·HCl
2-1 2-202-19
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Scheme 2-5: Proposed Mechanism for the Formation of Linear Alkylborane 2-20 
2.3.3 Optimization with Bis(pinacolato)diboron 
Taking into consideration the proposed mechanism outlined in Scheme 2-5, a new 
approach was devised drawing motivation from previous reports for hydroboration of terminal 
alkynes with a copper-NHC catalyst, which affords the branched vinylborane.78 Copper 
precursors were screened alongside the IMes·HCl and SIPr·HCl ligands, with 
bis(pinacolato)diboron as the boron source and methanol as the proton source (Table 2-2). CuCl 
with IMes·HCl in tetrahydrofuran resulted in the initial observation for regioreversal to the 
branched alkylborane 2-1 (entry 1). Although reactivity was low (3% conversion to desired 
product) and regioselectivity limited (2:1), this was the first indication that regioreversal was 
possible in a metal-NHC system. Increasing the steric bulk of the ligand to SIPr·HCl resulted in 
increased regioselectivity and yield (entry 2). After screening several solvents, it was determined 
that acetonitrile was the optimal solvent for regioselectivity, providing 95:5 in favor of the 
desired product 2-1 (entry 3). After optimization of regioselectivity, attention turned to 
increasing the yield of the reaction. It was predicted that use of a copper pre-catalyst would 
increase the yield of the reaction as formation of the reactive copper species might vary by pre-
LnM(0)
LnM(II)
BpinMLnH Bpin H
HBpin
Ph
2-19
Ph Bpin
2-20
Ph
2-21
 23 
catalyst. This prediction was verified as copper(II) bromide and copper(II) acetate both increased 
the overall yield of the reaction (entries 4-5). The discrete IPrCuCl catalyst showed the highest 
isolable yield while maintaining high regioselectivity (entry 6). Although, the trade off between 
yield and regioselectivity could be argued between entry 4 and entry 6, a discrete NHC-copper(I) 
catalyst was chosen as it is commercially available and able to be conveniently synthesized on a 
multi-gram scale with relative ease. 
 
Table 2-2: Copper-NHC Optimization for Hydroboration of 2-19 
2.4 Mechanistic Hypothesis 
 The proposed mechanism for the hydroboration reaction is analogous to other copper-
catalyzed addition reactions conducted with bis(pinacolato)diboron (Scheme 2-6 A).27,39,40,78–81 
The active copper-boron species 2-22 coordinates to the olefin forming complex 2-23.  
Orientation of the olefin to the copper center leads to the regiodetermining step (2-23 to 2-24). 
Increasing the steric bulk of the NHC ligand disfavors the formation of the linear alkylborane 
aAll experiments were conducted at rt for 2 h at 0.2M under nitrogen atmosphere. Experiments used 
CH3OH (2 equiv). bLigand HCl salts were used with KO-t-Bu. cNMR yields are shown using 1,3,5-
trimethoxybenzene as internal standard. Regioselectivity ratios were determined on crude reaction 
mixtures. dIsolated.
NN
Cl
NN
Cl
IMes·HCl
SIPr·HCl
1
2
3
6
5
4
CuCl IMes
CuCl
CuCl
Cu(Cl)IPr
Cu(OAc)2
CuBr2
SIPr
SIPr
---
SIPr
SIPr
B2pin2
B2pin2
B2pin2
B2pin2
B2pin2
B2pin2
THF
THF
CH3CN
CH3CN
CH3CN
CH3CN
67:33 (3)
79:21 (48)
95:5 (52)
92:8  (81d)
93:7 (62)
96:4 (78)
Entry Catalyst Reagent Solvent 2-1:2-20(% yield)cLigandb
NN
Cl
IPr·HCl
Ph conditions
a
Ph Ph
Bpin Bpin+
2-1 2-202-19
 24 
due to the increased steric clash between the ligand and substrate 2-26a (Scheme 2-6 B). 
Complex 2-26b avoids the steric interaction between the ligand and the substrate leading to the 
desired secondary alkylborane. Rapid protonation of the copper-carbon bond of 2-24 results in 
the desired branched alkylborane and copper alkoxy species 2-25. To close the catalytic cycle, 2-
23 is generated when 2-24 reacts with another equivalent of olefin and bis(pinacolato)diboron. 
 
Scheme 2-6: (A) Mechanism for the Hydroboration of Terminal Olefins (B) Coordination of Olefin to Copper Complex 
for the Regio-Determining Step 
2.5 Reaction Scope 
 Investigation into the scope of the copper-catalyzed hydroboration included a wide 
variety of functional groups (Scheme 2-7). A remote phenyl group is not needed to achieve high 
selectivity as 1-octene readily underwent hydroboration to 2-27 with 94:6 regioselectivity in 73% 
yield. Allylic branching of the olefin was tolerated (2-28), although regioselectivity was slightly 
R
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+
Bpin Bpin
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Bpin
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deteriorated to 87:13. Tri-substituted (2-29) and 1,1-disubsituted (2-30) olefins were tolerated 
with good yields and high regioselectivity, indicating that these olefins were inert to these 
reaction conditions. Benzyl- and silyl-ethers (2-31 and 2-32, respectively) performed well; 
however, synthesis of 2-33 demonstrated alcohols are also tolerated in these reaction conditions. 
Although this was not a surprising result, other previously mentioned methods for the synthesis 
of branched alkylboranes do not tolerate free alcohols – therefore, by tolerating free alcohols 
these reaction conditions expand the types of secondary alkylboranes that can be synthesized. 
Pivalates (2-34) were not observed to undergo transesterification, and the inclusion of aryl 
bromides into substrate 2-35 provides two different sites that may undergo further 
functionalization selectively depending upon the choice of cross-coupling reaction conditions. 
Allyl derived substrates 2-36 and 2-37 gave high selectivity for the branched secondary 
alkylborane without observation of racemization of the double bond to give the 3-borylated 
product. Higher catalyst loadings were required to provide adequate transformation of substrates 
bearing indole heterocycles 2-38 and 2-39. 
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Scheme 2-7: Substrate Scope for the Copper-Catalyzed Formal Hydroboration Reaction 
2.6 Cross-Coupling of Newly Synthesized Secondary Alkylborane 
The development of a streamlined approach for the synthesis of secondary alkylboranes 
supports the advancement for Suzuki-type cross-coupling reactions. In particular, Molander’s 
dual catalyst photocatalytic cross-coupling demonstrates the utility of secondary alkyl 
trifluoroborate salts (Scheme 2-8 A),48 which themselves may be readily converted from pinacol 
boronic esters such as those described in the methodology outlined above. The mechanism for 
the cross-coupling reaction involves two catalytic cycles working in tandem (Scheme 2-8 B). 
Excitation of iridium catalyst 2-40, allows 2-41 to undergo a single electron transfer with the 
secondary trifluoroborate species 2-42 resulting in radical 2-43 and reduced iridium 2-44. 
Radical 2-43 combines with nickel(0) species 2-45 forming nickel(I) complex 2-46. Oxidative 
addition into the aryl halide results in nickel(III) complex 2-48. It is possible for the oxidative 
Ph
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Bpin
Br
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TBSO
Bpin
Ph
Bpin
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Bpin Bpin
BnO
Bpin
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Bpin
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Bpin
Bpin
2-1
81%, 92:8
2-27
73%, 94:6
2-28
98%, 87:13
2-29
81%, >98:2 (dr 1:1)
2-31
83%, 92:8
2-32
92%, 90:10
2-33
88%, >98:2
2-34
73%, 92:8
2-36
98%, 95:5
2-37
77%, >98:2
2-35
92%, 90:10
2-38
56%, 96:4a
BpinIPrCuCl (10 mol %)
KO-t-Bu (1.5 equiv)
CH3OH (2.0 equiv)
CH3CN, rt, 2 h
R R
 a20 mol % IPrCuCl. b15 mol % IPrCuClN Bpin
2-39
79%, 94:6b
+ B2pin2
Bpin
2-30
79%, >98:2
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addition to the nickel center to occur before addition of the radical; however, both are plausible 
pathways.82 Rapid reductive elimination releases desired coupled product 2-49 and nickel(I) 
species 2-50. Another single electron transfer between 2-50 and 2-44 closes both catalytic cycles. 
 
Scheme 2-8: (A) Conditions for Photocatalytic Cross-Coupling of Secondary Alkyl Trifluoroborate Salts and Aryl Halides 
(B) Mechanism for Photocatalytic Cross-Coupling 
 Pinacol boronic esters 2-1, 2-33, 2-34 and 2-39 were readily converted to their respective 
trifluoroborate salts using potassium hydrogen difluoride in a mixture of acetone and water. 
These salts were subsequently subjected to the photocatalytic cross-coupling reaction conditions 
proposed by Molander (Scheme 2-9). Gratifyingly, the trifluoroborate salt derived from 2-1 
underwent cross-coupling to 2-52 without observation of isomerization to the benzylic position. 
Heterocycles, as well as both electron-withdrawing and electron-donating aryl halides were 
proficient in the formation of new carbon-carbon bond forming products, 2-53 through 2-55. 
 28 
More interestingly, products that contained free alcohols, 2-56, and esters, 2-57, were isolated, 
displaying the utility of the formal hydroarylation of the starting olefin. Lastly, heterocycles 
incorporated in the trifluoroborate salts coupling partner were tolerated, 2-58. 
 
Scheme 2-9: Photocatalytic Cross-Coupling of Newly Synthesized Trifluoroborate Salts. Note: Reported Yields 
Correspond to the Cross-Coupling Step. 
2.7 Enantioselective Hydroboration of Terminal Olefins 
 As mentioned previously (Scheme 2-1), most transformations of alkylboronic pinacol 
esters are stereoretentive, maintaining the original identity of the carbon-boron bond. Installing 
enantioenriched carbon-boron bonds using chiral boron reagents has been demonstrated as a 
powerful method to build up molecular complexity.54,56,83 Hartwig has demonstrated that chiral 
copper-phosphine catalysts are proficient in installing boranes with high enantioselectivity, 
through the use of a directing group on the olefin.37 However, one of the most powerful advances 
was introduced by Hoveyda and coworkers when they demonstrated that a chelating chiral 
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copper-NHC complex readily performs asymmetric hydroboration on styrene derivatives26,27 and 
other activated olefins.84,85  
Using these examples as motivation, investigation into enantioselective hydroboration 
began with chiral copper-NHC catalysts (Scheme 2-10). In order to analyze the results of these 
chiral reactions via SFC (supercritical fluid chromatography) or HPLC (high-performance liquid 
chromatography), oxidation of the chiral alkylborane to a chiral alcohol was required (see 
Chapter 6 for more details). Chelating ligands 2-59 and 2-60 were synthesized and used in the 
aforementioned hydroboration method. Ligand 2-59 showed promise as 24% enantioselectivity 
was obtained; however, regioselectivity eroded to 86:14. Changing the non-chelating aryl group 
of the NHC to a biphenyl derivative decreased both enatioselectivity and regioselectivity to 13% 
and 79:13, respectively. Decreasing reaction temperature to -35 °C improved neither the 
enantioselectivity nor the regioselectivity. Previously, the Montgomery group has demonstrated 
that large NHCs with chiral backbones control regioselectivity and induce enatioselectivity for 
reductive couplings of alkynes and aldehydes.86 Using the analogous chiral IPr ligand, 2-61, low 
enantioselectivity was observed (8%) but high regiocontrol and reactivity were restored. 
Incorporating another iso-propyl group to the para-position of the aryl groups on the NHC, 
discrete copper complex 2-62 was synthesized to examine the enantioselectivity in varying 
solvents. In tetrahydrofuran, toluene, and acetonitrile the enantioselectivity was poor but the 
regioselectivity nevertheless remained high. 
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Scheme 2-10: Investigation into Enantioselective Hydroboration of Terminal Olefins 
 Further investigation into the enantioselective hydroboration of terminal olefins ceased as 
two attractive methods were published for this exact transformation. The first, by Aggarwal, 
detailed the development of a rhodium-catalyzed method using Nishiyama’s catalyst.87 The other 
methodology was reported using a chiral copper-NHC complex; however, the chirality was not 
on the backbone of the ligand and rather on the aryl groups derived from aniline.31 
2.8 Progress Towards Regioselective Hydroboration of 1,2-Disubstituted Olefins 
 Recent advances in metal-catalyzed hydroboration of 1,2-disubsituted olefins often 
involve isomerization of the olefin to the terminal position before hydroboration occurs, resulting 
in the synthesis of linear alkylboranes.88–92 Despite the prevalence of such transformations, 
N N
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iPr
iPr
iPr
iPr
N N
PhPh iPr
iPr
iPr
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CH3CN: 33%, 95:5, 2% ee
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Hartwig demonstrated a copper-catalyzed hydroboration of internal olefins that do not undergo 
olefin isomerization (Scheme 2-11).37 In this methodology, a remote directing group in 
unsymmetrical olefins was used to control the regioselectivity of the reactions; notably, a few 
examples were provided in which symmetrical olefins in the absence directing groups performed 
well under the non-regioselective hydroboration reaction conditions. While this methodology 
addresses both olefin isomerization and the hydroboration of unactivated symmetrical olefins, 
there is still a gap in the literature for the regioselective hydroboration of unactivated, 
asymmetrical olefins. 
 
Scheme 2-11: Hartwig’s Directing Group Regiocontrolled Hydroboration of Internal Olefins 
 For this study, 2-ocetene (2-63) was chosen as the model substrate because the olefin was 
not activated, and distinguishing between a methyl group and a longer, linear alkyl chain makes 
analysis of products significantly easier. Both the trans- and cis-isomers are commercially 
available, and standards of 2-27a-d for rapid analysis via GCFID are synthesized in a facile 
manner (see Chapter 6 for more information).37,93 Initially, the previously established copper-
catalyzed hydroboration conditions for terminal olefins were examined (Table 2-3). Trans-2-63 
in both acetonitrile and dichloromethane did not result in any hydroboration products (entries1-
2). Similarly, cis-2-63 also did not result in hydroboration products (entries 3-4). 
R DG + HBpin
2.5-10 mol % CuCl
5-20 mol % KO-t-Bu
3-11 mol % (S)-DTBM-SEGPHOS
cyclohexane, rt
R DG
Bpin
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Table 2-3: Copper-Catalyzed Hydroboration of 2-Octene 
 Using pinacol borane as the boron and proton source, vast investigation into other metal 
and ligand sources were examined and are summarized in Table 2-4 (see Chapter 6 for more 
extensive data). Hartwig’s hydroboration conditions resulted in incorporation to the a, b, and c 
positions without showing regioselectivity between the b and c positions (entry 1). Olefin 
isomerization was observed using both a cobalt and iron catalyst with ligand 2-64 as 2-27a was 
the exclusive product formed (entries 2-3). Pd(OAc)2 with ligand 2-65 in toluene at 100 °C 
resulted in the best regioselectivity for the b/c position; however, there was no selectivity 
between the two positions (entry 4). Decreasing the temperature to 80 °C to try and minimize 
olefin isomerization decreased overall reactivity (entry 5). Changing solvents to tetrahydrofuran 
also resulted in decreased reactivity and higher olefin isomerization, as more 2-27a was observed 
(entry 6). Moving to a palladium(0) source, Pd2(dba)3 with ligand 2-66 showed comparable 
reactivity but higher olefin isomerization (entry 7). NiCl2·dme resulted in the highest reactivity 
and highest selectivity for branched isomers 2-27b-d; however, control over the regioselectivity 
was minimal (entry 8). 
IPrCuCl (10 mol %)
KO-t-Bu (1.5 equiv)
MeOH (2.0 equiv)B2pin2
2.0 equiv solvent, rt
Entry trans/cis solvent yield
1
2
3
trans
trans
cis
0%
0%
0%
4 cis 0%
CH3CN
CH3CN
2-63
Bpin
2-27
a
b
c d
CH2Cl2
CH2Cl2
+
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Table 2-4: Investigation into the Hydroboration of 1,2-Disubstituted Olefins 
2.9 Progress Towards the Synthesis of Tertiary Alkylboranes 
 As mentioned previously, secondary alkylboranes can be synthesized via nickel or iron 
cross-coupling between an alkyl halide and a boron reagent; additionally, tertiary alkylboranes 
have been synthesized in an analogous manner.68 While this method has been powerful, 
regioselective hydroboration of 1,1-disubstituted olefins would provide a complementary 
method. Furthermore, Molander developed a photocatalytic cross-coupling reaction using 
tertiary alkyl trifluoroborate salts, but again scope is limited due to narrow methodology for the 
synthesis of tertiary alkylboranes.94 The goal of this project is to develop a hydroboration 
Metal (10 mol %)
Ligand (12 mol %)HBpin
solvent, temp
Entry Metal Ligand a:b:c:d
1
2
4
CuCla
CoI2b
Pd(OAc)2a
2-64
7 Pd2(dba)3a,c 2-66
(S)-DTBM-SEGPHOS
2-65
GCFID yield
13:47:41:0 <1%:2%:2%:0%
Solvent Temp
cyclohexane rt
PhMe 60 °C 100:0:0:0 55% (isolated)
PhMe 100 °C 19:39:40:3 11%:23%:24%:2%
Ph N NH
Ph
P
2-64
N NnBu
Cl
2-65
PhMe 100 °C 60:22:14:4 34%:12%:8%:2%
8 NiCl2·dmea 2-66 PhMe 100 °C 12:27:34:27 11%:25%:31%:25%
N
N
O
O
Cl
2-66
a12 mol % NaO-t-Bu added b30 mol % LiBHEt3 added c5 mol % catalyst loading
3 Fe(OAc)2b 2-64 PhMe 60 °C 100:0:0:0 trace
5 Pd(OAc)2a 2-65 PhMe 80 °C 31:17:20:32 3%:2%:2%:3%
6 Pd(OAc)2a 2-65 THF 80 °C 70:13:6:10 2%:<1%:<1%:<1%
Bpin
2-27
a
b
c d
+
2-63
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methodology that utilizes 1,1-disubsituted olefins that provides precursors for photocatalytic 
cross-coupling (Scheme 2-12). 
 
Scheme 2-12: Project Goals for Hydroboration of 1,1-Disubstituted Olefins 
Investigation for regioselective hydroboration of 2-67 (Table 2-5) began with reaction 
conditions previously optimized for terminal olefins. Unfortunately, no desired product was 
observed using these reaction conditions (entry 1). Use of dichloromethane in lieu of acetonitrile 
resulted in 12% product formation and a 94:6 regioselectivity (entry 2). Changing the counter ion 
of the base from potassium to sodium increased the yield of the reaction drastically to 77%, 
although regioselectivity slightly deteriorated to 87:13 (entry 3). Increasing the equivalents of 
sodium tert-butoxide from 1.5 to 2.0 began to shut down the reaction (entry 4), but decreasing to 
1.0 equivalent increased both reactivity and regioselectivity (entry 5). Again, these optimized 
conditions resulted in no observation of desired product when run with acetonitrile as the solvent 
(entry 6). 
Ir Ni
Ph
R''
Ph
BF3K
Ph
hydroboration
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Table 2-5: Optimization of Hydroboration for 1,1-Disubstituted Olefins 
 Examining the effects of the substituents on the olefin, when the methyl group was 
extended to the ethyl group (2-70) a decrease in yield was observed (Scheme 2-13). This 
decrease in yield suggests the steric bulk of the olefin may play a role in the ability of the active 
catalyst to coordinate. At present, the nature of the solvent, the base (and equivalence), and the 
steric attributes of the olefin all significantly impact the desired hydroboration transformation. 
 
Scheme 2-13: Hydroboration of 2-70 
2.10 Conclusion and Future Directions for Hydroboration of Olefins 
 Overall, conditions were established for efficient synthesis of branched, secondary, 
alkylboranes from terminal olefins. This method has shown how rapid complexity of simple 
commodity feedstocks is established as new carbon-carbon bonds are formed in a three-step 
process. Moving to other olefin classes continues to provide a difficult challenge. The lack of 
directing groups or electronic bias in the hydroboration of 1,2-disubstitued olefins remains 
difficult, as not only regioselectivity but also olefin isomerization is difficult to control.  
Ph Ph Ph Bpin
+
Entry Solvent Equiv. Base Yieldb 2-68:2-69c
1
2
3
4
5
6
Base
KO-t-Bu 1.5 0% -
KO-t-Bu 1.5 12% 94:6
CH2Cl2
CH2Cl2
NaO-t-Bu
NaO-t-Bu
1.5
2.0
77%
46%
87:13
80:20
CH2Cl2
CH3CN
NaO-t-Bu
NaO-t-Bu
1.0
1.0
87%
0%
91:9
-
aAll experiments were conducted at rt for 2 h at 0.2 M under nitrogen atmosphere.  bIsolated. 
cRegioselectivity ratios were determined on crude reaction mixtures.
Bpin
IPrCuCl (10 mol %)
base
MeOH (2.0 equiv)
solvent, rt, 2 h2-67 2-68 2-69
CH3CN
CH2Cl2
IPrCuCl (10 mol %)
NaO-t-Bu (1.0 equiv)
CH3OH (2.0 equiv)
CH2Cl2, rt, 2 h
+ B2pin2
Ph
Bpin
2-71
59% 97:3
Ph
2-70
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Hydroboration of 1,1-disubsituted olefins provides its own challenges as well. Seemingly small 
differences (such as the base counter ion) result in large differences in reactivity. Furthermore, 
the steric character of the substituents of the olefin drastically impacts the efficiency of the 
reaction. 
 The most direct path for future hydroboration work will be investigating the differences 
in the 1,1-disubstituted reaction conditions from the monosubstituted reaction conditions. 
Expansion of the substrate scope to include a variety of functional groups highlighting 
chemoselectivity would increase the attractiveness of the reaction. Furthermore, transforming the 
newly synthesized tertiary pinacol esters to the corresponding trifluoroborate salts would provide 
access to cross-coupling partners for photocatalysis similar to that demonstrated with secondary 
alkylboranes. It is unclear the direct path to take for regioselective hydroboration of 1,2-
disubstituted olefins as olefin isomerization is a large barrier to overcome, not to mention the 
subtle variation in substituents that need to be differentiated. 
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 Chapter 3 Introduction to Intramolecular Aglycone Delivery and Glycoside Activation 
 
3.1 Factors that Affect Glycosylation Reactions 
O-Glycosides are present in a number of natural products, which possess antibiotic 
properties.95 Two of the most common monosacharrides are glucose and mannose, a C-2 epimer 
of glucose. The positioning of the anomeric oxygen relative to the C-2 substituent partially 
defines the name of the glycoside, resulting in four different combinations α-1,2-cis glucose, β-
1,2-trans glucose, β-1,2-cis mannose and α-1,2-trans mannose (Figure 3-1). The difference in 
orientation between 1,2-cis glycosides and 1,2-trans glycosides is significant, and results in very 
different properties. One example of the major effects of these properties is in comparing 
polymers of glucose in nature. Polymeric 1,2-cis glycosides take the form of amylose (starch), 
which is the sweet taste in potatoes; on the other hand, polymeric 1,2-trans glycoside bears the 
structure of cellulose, which gives wood its structure.96 
 
Figure 3-1: Common 1,2-cis and 1,2-trans glycosides 
 Due to the importance of the stereochemical layout at the anomeric carbon, methods to 
synthesize both the trans and cis glucoside have been of interest. One of the first insights into 
controlled glycosylation is credited to Koenigs and Knorr.97 In this reaction, the anomeric 
bromide in bromosugar 3-1 was replaced with an alcohol through the use of a silver carbonate 
promoter (Scheme 3-1). The protecting group on the C-2 alcohol plays a major role in the 
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stereochemical outcome. If the protecting group employed was acetate, neighboring group 
participation through a cyclic intermediate 3-2 results in exclusive addition of the alcohol trans to 
the C-2 position, 3-3. However, if the neighboring group could not participate in the reaction 
such as a benzyl group, a mixture of anomers were observed favoring the 1,2-cis product 3-4. 
 
Scheme 3-1: Koenigs and Knorr Glycosylation Reaction with Mechanism 
 Neighboring group participation is one of the most common methods to synthesize 1,2-
trans glycosides. However, 1,2-cis glycosides provide a different challenge, as there are many 
factors involved that affect the stereochemical outcome at the anomeric position (Scheme 3-2).98 
The anomeric effect itself plays a major role in glycosylation reactions, as thermodynamic 
conditions lead to the more stable anomer. Temperature, pressure, additives and concentration of 
the reaction are just a few of the myriad alterations to reaction conditions that affect the 
glycosylation reaction. In addition to changing conditions, the structure of the starting 
carbohydrate also plays a role in reactivity. Long-range group participation (Scheme 3-2 B), 
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similar to neighboring group participation but from another protected alcohol, and steric 
hindrance (Scheme 3-2 C) from the alcohol protecting groups – more specifically, the C-6 
substituent – have potential to inhibit the attack of the incoming alcohol. Coordination of solvent 
to the intermediate oxocarbenium ion additionally affects the stereochemical outcome of the 
glycosylation reaction (Scheme 3-2 D). The identity of the leaving group affects the mode of 
glycosylation (Scheme 3-2 E). Furthermore, indirect aglycone deliveries (Scheme 3-2 F) such as 
intramolecular aglycone delivery, ‘molecular clamp’ methods, and leaving group-based methods 
are powerful techniques to control glycosylation reactions. Most relevant to the work presented 
in the following chapter, intramolecular aglycone delivery and leaving group identity will be 
discussed further. 
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Scheme 3-2: Factors that Affect Glycosylation Reactions 
3.2 Indirect Glycosylation Methods Via Intramolecular Aglycone Delivery 
Intramolecular aglycone delivery is a very straightforward and powerful method for 
synthesizing 1,2-cis glycosides with high stereochemical control (Scheme 3-3). This process 
begins with tethering of the aglycone to the starting substrate. This either occurs in a ‘forward’ 
tethering manner – where the sugar molecule acts as the electrophile and the external alcohol is 
the nucleophile – or in a ‘reverse’ tethering manner – where the aglycone is the electrophile and 
the sugar is the nucleophilic alcohol. Regardless of the method chosen, both methods arrive at 
the tethering aglycone-sugar species 3-6. Activation of intermediate 3-6 and delivery of the 
aglycone from the same side of the tether forms the 1,2-cis-glycosidic bond (3-7). Hydrolysis to 
the free C-2 hydroxyl group 3-8 completes the intramolecular aglycone delivery process. 
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Scheme 3-3: General Scheme for Intramolecular Aglycone Delivery 
Intramolecular aglycone delivery was first introduced by Hindsgaul and Barresi in the 
early 1990s (Scheme 3-4).99 Using an acid-catalyzed ‘forward’ tethering, mixed acetal 3-10 was 
synthesized. Subsequently, use of N-iodosuccinimide (NIS) as an activator promotes exclusive 
formation of 3-8. Addition of di-tert-butyl methyl pyridine (DTBMP) increased glycosylation 
yields by inhibiting the breakdown of the mixed acetal. Mechanistic studies revealed that more 
sterically hindered mixed acetals were converted in situ to less sterically hindered alcohols under 
aglycone delivery conditions, but the observed product was always a 1-2-cis glycoside – 
suggestive of an intramolecular SN2 type mechanism.100 Although this was the first introduction 
to intramolecular aglycone delivery, the scope was very limited, as increased steric bulk of the 
aglycone decreased the efficiency of the reaction and the reaction was limited to the mannose 
derived sugars.99–101  
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Scheme 3-4: Hindsgaul and Barresi Introduction of Intramolecular Aglycone Delivery 
 Fairbanks expanded upon Barresi and Hindsgaul’s work by using an iodonium tethering 
method to synthesize mixed acetals to be used in intramolecular aglycone deliveries (Scheme 
3-5).102 Using NIS and sugars similar to those used by Hindsgaul, tethering of primary and 
simple secondary alcohols was achieved in both the mannose and glucose sugar series. As both 
the tethering conditions and the aglycone delivery conditions were similar, a one-pot 
tethering/delivery approach was developed.103 Subsequently, a second generation method was 
developed using 1,2-disubstituted allyl groups to expand the scope to be able to tether more 
complex secondary alcohols.104,105 Although the use of 1,2-disubstituted allyl groups improved 
the original Fairbanks method, tethering of the alcohol was truncated before full conversion in 
order to preserve the aglycone delivery as the tethered compound decomposed – this resulted in 
lower conversions, which means the overall process was not as efficient. 
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Scheme 3-5: Fairbanks Iodonium Tethering for Intramolecular Aglycone Delivery 
 Ogawa and Ito have done extensive work using oxidative tethering methods for aglycone 
delivery.106–117 Uniformly, these methods make use of a para-methoxyphenyl group installed on 
the C-2 hydroxy position (3-16), which was oxidatively tethered using 2,3-dichloro-5,6-dicyano-
p-benzoquinone (DDQ) to form mixed acetal 3-17 that subsequently undergoes aglycone 
delivery (Scheme 3-6 A). Interestingly, the ‘forward’ tethering reaction arrives at the S-only 
diastereomer 3-18 while the ‘reverse’ tethering produced either the R-only diastereomer or a 
mixture of R and S 3-19 (Scheme 3-6 B).111 Although it is currently accepted that the tethering 
operates under kinetic conditions, it remains unclear what caused the stereoselectivity of the 
tethering. In certain cases, the identity of the tethered species does not affect the aglycone 
delivery, while in others it plays a significant role,111,114 indicating that the effectiveness of 
aglycone delivery is substrate dependent.  
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Scheme 3-6: (A) General Scheme for Oxidative Tethering and Aglycone Delivery (B) Affect of Tethering on the 
Stereochemical Outcome of the Mixed Acetal 
 Inspired by the initial groundwork laid by Ito and Ogawa, several advancements and 
applications have been developed using the oxidative tethering method for aglycone delivery. Ito 
and Ogawa have applied their method to a system involving a polymer support. The p-
alkoxybenzyl group was attached to both the C-2 position and polymer support 3-20 acts as a 
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“gatekeeper” – only releasing desired product from the aglycone delivery (Figure 3-2 A).118 
Bertozzi applied the oxidative tethering/intramolecular aglycone delivery method to the synthesis 
of the α,α-trehalose core of Sulfolipid-I (3-21) and its derivatives (Figure 3-2 B).119,120 
Establishing a synthetic pathway to Sulfolipid-I and its derviatives allowed for more extensive 
exploration into the biological activity since it is known that these compounds affect the human 
immune system. 
 
Figure 3-2: (A) Solid-Support for Oxidative Tethering/ Intramolecular Aglycone Delivery (B) Sulfolipid-I 
 Stork advanced the field by revealing that silicon tethers perform intramolecular aglycone 
deliveries after an in situ tethering of both alcohol components using dichlordimethylsilane and 
mannose-derived donor 3-22 (Scheme 3-7).121 He later demonstrated that the order of tethering 
and oxidation of the thioglycoside could be reversed.122 Simultaneously, Bols revealed that a 
similar silicon tethering intramolecular aglycone delivery technique was possible using glucose 
and galactose sugar donors.123,124 Furthermore, Bols extended the silicon tethering from the C-2 
alcohol to the C-3, and C-4 alcohols all of which successfully underwent intramolecular 
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aglycone delivery but not as cleanly.125Aglycone delivery after C-3 tethering resulted in a 
mixture of α/β selectivity (1:4), while delivery from C-4 tethering gave modest yields (45%), 
and delivery from C-6 tethering had high conversion but low desired product as the 1,6-
anhydrosugar was the major product. Advancement of silicon tethering for intramolecular 
aglycone delivery by the Montgomery group will be discussed in Chapter 4. 
 
Scheme 3-7: Silicon Tethering for Intramolecular Aglycone Delivery 
3.3 Anomeric Identity and Activation for the Synthesis of 1,2-cis Glycosides 
 The identity of the anomeric leaving group of the glycosyl donor is widely varied (Figure 
3-3).126 The earliest examples by Michael,127 Fischer,128 Koenigs and Knorr97 used bromides, 
chlorides, hemiacetals, and acetates as leaving groups for glycosylation reactions. For many 
years, these anomeric leaving groups were used to synthesize a variety of glycosylations 
spanning from simple bond formation to complex oligosaccharide synthesis. It was not until the 
1970’s that a deeper understanding of glycosylation caused exploration into new anomeric 
leaving groups on glycosyl donors, including the first examples of thioglycosides,129–131 O-
imidates132 and thioimidates.133 Consequently, glycoscience boomed and led to the development 
of many new anomeric leaving groups, as well as non-traditional glycosylation groups such as 
glycals134 and epoxides.135 While all of these glycosyl donors have their own niche in 
glycosylation reactions, focus herein will be on the activation of thioglycosides and alkenyl 
glycosides, as these anomeric groups are the most relevant to further discussion in Chapter 4. 
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Figure 3-3: Various Leaving Groups of Glycosyl Donors 
3.3.1 Activation of Alkenyl Glycosides 
A serendipitous reaction by Fraser-Reid led to the discovery of n-pentenyl glycosides as 
efficient glycosylation partners. During the synthesis of the ansa chain of streptovarcin, 
compound 3-25 was subjected to a mixture of N-bromosuccinimide (NBS) in water in attempts 
to form the bromohydrin – but rather than the expected product, 3-26 was isolated (Scheme 
3-8).136,137  
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Scheme 3-8: Fraser-Reid Serendipitous Discovery 
This unforeseen reactivity was further explored using formal carbohydrates with a pent-
4-enyl group (also known as n-pentenyl glycosides) and different alcohol protecting groups. 
Observations led to the hypothesis that the n-pentenyl glycosides can undergo glycosylation to 
the hemi-acetal; however, the protecting group of the alcohols has a major effect on the relative 
rates of the reaction (Scheme 3-9). Each reaction was stopped at approximately 50% conversion 
to determine relative rates of the reaction. Benzyl protected 3-27 only took 6 hours to reach 50% 
conversion while acetate protected 3-27 took 36 hours to reach the same point.138  
 
Scheme 3-9: Relative Rates of Glycosylation Reactions of n-Pentenyl Glycosides Affected by Alcohol Protecting Group 
The differences in rates supported the formation of an oxocarbenium ion, which was 
stabilized by the alcohol protecting groups protecting and the concept of armed/disarmed was 
introduced. An armed glycosyl donor refers to the oxocarbenium ion being stabilized by the 
electron donating capabilities of the protecting groups, whereas disarmed refers to the instability 
of the oxocarbenium ion due to the electron withdrawing effects of the protecting group.139 
Typically, an armed glycosyl donor and a disarmed glycosyl acceptor favor facile glycosylation 
formation. The accepted mechanism for the glycosylation reaction with n-pentenyl glycosides is 
shown below in Scheme 3-10. The alkene of n-pentenyl glycoside 3-27 forms bromonium ion 3-
29 in the presence of NBS. The bromonium ion is then opened with the anomeric oxygen 
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forming furanylium 3-30. Here, the alcohol protecting groups affect the rate of formation of 
oxocarbenium ion 3-31, which undergoes glycosylation. By-product 3-32 is volatile and does not 
interfere with the desired reaction.  
 
Scheme 3-10: Mechanism of Glycosylation with n-Pentenyl Glycosides 
 Fraser-Reid’s work with n-pentenyl glycosides inspired many others to advance latent-
active glycosylation methods (Scheme 3-11). In 1997, Mukai, Hanaoka and coworkers published 
a glycosylation method wherein a dicobalthexacarbonyl-complexed propynyl ether derivative – 
once activated with a Lewis acid – produced the desired glycosylation product and a cobalt-
complexed γ-lactone (Scheme 3-11 A).140 Yields of glycosylation were modest, but α/β 
selectivity was variable. A few years later in 2001, Kim reported a latent-active glycosylation via 
activation of 2-(hydroxycarbonyl)benzyl glycosides (Scheme 3-11 B).141 Kim’s glycosylation 
reaction has good stereoselectivity, as β-mannosides and α-glucosides were at times exclusively 
formed, successfully synthesizing 1,2-cis glycosides via an intermolecular glycosylation 
reaction. Subsequent investigations by Hotha demonstrated that gold affinity for alkynes could 
be used for activation of propargyl glycosides (Scheme 3-11 C).142 Heating this reaction to 60 °C 
increases the rate of production of the desired glycoside and methyleneoxirane which can further 
rearrange to the unreactive cyclopropanone. Follow up studies demonstrated how activation of 
propargyl alkynes with AuBr3 was orthogonal to activation of n-pentenyl glycosides with 
O
RO
RO
RO
OR
O
3-27
NBS O
RO
RO
RO
OR
O
3-29
Br
O
RO
RO
RO
OR
O
3-30
Br
O
RO
RO
RO
OR
3-31
O
Br
O
RO
RO
RO
OR
OH
3-28 3-32
 50 
NIS/TMSOTf.143 In 2015, Yu furthered the activation of alkynes for glycosylation when ortho-
(methyltosylaminoethynyl)benzyl glycosides were activated with trimethylsiyl 
trilfuromethanesulfonate (TMSOTf) (Scheme 3-11 D).144 The reaction is believed to go through 
a keteniminium cation that is intramolecularly attacked with the anomeric oxygen forming a 1H-
isochromene. This method has been used for the synthesis of oligosaccharides. That same year, 
another latent-active glycosylation involving an interrupted Pummerer reaction was published by 
Wang (Scheme 3-11 E).145–147 The byproduct in the glycosylation reaction is 2-(2-
propylsulfinyl)benzyl alcohol which is one of the starting materials for synthesizing the original 
glycoside making the reaction very atom economical. 
 
Scheme 3-11: Various Latent-Active Glycosylation Reactions 
 As mentioned above, Fraser-Reid’s work inspired numerous latent-active glycosylations 
with his serendipitous discovery that n-pentenyl glycosides underwent glycosylation when 
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exposed to NBS. Thus far, there are no reports of intramolecular glycosylations using latent-
activation methods.  
3.3.2 Recent Advances on Activation of Thioglycosides 
Seminal work by Ferrier129 and Garegg131 activated thioglycosides for glycosylation 
through the use of mercury (II) salts, which have high affinity for sulfur group complexation. 
Concurrently, Nicolaou reported activation of thioglycosides with N-bromosuccinimide and 4 Å 
MS.130 While these methods served as groundbreaking development in thioglycoside 
methodology, the toxicity of mercury salts means they tend to be avoided in chemical syntheses. 
Additionally, the α/β selectivity using these methods tends to be low. Over the years, other 
methods to activate thioglycosides have been developed and include the use of MeOTf,148,149 
dimethyl(methylthio)sulfonium triflate (DMTST),150 and iodonium dicollidine perchlorate 
(IDCP)151,152 (Figure 3-1) which are only a subset of the extensive list of thioglycoside 
activators153 where NIS and triflic acid (TfOH) are the most commonly used activators.154 Even 
though there is an extensive repertoire of thioglycoside activators, there is still a push to find new 
methods of activation that eliminate toxic chemicals, expand the scope of glycosylations, and 
avoid sub-ambient temperatures. 
 
Figure 3-4: Structures of DMTST and IDCP 
 In glycosylation reactions, rigorously anhydrous conditions are needed due to water 
competing as the glycosyl acceptor, which inhibits desired glycosylation reactions. Often, 
molecular sieves are used to ensure dry reaction conditions. Lee showed how acid washed 
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molecular sieves could play a dual role in addition to drying the reaction (Scheme 3-12).154 
When paired with NIS, acid washed (AW)-300 molecular sieves (MS) activate thioglycosyl 
donor 3-33 and glycosyl acceptor 3-34 forming 3-35 in 86% yield with 1:1.6 α:β selectivity. 
When compared to standard activation conditions of NIS/TfOH, comparable yields were 
obtained, although a switch in α:β selectivity was observed – indicating TfOH and AW-300 MS 
play a role in the α/β selectivity of the reaction. Furthermore, the NIS/AW300-MS methodology 
could be applied to a one-pot synthesis of a branched trisaccharide starting with three distinct 
sugar moieties.  
  
Scheme 3-12: Lee's Activation of Thioglycosides with NIS/AW-300 MS 
 In the mid 1990’s, Fukase demonstrated that hypervalent iodine PhIO – when paired with 
various inorganic Lewis acids (i.e. Sn(OTf)2, SnCl4-AgClO4, SbCl3-AgClO4) – activate 
thioglycosides forming new O-glycosides.155 Product α/β selectivity was affected by the identity 
of the Lewis acid(s) added to the reaction conditions. More recently, Kajimoto, Kita and 
coworkers eliminated the need for inorganic Lewis acids when phenyliodine(III) 
bis(trifluoroactate) (PIFA) and an organic Lewis acid (i.e. TfOH, TMSOTf) perform similar 
glycosylation reactions by activating thioglycosides.156 Typically, glycosylation reactions are 
performed with aforementioned “armed” donors (sugars with protected alcohols that stabilize the 
oxocarbenium ion) and “disarmed” acceptors (sugars with electron withdrawing groups that 
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destabilize the oxocarbenium ion); however, using PIFA “disarmed” thioglycoside donor 3-36 
and “armed” acceptor 3-37 proceeded in the glycosylation reaction in high yields (Scheme 3-13). 
 
Scheme 3-13: "Disarmed" Thioglycosyl Donor and "Armed" Acceptor Addition via Hypervalent Iodine 
 Applicability of hypervalent iodine as a thioglycoside activator for glycosylation helps 
attain the overarching goal of synthetic glycosciences: reproducibility of methodology. An 
iterative glycosylation-deprotection automatic flow system utilizing a water- and air-stable 
hypervalent iodine species was used to synthesize a β-1,6-glucan tetramer in 16% yield over 6 
steps.157 The reaction was optimized to maximize yield while minimizing undesirable by-
products by using strained olefins as acid scavengers instead of the typical amine bases seen in 
glycosylation reactions.   
 Distinct from NIS or hypervalent iodine compound use, another iodine activation method 
for thioglycosides is 1,3-diiodo-5,5-dimethylhydantoin (DIDMH).158 When paired with TfOH or 
AgOTf, glycosylation with thioglycoside 3-39 and L-menthol resulted in quantitative yields and 
increased α/β selectivity of 3-40 compared to typical NIS/TfOH methodology (Scheme 3-14). 
Furthermore, the authors note that using DIDMH is more atom economical, as one molecule of 
DIDMH can activate two thioglycosides as opposed to the single molecule activation of one 
molecule of NIS. 
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Scheme 3-14: Activation of Thioglycosides with DIDMH for Glycosylation 
 Although the use of iodine-based reagents (i.e., NIS, hypervalent iodine, or DIDMH) 
provides good yield and selectivity, halogenated starting materials require special waste disposal. 
Consequently, a push for methods of thioglycoside activation that do not use iodine reagents are 
of interest. Drawing inspiration from Mukai and Hanaoka’s latent-active glycosylation 
reaction,140 an intermolecular glycosylation using Co2(CO)6 propargyl cation as an activator was 
reported (Scheme 3-15 A).159 A propargyl Co2(CO)6 appended to glycosyl donor 3-42 was 
activated with TMSOTf, thereby initiating the glycosylation reaction with thioglycoside donor 3-
41 to form 3-43. The mechanism of this reaction involves cationic cobalt species 3-44, which 
undergoes nucleophilic attack by the sulfur forming oxocarbenium species 3-45, which forms the 
desired product with the depropargylated glycosyl donor (Scheme 3-15 B). This methodology 
provides efficient glycosylation reactions, as yields range from moderate to excellent; however, 
the α/β selectivity ranges from one anomer, to a mixture, to the other anomer. The shift in α/β 
selectivity indicates that the stereoselectivity of the reaction was dictated by the identity of the 
donor/acceptor, and not by the activation method. 
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Scheme 3-15: (A) Intermolecular Glycosylation Reaction Using Propargyl Co2(CO)6 as the Glycosyl Acceptor (B) 
Mechanism for Glycosylation Reaction using Propargyl Co2(CO)6 as Thioglycoside Activator 
 Intriguingly, several thioglycoside activations do not fully discriminate between ethyl 
thioglycosides and phenyl thioglycosides. An orthogonal approach to those outlined above which 
is able to discriminate between alkyl thioglycosides and phenyl thioglycosides provided the 
inspiration for developing an electropositive nitrogen promoter (Scheme 3-16).160 In combination 
with Cu(OTf)2, the soft Lewis acidity of O-mesitylenesulfonylhydroxylamine (MSH) 3-50 was 
able to activate the soft alkyl thioglycoside 3-48 – even in the presence of the phenyl 
thioglycoside 3-49 – forming 3-51 albeit in 50% yield. 
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Scheme 3-16: Selective Alkyl Thioglycosides Activation 
 In conclusion, there are a countless number of thioglycoside activation promoters for 
glycosylation reactions. Each method provides its own advantages or disadvantages; however, 
further investigation into thioglycosides activations would provide more atom economical or 
orthogonal alternatives to those currently in literature. 
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 Chapter 4 Advances in Intramolecular Aglycone Delivery via Latent-Activation 
 
4.1 Montgomery Group Contributions to Glycosciences via Synthesis of 1,2-cis- Glycosides 
As mentioned previously in Chapter 3, Stork laid the groundwork for the synthesis of 1,2-
cis glycosides by using a silicon group to tether a sugar and aglycone to enable glycosylations by 
intramolecular aglycone delivery.121 The Montgomery group has expanded upon this work with 
the synthesis of sugar silanes.161–163 Instead of a three-component synthesis with two alcohols 
and a silicon group to synthesize the precursor for aglycone delivery, the silane was attached to 
the sugar itself using dimethylchlorosilane (Scheme 4-1). Not only did this synthesis eliminate 
unproductive homocoupling of alcohols, this process additionally installed a silicon-hydride 
functionality that could be further exploited through its use in hydrosilylation,161 
dehydrogenative silylation,161,163 and reductive coupling162 reactions. The remainder of this 
introduction will focus on the application of hydrosilylation and dehydrogenative silylation 
pathways developed by the Montgomery group with sugar silane systems. 
 
Scheme 4-1: Synthesis of a Glucose Sugar Silane from a 2-Hydroxy Sugar 
 The Montgomery group demonstrated that in situ generation of a nickel-IMes complex 
catalyzes the hydrosilylation of ketones with the dimethyl sugar silane, tethering the aglycone to 
the sugar with 5:1 diastereoselectivity (Scheme 4-2).161 Using conditions similar to Stork’s 
glycosylation to activate the thioglycoside tethered substrate 4-4, the 1,2-cis glycoside was 
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achieved in high regioselectivity at the anomeric postition.161 Moreover, dehydrogenative 
silylation using a copper-IMes complex tethered the sugar silane with a free alcohol, which may 
then undergo aglycone delivery under analogous glycosylation conditions (Scheme 4-2).161 
These methods are orthogonal to one another in that the selected catalyst system will 
chemoselectively react in divergent pathways from one another. Substrate 4-3 contains both a 
ketone and alcohol functionality, but exclusively undergoes either hydrosilylation or 
dehydrogenative silylation based on choice of reaction conditions. Complementary to the copper-
IMes complex, which tethers primary and other simple alcohols well, dehydrogenative silylation 
of secondary and more complex alcohols was achieved using tris(pentafluorophenyl)borane as 
the catalyst.163 Lastly, delivery of the aglycone is not limited to the C-2 position of the sugar; C-6 
sugar silanes will also undergo tethering and aglycone delivery upon subjection to similar 
conditions, although specialized trans diol protecting groups are required.163 
 
Scheme 4-2: Dehydrogenative Silylation of Alcohols and Hydrosilylation of Ketones with Sugar Silanes 
 While the synthesis of sugar silanes introduced facile new ways to catalytically tether the 
aglycone species and expand the scope of the aglycone, there remains space to improve upon this 
methodology. Dimethyl sugar silanes are non-chromatographable, and deprotect on contact with 
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silica gel chromatography to the corresponding C2-alcohol. Additionally, dimethyl sugar silanes 
are not bench stable and require storage under vacuum or freezing in benzene to slow 
decomposition – neither option being ideal for the synthetic community. As a graduate student in 
the Montgomery group, Dr. Allison Knauff discovered that upon exchanging the dimethyl 
groups on the silane for diisopropyl groups, the sugar became chromatographable due to the 
increase of sterics around the silicon center – which is hypothesized to disrupt the hydrogen 
bonding-and acidity-based degradation effects of silica gel chromatography (Figure 4-1).164 
Bench stability of diisopropyl sugar silanes is substantially greater than the related dimethyl 
sugar silanes, as they can be stored in a desiccator for several months without noticeable 
deterioration in reactivity. 
 
Figure 4-1: Diisopropyl Thiosugar Silanes 
 While increased bench stability was one of the goals to improving existing sugar silane 
methodology, this increase in bench stability carried with it an inherent increase in stability of 
the silicon-hydride bond – thereby decreasing the reactivity of the sugar silanes. Simple alcohols 
could be tethered readily; however, more complex secondary alcohols – such as menthol – 
required more forceful conditions. Upon generation of the menthol-tethered sugar silane, it was 
observed that the identity of the thiol-leaving group played a role in the efficiency of subsequent 
aglycone delivery (Scheme 4-3). The thiophenyl-tethered silane 4-12 was superior to the 
thioethyl-tethered silane 4-10, increasing the yield of aglycone delivery from 17% to 52%.  
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Scheme 4-3: The Effect of the Thiol Leaving Group on Aglycone Delivery 
 At this point, the mechanism of aglycone delivery is still not fully understood (Scheme 
4-4). What has been accepted is that TMSOTf activates N-iodosuccinimide, increasing reactivity 
and generating a much more electrophilic iodine species, which can be attacked by the 
nucleophilic sulfur atom from thioglycoside 4-13. From activated thioglycoside 4-14, there are 
two potential possibilities: (a) An SN2-like attack of the aglycone results in the formation of 
cationic silicon species 4-15a, which upon addition of Bu4NF results in the desired 1,2-cis 
glycoside product, or (b) an SN1-like pathway thought to proceed via oxocarbenium ion structure 
4-15b, which would be susceptible to nucleophilic attack from the aglycone resulting in the same 
cationic silicon species as described above (4-15a). It is important to note that both pathways 
liberate an activated thiol species, which is non-innocent at times and can result in non-
productive pathways that are harmful to the aglycone delivery process.165 It is hypothesized that 
the true mechanistic pathway contains characteristics of both of the aforementioned possible 
pathways, potentially incorporating a tight ion pair interaction, which would help explain why 
the identity of the thio-leaving group is significant. Further computations and mechanistic studies 
need to be performed in order to probe these mechanistic hypotheses.  
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Scheme 4-4: Potential Mechanistic Pathways for Aglycone Delivery 
4.2 Motivation and Project Goals 
As developments outlined in Section 4.1 have highlighted, alkyl groups on the silicon 
dictate stability of the sugar silane. As efficient aglycone delivery relies on the nature of the 
leaving group at the anomeric position, other classes of leaving groups is one option to explore to 
increase the efficiency of the intramolecular aglycone delivery. Recently, the Sun group reported 
an intermolecular O-glycosylation reaction using an o-(p-methoxyphenylethynyl)phenyl group as 
the leaving group (Scheme 4-5 A).166 Using the same TMSOTf/NIS activated electrophilic 
iodine source as previously published by Montgomery, the nucleophilic alkyne from 4-16 attacks 
the iodine forming vinyl cation 4-18. Cyclization from the anomeric oxygen to the vinyl cation 
results in oxocarbenium ion 4-20 and benzofuran byproduct 4-19 (Scheme 4-5 B). Compound 4-
20 then proceeds to intermolecular glycosylation. Isolation and characterization of 4-19 indicates 
that the benzofuran byproduct remains inert under glycosylation reaction conditions. 
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Scheme 4-5: A) Sun's Intermolecular Glycosylation B) Proposed Mechanism for Sun's Intermolecular Glycosylation 
 Based on Sun’s and Montgomery’s prior results, it was hypothesized that by combining 
the use of diisopropyl groups to increase stability and the o-(p-methoxyphenylethynyl)phenyl 
group as the leaving group to eliminate by-product interference, more efficient intramolecular 
glycosylation could be achieved. The goal of this project is to explore the reactivity and stability 
of sugar silanes that contain the o-(p-methoxyphenylethynyl)phenyl leaving group (4-21, 4-22) 
in efforts to increase the scope and user-friendliness of sugar silane chemistry for aglycone 
delivery (Figure 4-2). 
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Figure 4-2: New Sugar Silanes 
4.3 Continued Progress Towards Bench Stable Sugar Silanes 
4.3.1 Synthesis of Mannose Sugar Silanes 
The synthesis of C-2 hydroxy mannose with the o-(p-methoxyphenylethynyl)phenyl 
leaving group was achieved in seven steps with five discrete isolations (Scheme 4-6). 
Commercially available D-(+)-mannose was globally protected and α-brominated to generate 
polyacetylated bromosugar 4-23. Subsequently, 4-23 was transformed to orthoformate 4-24 
before protecting group manipulation generated benzyl protected 4-25. Opening of orthoformate 
4-25 with 2-iodophenol led to the α-anomer 4-26. Upon deprotection of the C-2 alcohol, 4-27 
was used as a cross-coupling partner with para-methoxyphenyl acetylene in a Sonogashira cross-
coupling reaction affording 4-28. Although the synthesis was straightforward, future 
optimization of a more convergent synthesis would eliminate one step and address some of the 
purification issues. For instance, performing the Sonogashira cross-coupling on 2-iodophenol 
before addition to 4-25 may help reduce the palladium byproducts that tend to be difficult to 
remove.  
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Scheme 4-6: Synthesis of 2-Hydroxy Mannose Sugar Silane Precursor 
 Using reaction conditions previously established by the Montgomery lab,161 4-28 was 
then transformed to the desired sugar silane substrates (Scheme 4-7). After a liquid-liquid 
extraction, dimethyl sugar silane 4-29 was isolated as viscous yellow oil that was used without 
further purification. The yellow discoloration was attributed to NMR-silent impurities from the 
Sonogashira cross-coupling reaction, as diisopropyl sugar silane 4-21 was chromatographable 
(silica gel) and isolated as a white crystalline solid. Diisopropyl sugar silane 4-21 was found to 
be bench stable, as decomposition was not observed after being left open to air at room 
temperature for several months. While the yields of 4-29 and 4-21 were above 80%, diisobutyl 
sugar silane 4-30 was isolated after silica gel chromatography in 47% yield. Low yields are 
attributed to semi-stability upon exposure to silica gel. Diisobutyl sugar silane 4-30 could be 
isolated from silica gel chromatography if a small amount was exposed for a short period of 
time. However, prolonged exposure to silica gel resulted in decomposition of 4-30 to the 
diisobutyl silyloxane and 4-28. Despite this drawback, there is no further observed effect on the 
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bench stability of 4-30, as several months storage in the freezer did not result in decomposition 
or decreased reactivity. 
 
Scheme 4-7: Synthesis of Several Mannose Sugar Silanes 
4.3.2 Synthesis of Glucose Sugar Silanes 
The synthesis of glucose-derived sugar silanes was initially analogous to the synthesis of 
mannose sugar silanes described above (Scheme 4-8). Glucose pentaacetate is not only 
commercially available but is inexpensive to begin the synthesis here rather than performing the 
global protection on glucose. Glucose pentaacetate was α-brominated then transformed to the 
orthoformate 4-31 in 68% yield over two steps. Protecting group manipulation to the benzyl-
protected sugar 4-32 was achieved in high yield (92%). 
 
Scheme 4-8: First Three Steps of the Synthesis of Glucose Sugar Silanes 
 Unlike the aforementioned mannose-based synthesis, addition of 2-iodophenol to 4-32 
provided a greater challenge, requiring an adjustment in reaction conditions (Scheme 4-9). 
Performing the addition while gradually warming from 0 °C to room temperature overnight 
resulted in formation of the expected β-anomer 4-33, albeit in low (26%) yield. In an attempt to 
improve the yield, more equivalents of BF3·OEt2 were added over an extended period of time. 
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However, instead of the anticipated increase in yield of the β-anomer, α-anomer 4-34 was 
isolated. The results of this reaction likely indicates that the addition of 2-iodophenol is 
reversible and that the thermodynamic product is the α-anomer 4-34, which has increased 
stability due to the anomeric effect. Increasing the yield of the reaction and controlling the 
equilibrium of this reversible step remains an outstanding optimization problem, but this 
serendipitous discovery allowed for derivatization of the glucose sugar silane to allow for 
comparison of both the α- and β-anomers. 
 
Scheme 4-9: Addition of 2-Iodophenol to Orthoformate 4-31 
 It is important to note that previously the Montgomery lab had not been able to study 
both anomers as prior sugar silane substrates in the glucose series were produced as solely the β-
anomer. Being able to study the behavior of both anomers in not only the synthesis but also the 
tethering and aglycone delivery steps would provide insight into reactivity and selectivity of the 
silane. For the remainder of the synthesis, both α- and β-anomers followed the same synthetic 
route to the 2-hydroxy glucose sugar as utilized previously for the mannose series (Scheme 
4-10). Deprotection of 4-33 and 4-34 to the free alcohol 4-35 and 4-37 using sodium methoxide 
and methanol gave modest yields of 61% and 59%, respectively. Both anomers performed 
similarly in the Sonogashira cross-coupling reaction resulting in the formation of β-anomer 4-36 
and α-anomer 4-38.  
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Scheme 4-10: (A) Synthesis of Glucose β-2-Hydroxy Sugar (B) Synthesis of Glucose α-2-Hydroxy Sugar 
 The final step of the synthesis of glucose sugar silanes 4-22 and 4-39 followed reaction 
protocols established by the Montgomery lab (Scheme 4-11).161 Although the β-anomer 4-22 
was isolated in only 57% yield compared to the α-anomer 4-39 which was isolated in 70% yield, 
this was not significant enough of a disparity to indicate a difference in reactivity between the 
two anomers. 
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Scheme 4-11: Synthesis of α- and β-Glucose Sugar Silanes 
4.3.3 Mannose Sugar Silane Tethering and Aglycone Delivery 
To explore the scope of silane tethering and subsequent aglycone delivery, (-)-menthol 
was chosen as the model alcohol. As mentioned earlier, diisopropyl thiosugar silane was able to 
tether to menthol, but aglycone delivery was not as efficient when compared to dimethyl 
thiosugars (72-74%) (Scheme 4-3). Both copper and borane-catalyzed dehydrogenative silylation 
methods were investigated with substrate 4-29 to see the compatibility of the alkyne under these 
conditions. Desired product formation was only observed with the borane catalyst and further 
optimization of the tethering was required (Table 4-1). Initial results showed 4-29 was able to be 
tethered in a 49% isolated yield; however, the incomplete conversion of starting material resulted 
in inseparable mixture of 4-40 and (-)-methanol, which artificially lowered the isolated yield 
(entry 1).  Adding 4 Å molecular sieves (entry 2) and extending the time (entry 3) were 
detrimental and decreased the yield of the reaction. However, when silane 4-21 was used instead 
of 4-29 the product and remaining (-)-menthol cleanly separated and 4-41 was isolated in a 55% 
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yield (entry 4). By increasing the equivalence of silane to 1.1 equivalents and adding a second 4 
mol % catalyst after 5 hours of reaction time, 4-40 was cleanly isolated in 60% yield (entry 5), 4-
41 in 85% yield (entry 6) and 4-42 in 65% yield (entry 7).  Even though silane 4-21 has more 
sterics than 4-30, the higher yield was credited to the user-friendliness of the crystalline solid 
over the viscous liquid of 4-30 that tends to be more difficult to handle. 
 
Table 4-1: Optimization of Tethering (-)-Menthol to Mannose Sugar Silanes 
4-40, 4-41, and 4-42 were subjected to aglycone delivery conditions employing the use of 
NIS, TMSOTf, and 2,6-DTBMP (Scheme 4-12). After letting the reactions run for several hours, 
full conversion of starting material was not observed; in fact, extending reaction time to 16 hours 
did not drive the reaction to completion, leading to the recovery of 2-hydroxy sugar 4-28 and 
untethered (-)-menthol. Of the substrates explored, 4-40 was the least efficient for aglycone 
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delivery, while 4-42 was the most efficient with a 56% isolated yield of 4-11. Surprisingly, the 
yields among the three silanes do not follow any steric trend, as 4-40 was the least efficient in 
terms of conversion, despite the initial hypothesis that it would be the most efficient.  
 
Scheme 4-12: Aglycone Deliveries with Mannose Derived Sugar Silanes 
 With preliminary results for aglycone delivery with (-)-menthol in hand, more complex 
aglycones were examined (Scheme 4-13). Sugar silane 4-21 was used in these experiments, as 
the solid silane could be prepared on a multigram scale. As described in the literature, tethered 4-
hydroxy sugars are the Achilles heel of silicon tethered intramolecular aglycone deliveries where 
de-benzylation and delivery of the C-6 hydroxygroup is often observed.122 Substrate 4-43 was 
not only more difficult to tether, but the aglycone delivery resulted in the formation of a several 
identifiable products, likely indicating the decomposition of 4-44 under these reaction conditions 
(Scheme 4-13 A). Less sterically hindered C-6 hydroxy sugar 4-45 underwent tethering with 
greater ease, yet still resulted in several unidentifiable products during the aglycone delivery step 
(Scheme 4-13 B). At present, it is hypothesized that changing the sterics around the silane would 
not significantly impact the tethering or aglycone delivery of the saccharides. Rather, these 
results suggest aglycone delivery using the o-(p-methoxyphenylethynyl)phenyl leaving group 
requires further optimization. 
R= Me, 4-40
R= iPr, 4-41
R= iBu, 4-42
O
BnO
BnO
BnO
O
O
OMe
Si
R R
O NIS (1.3 equiv)
TMSOTf (1.2 equiv)
4-11
2,6-DTBMP (2.0 equiv)
CH2Cl2, -40 °C- 0 °C
(Bu4NF work up)
O
BnO
BnO
BnO
OH
O
yield when R=
Me  34%
iPr  45%
iBu  56%
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Scheme 4-13: Tethering and Aglycone Deliveries of Hydroxy Sugars 
 Investigation into optimizing the efficiency of the aglycone delivery involved changing 
the electrophilic halogen source or solvent of the reaction (Table 4-2). Neither N-
chlorosuccinimide, NCS, (entry 1), nor N-bromosuccinimide, NBS, (entry 2) resulted in the 
desired product, demonstrating that the more electrophilic iodine species was needed. 
Furthermore, using NIS but changing the solvent form dichloromethane to dichloroethane (entry 
3), toluene (entry 4) or tetrahydrofuran (entry 5) negatively impacted the reaction, as formation 
of the desired product was not observed. 
O
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Table 4-2: Attempted Aglycone Delivery with Other Electrophilic Halogen Sources and Solvents 
 Expanding optimization experiments to include other Lewis acids that could activate the 
alkyne to the benzofuran by-product were investigated (Table 4-3). In situ generated cationic 
gold did not result in desired product formation (entry 1). AlCl3 (entry 2), PtCl3 (entry 3) and 
AuCl3 (entry 4) did not show any reactivity, as the C2-hydroxy sugar 4-28 and untethered (-)-
menthol were observed after the tetrabutyl ammonium fluoride work up. Increasing the 
temperature of the reaction with AuCl3 (entry 5) and Cu(OTf)2 also gave the untethered starting 
materials, 4-28 and (-)-menthol. The results of Table 4-2 and Table 4-3 show that the 
NIS/TMSOTf combination is, to our knowledge, the best for activating the o-(p-
methoxyphenylethynyl)phenyl leaving group. Further optimization could focus on further 
improving these established reaction conditions by examining the equivalents, solvent, and 
temperature effects of the reaction.   
NXS (1.3 equiv)
TMSOTf (1.2 equiv)
2,6-DTBMP (2.0 equiv)
Solvent, -40 °C- 0 °C
(Bu4NF work up)
O
BnO
BnO
BnO
O
O
OMe
Si
iPr iPr
O
O
BnO
BnO
BnO
OH
O
Entry NXS Solvent
1 NCS
2 NBS
3 NIS
4 NIS PhMe
5 NIS THF
4-41
4-11
CH2Cl2
CH2Cl2
C2H4Cl2
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Table 4-3: Lewis Acid Screen for Aglycone Delivery 
4.3.4 Glucose Sugar Silane Tethering and Aglycone Delivery 
With both the β-anomer 4-22 and the α-anomer 4-39 in hand, the goal of exploring 
differences in reactivity could be further pursued. Upon subjection to the optimized tethering 
conditions there was a stark contrast in reactivity between both anomers (Scheme 4-14). The β-
anomer 4-22 proved difficult to tether, even when catalyst loading was increased. Possible 
product formation occurred when the reaction unintentionally dried up; however, the resulting 
material was isolated along with several inseparable impurities, making it difficult to state with 
certainty that 4-47 was formed. Heating the reaction to 50 °C with increased catalyst loading was 
detrimental to the reaction, as multiple unwanted by-products were observed. Conversely, α-
anomer 4-39 tethered very well, resulting in the synthesis of 4-48 in an 87% yield. These results 
were unexpected, given the 1-2-trans orientation of 4-22 was the same relative configuration as 
the thiosugar silane 4-2 that was previously used in both the tethering and aglycone delivery 
Entry Lewis Acid Solvent Temp
2 AlCl3 rt
3 PtCl2 rt
4 AuCl3 rt
1a PPh3AuCl/AgOTf rt
5 AuCl3 80 °C
6a Cu(OTf)2 80 °C
a2.0 equiv MeOH added to the reaction
5-10 mol %  Lewis Acid
(Bu4NF work up)
O
BnO
BnO
BnO
O
O
OMe
Si
iPr iPr
O
O
BnO
BnO
BnO
OH
O
4-41
4-11
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
C2H4Cl2
C2H4Cl2
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steps. Examining the size of the anomeric group has led to some hypotheses regarding the 
preferred conformation of the o-(p-methoxyphenylethynyl)phenyl leaving group. If the alkyne 
orientation points back towards the C-6 position, steric interaction with the benzyl-protected 
alcohol would force the alkyne to rotate toward the opposite side of the sugar – oriented towards 
the silane. This orientation would make the silicon-hydride bond inaccessible, thus inhibiting the 
formation of the cationic silicon species derived from the borane catalyst and rendering the silane 
unreactive. Upon subjection of 4-22 to catalyst and (-)-menthol, unreacted silane was isolated, 
which supports this hypothesis. 
 
Scheme 4-14: Tethering of (-)-Menthol with both Anomers of Glucose Sugar Silanes 
When 4-48 was subjected to the aglycone delivery conditions, the desired 1,2-cis 
glycoside 4-49 was obtained in 51% yield without observation of the 1,2-trans glycoside 
(Scheme 4-15). These results provide valuable insight into the mechanism of the reaction. For 
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the 1,2-cis tethered sugar 4-48 to undergo intramolecular aglycone delivery, either an SN1 type 
mechanism or a double inversion pathway must be involved. The direct displacement of the 
anomeric leaving group by the aglycone is very unlikely in the cis orientation when compared to 
the delivery of the aglycone to an oxocarbenium ion intermediate. 
 
Scheme 4-15: Glucose Aglycone Delivery of (-)-Menthol 
4.4 Progress Towards Asymmetric Hydrosilylation of Ketones 
Additional work that has been conducted in this area includes the asymmetric 
hydrosilylation of pro-chiral ketones. The motivation for this work was to expand the utility of 
previously established methodology by setting an additional stereocenter in the tethering step.  
This chirality would be maintained throughout aglycone delivery, thereby setting two 
stereocenters over the course of the reaction sequence (Scheme 4-16). Based on the racemic 
hydrosilylation of ketones previously performed with nickel,161 it was hypothesized that the 
asymmetric hydrosilylation could also be accomplished via use of a nickel catalyst system. The 
only prior report of asymmetric nickel-catalyzed hydrosilylation of ketones up to this point 
employed the use of a nickel(II) precatalyst and phosphine ligands system open to air.167 
Although this method lends itself well to setting up reactions without a glove box, this 
methodology may not translate well to sugar silane substrates, as the air stability of sugar silanes 
is variable. Therefore, a nickel-N-heterocyclic carbene (NHC) approach was taken that mimics 
reaction conditions previously established by the Montgomery group.161  
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Scheme 4-16: Goals for Asymmetric Tethering before Aglycone Delivery 
 Initial investigations employed the use of commercially available silanes instead of the 
synthetically precious sugar silanes, as this allowed for deeper investigation due to a rapid 
screening approach (Scheme 4-17). The Montgomery group has previously demonstrated that 
C2-symmetric NHC A provides high enantioselectivity when employed in analogous reductive 
coupling reactions.86 When applied to the hydrosilylation of acetophenone to form product 4-53, 
poor enantioselectivity was achieved (13% ee). Shifting ligands from an ortho/para-substituted 
ligand to a meta/para-substituted ligand, B provided an increase in yield, yet poor 
enantioselectivity (23% ee) remained. Use of ligand C – a non-C2 symmetric hybrid of ligand A 
and B – provided decent enantioselectivity (56% ee), but was very dependent on the identity of 
the silane. Removal of the para-methoxy group (ligand D) showed a similar silane dependency. 
while cooling reactions to 0 °C slightly increased the enantioselectivity to 63% ee. Further 
alteration of the meta-substituents from tert-butyl groups to phenyl groups (ligand E) narrowed 
the range of silane dependence, but still maintained moderate enantioselectivity (53% ee). 
Moving away from an aniline derived NHC to mixed aniline/amine NHC F drastically decreased 
the enantioselectivity indicating the free rotation around the nitrogen-carbon bond was 
detrimental to the enantioselectivity of the reaction.  
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Scheme 4-17: General Trends for Nickel-Catalyzed Asymmetric Hydrosilylation of Acetophenone 
 After gaining insight into the nickel-catalyzed hydrosilylation of ketones with various 
simple silanes, focus shifted to using sugar silanes as the silane source (Scheme 4-18). When 
sugar silane 4-2 was employed in the hydrosilylation reaction with ligand D (which showed the 
most promise in previous screens) low diastereoselectivity (40:60) was observed. The silane 
dependence that was observed in initial screenings appears to play a large role in sugar silane 
optimizations as well. To improve the asymmetric hydrosilylation of ketones with sugar silanes, 
further optimization reactions must be conducted using the desired sugar silane. 
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Scheme 4-18: Asymmetric Hydrosilylation with Glucose Thiosugar Silane 
4.5 Conclusion and Future Directions For Latent-Activation for Intramolecular Aglycone 
Delivery 
In summary, further insights into the tethering and intramolecular aglycone delivery of 
sugar silanes were developed. Five new sugar silanes were synthesized – three in the mannose 
series with the 1,2-trans orientation and two in the glucose series in both the 1,2-cis and 1,2-
trans orientation – all bearing an o-(p-methoxyphenylethynyl)phenyl leaving group. 
Dehydrogenative silylation was performed with optimized conditions using 
tris(pentafluorophenyl)borane. All three mannose-derived silanes were successful in both 
tethering and aglycone delivery reactions, albeit with moderate aglycone delivery yields. 
Additionally, the α-glucose anomer successfully was tethered and performed modestly in 
subsequent aglycone delivery. The inability for the β-glucose anomer to undergo 
dehydrogenative silylation with (-)-menthol may be attributed to the steric hindrance of the o-(p-
methoxyphenylethynyl)phenyl leaving group. 
Optimization of the activation of the o-(p-methoxyphenylethynyl)phenyl leaving group in 
the intramolecular aglycone delivery should be further explored. Varying the equivalents of the 
electrophilic iodine species is predicted to have a large effect on the efficiency of the aglycone 
delivery. Other modes of activation, such as the use of hypervalent iodine species, could provide 
insight as to whether other activation pathways are accessible that may confer higher yields or 
greater selectivity. Lastly, other alkynes can be installed to vary the electronics and the sterics for 
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the latent-activation (Figure 4-3). Cyclopropane (4-53) and tosyl-protected amines (4-54) would 
provide a difference in electronics for the initial nucleophilic attack of the electrophilic iodine 
species. Adding an extra methylene spacer (4-55) would result in a benzopyran by-product rather 
than the observed benzofuran, potentially changing the efficiency of the reaction. 
 
Figure 4-3: Various Electronics and Sterics of the Alkyne for Latent-Activation 
Additionally, exploration into the asymmetric hydrosilylation of ketones with sugar 
silanes resulted in the conclusion that optimization must be performed using the synthetically 
precious sugar silane. 
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 Chapter 5 Conclusion 
 
5.1 Conclusion 
In summary, two areas of research have been explored for regioselective additions to 
small molecules. The first area explored was the regioselective synthesis of secondary 
alkylboranes from additions to olefins (Scheme 5-1). A copper-N-heterocyclic carbene catalyst 
was shown to control the regioselectivity of hydroboration of terminal olefins, selectively 
synthesizing secondary alkylboranes. These products were later converted into cross-coupling 
partners for a subsequent dual catalyst/photocatalytic reaction (Scheme 5-1 A). When this 
hydroboration methodology was applied to 1,1-disubstituted olefins, a few modifications to the 
reaction conditions were necessary for high yields and regioselectivity; however, it remains 
unclear as to how these changes in conditions impact observed differences in reactivity (Scheme 
5-1 B). Furthermore, regioselective hydroboration of 1,2-disubstituted olefins without directing 
groups remains an unsolved challenge in the field (Scheme 5-1 C). Finding a catalyst system that 
is not prone to chain walking and can differentiate minute steric differences in alkyl substituents 
was probed, but proved unsuccessful. 
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Scheme 5-1: Summation of Regioselective Hydroboration of Olefins 
The second synthetic method pursued was the synthesis of 1,2-cis glycosides from a 
latent-active intramolecular aglycone delivery (Scheme 5-2). After successful synthesis of five 
new sugar silanes, tethering and aglycones delivery methods were explored. (-)-Menthol was 
tethered to four silanes; albeit with modest aglycone delivery. Further attempts at optimizing the 
aglycone delivery with different Lewis Acids concluded that the use of an N-
iodosuccinimide/trimethylsilyltriflate system provided optimal activity thus far; however, further 
investigation is necessary.  
 
Scheme 5-2: Summation of the Synthesis of Mannose Sugar Silane and Aglycone Tethering/Delivery of Menthol 
In conclusion, progress has been made towards an ultimate goal of complete regio- and 
diastereocontrol in chemical synthesis. Further catalyst design is necessary to facilitate 
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regioselective hydroboration of unactivated internal olefins, as well as optimization of latent-
active intramolecular aglycone delivery. 
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 Chapter 6 Experimental 
6.1 General Considerations 
All reactions were conducted in a flame-dried or oven dried (120 °C) glassware with 
magnetic stirring under an atmosphere of dry nitrogen. Solvents were purified under nitrogen 
using a solvent purification system (Innovative Technology, Inc. Model # Sps-400-3 and PS-
400-3). Unless otherwise noted all reagents were used as received. Allyltrimethylsilane, 
TMSOTf, 2,6-lutidine, diisopropylamine and allylbenzene were distilled.  Copper salts (Sigma 
Aldrich, Strem Chemicals, Inc), N-heterocyclic carbene salts (Sigma Aldrich, Strem), KO-t-Bu 
(Strem), NaO-t-Bu (Strem) B2pin2 (Combi Blocks, recrystallized from pentane) were stored and 
weighed in an inert atmosphere. NIS (recrystallized from dioxane/ether) and 2,6-DTBMP 
(recrystallized from pentane) were stored away from light and at -20 °C. IPrCuCl was 
synthesized168, stored, and weighed in an inert atmosphere. MeOH was distilled from CaH2 and 
stored under nitrogen. 
1H and 13C were obtained in CDCl3 at rt in a Varian Mercury 400 MHz instrument, a 
Varian Unity 500 MHz, or a Varian Unity 700 MHz instrument. Chemical shifts of 1H NMR 
spectra were recorded in parts per million (ppm) on the δ scale from an internal standard of 
residual chloroform (7.24 ppm). Chemical shifts of 13C NMR spectra were recorded in ppm from 
the central peak of CDCl3 (77.1 ppm) on the δ scale. High-resolution mass spectra (HRMS) were 
obtained at the University of Michigan Mass Spectrometry Laboratory on a VG-70-250-s 
spectrometer manufactured by Micromass Corp. (Manchester UK). When noted, Biotage 
purification was performed on an Isolera One purification system with SNAP silica columns. 
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Regioisomeric ratios were determined on crude reaction mixtures using GC. GCMS analysis was 
carried out on a HP 6980 Series GC System with HP-5MS column (30 m x 0.250 mm x 0.25 
µm). GCFID analysis was carried out on a HP 6980N Series GC system with a HP-5 column (30 
m x 0.32 mm x 0.25 µm). 
6.2 Chapter 2 Experimental 
6.2.1 Substrates Synthesized by Literature Procedures 
The following substrates were prepared according to literature procedures: 
tert-Butyldimethyl(pent-4-enyloxy)silane,169 
(R)-4,8-Dimethylnona-1,7-diene,170 
((Hex-5-enyloxy)methyl)benzene,171,172  
1-Allyl-1H-indole,173,174  
(3-methylbut-3-enyl)benzene170,175 
(3-methylenepentyl)benzene170,176 
6.2.2 Synthesis of Starting Material 
1-Allyl-2-methylenecyclohexane 
 
Methyltriphenylphosphonium bromide (2.7 g, 7.6 mmol) was added to a flask and backfilled 
with N2. THF (18 mL, 0.4M) was added and the reaction was cooled to 0 °C. n-butyllithium 
solution (3.0 mL, 2.5M, 7.6 mmol) was added dropwise. The mixture was allowed to stir at 0 °C 
for 30 minutes before being cooled to -78 °C. 2-allyl-cylcohexanone (0.68 mL, 7.2 mmol) was 
added dropwise. The reaction was allowed to stir overnight; gradually warming to rt. 75 mL 
O
nBuLi (1.05 equiv)
MePPh3Br (1.05 equiv)
THF, -78 °C-rt
45%
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saturated NH4Cl was added. The aqueous layer was washed with Et2O (3x75 mL). The organic 
layers were combined, washed with brine dried over MgSO4, filtered, and concentrated. The 
reaction mixture was purified via column chromatography (100% hexanes) (442 mg, 3.2 mmol, 
45 % yield). 1H NMR (500 MHz, CDCl3): δ 5.87 – 5.72 (m, 1H), 5.08 – 4.93 (m, 2H), 4.67 (s, 
1H), 4.58 (s, 1H), 2.43 – 2.33 (m, 1H), 2.30 – 2.21 (m, 1H), 2.12 – 1.97 (m, 3H), 1.84 – 1.74 (m, 
1H), 1.72 – 1.61 (m, 2H), 1.51 – 1.40 (m, 2H), 1.25 – 1.12 (m, 1H). 13C NMR (126 MHz, 
CDCl3): δ 152.64, 137.80, 115.38, 105.38, 42.83, 36.89, 35.36, 33.49, 28.75, 24.72. IR (thin 
film): ν 2926, 2854, 1642, 1446, 992, 909, 889, 495, 416 cm-1. HRMS (EI) (m/z): [M+] 
calculated for C10H16, 136.1252 found, 136.1253.  
Hex-5-enyl pivalate 
 
DMAP (611 mg, 5.0 mmol) was added to a flask and backfilled with N2. CH2Cl2 (44 mL 0.2 M) 
was added and the reaction was cooled to 0 °C. 5-hexen-1-ol (1.2 mL, 10 mmol) and freshly 
distilled Et3N (7.0 mL, 50.0 mmol) were added. Pivaloyl chloride (2.0 mL, 15.0 mmol) was 
added dropwise. The reaction was allowed to stir overnight; gradually warming to rt.  30 mL 
saturated NaHCO3 was added. The aqueous layer was washed with EtOAc (3x50 mL). The 
organic layers were combined, washed with brine, dried over MgSO4, filtered, and concentrated. 
The reaction mixture was purified via column chromatography (5% EtOAc in hexanes) (1.29 g, 
7.01 mmol, 70% yield). 1H NMR (500 MHz, CDCl3): δ 5.80 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 
5.09 – 4.89 (m, 2H), 4.06 (t, J = 6.6 Hz, 2H), 2.13 – 2.04 (m, 2H), 1.69 – 1.59 (m, 2H), 1.51 – 
1.39 (m, 2H), 1.19 (s, 9H). 13C NMR (126 MHz, CDCl3): δ 178.63, 138.40, 114.75, 64.21, 
38.73, 33.27, 28.05, 27.20, 25.20.IR (thin film): ν 2975, 2938, 2871, 1728, 1480, 1459, 1283, 
t-Bu
O
O
Pivaloyl Chloride (1.5 equiv)
DMAP (0.5 equiv)
Et3N (5.0 equiv)
CH2Cl2, 0 °C- rt
70%
HO
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1036, 994, 910 cm-1. HRMS (EI) (m/z): [M+] calculated for C11H20O2, 184.1463 found, 
184.1467. 
1-(But-3-enyl)-1H-indole 
 
Indole (562 mg, 4.8 mmol) and crushed KOH pellets (539 mg, 9.6 mmol) were added to a flask 
and backfilled with N2. DMSO (20 mL, 0.25 M) and then but-3-enyl methanesulfonate (1.44 g, 
9.6 mmol) were added. The reaction mixture was allowed to stir at rt overnight. 100 mL H2O 
was added. The reaction mixture was extracted with EtOAc (3x100 mL). The organic layers 
were combined, washed with brine, dried over MgSO4, filtered, and concentrated. The reaction 
was purified via column chromatography (100% hexanes) (505 mg, 2.95 mmol, 61%).  1H NMR 
(500 MHz, CDCl3): δ 7.65 (d, J = 7.9 Hz, 1H), 7.37 (d, J = 8.2 Hz, 1H), 7.26 – 7.20 (m, 1H), 
7.16 – 7.06 (m, 2H), 6.50 (s, 1H), 5.80 (ddt, J = 17.1, 10.3, 6.8 Hz, 1H), 5.09 (d, J = 17.0 Hz, 
1H), 5.07 (d, J = 10.0 Hz, 1H), 4.20 (t, J = 7.2 Hz, 2H), 2.60 (q, J = 7.1, 6.7 Hz, 2H). 13C NMR 
(126 MHz, CDCl3): δ 135.84, 134.65, 128.60, 127.70, 121.36, 120.95, 119.24, 117.36, 109.30, 
101.03, 45.98, 34.54. IR (thin film): ν 2927, 1641, 1612, 1510, 1463, 1313, 913, 735, 714 cm-1. 
HRMS (EI) (m/z): [M+] calculated for C12H13N, 171.1048 found, 171.1049. 
6.2.3 Synthesis of Branched Alkylboranes 
General procedures for copper-catalyzed hydroboration of alkenes: 
1.5 mL of acetonitrile was added to a solid mixture of IPrCuCl (0.03 mmol) and KO-t-Bu (0.45 
mmol) under N2. The reaction was allowed to stir at rt for 10 minutes. B2pin2 (0.6 mmol) was 
added under N2 and the reaction was allowed to stir for an additional 30 minutes at rt. The alkene 
(0.3 mmol) and MeOH (0.6 mmol) were added to the mixture by syringe. The reaction mixture 
NKOH (2.0 equiv)
DMSO, r.t.
61%
NH MsO+
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was allowed to stir at rt for 2 h and was then filtered through silica gel, eluting with 50% v/v 
EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via flash 
chromatography on silica gel to afford the desired product. 
4,4,5,5-Tetramethyl-2-(4-phenylbutan-2-yl)-1,3,2-dioxaborolane (2-1) 
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 4-phenyl-1-butene (40 mg, 0.3 mmol) and MeOH (19 mg, 
0.6 mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 92:8 
mixture of regioisomers (63 mg, 0.24 mmol, 81% yield). 1H NMR (500 MHz, CDCl3): δ 7.30 – 
7.23 (m, 2H), 7.23 – 7.13 (m, 3H), 2.69 – 2.57 (m, 2H), 1.85 – 1.74 (m, 1H), 1.64 – 1.54 (m, 
1H), 1.27 (s, 12H), 1.14 – 0.99 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 143.08, 128.42, 
128.18, 125.48, 82.87, 35.31, 35.29, 24.79, 24.74, 15.41. The spectral data matched the 
literature.68 
4,4,5,5-Tetramethyl-2-(octan-2-yl)-1,3,2-dioxaborolane (2-27) 
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 1-octene (34 mg, 0.3 mmol) and MeOH (19 mg, 0.6 mmol) 
by following the general procedure. The crude residue was purified via flash chromatography 
(100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 95:5 mixture of 
regioisomers (56 mg, 0.23 mmol, 77% yield). 1H NMR (500 MHz, CDCl3): δ 1.47 – 1.39 (m, 
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1H), 1.33 – 1.18 (m, 21H), 1.03 – 0.92 (m, 4H), 0.92 – 0.82 (m, 3H). 13C NMR (126 MHz, 
CDCl3): δ 82.73, 33.25, 31.87, 29.54, 28.94, 24.74, 24.71, 22.65, 15.52, 14.11. The spectral data 
matched the literature.71 
2-(1-Cyclohexylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-28)  
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), vinylcyclohexane (33 mg, 0.3 mmol) and MeOH (19 mg, 0.6 
mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as an 
87:13 mixture of regioisomers (70 mg, 0.29 mmol, 98% yield). 1H NMR (500 MHz, CDCl3): δ 
1.83 – 1.57 (m, 5H), 1.40 – 1.19 (m, 15H), 1.19 – 1.08 (m, 1H), 1.08 – 0.83 (m, 6H). 13C NMR 
(126 MHz, CDCl3): δ 82.68, 40.46, 32.68, 31.81, 26.75, 26.70, 24.80, 24.72, 12.50. 11B NMR 
(128 MHz, CDCl3): δ 34.29. IR (thin film): ν 2978, 2921, 2851, 1378, 1370, 1357, 1308, 1143, 
863, 845 cm-1. HRMS (EI) (m/z): [M+] calculated for C14H27BO2, 238.2104 found, 238.2113. 
The spectral data matched the literature.71 
2-(4,8-dimethylnon-7-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-29)  
 
The title was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 mmol), 
B2pin2 (152 mg, 0.6 mmol), ((R)-4,8-dimethylnona-1,7-diene (46 mg, 0.3 mmol) and MeOH (19 
mg, 0.6 mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product observed 
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as a single isomer (1:1 diastereomeric ratio) (69 mg, 0.24 mmol, 81% yield). 1H NMR (500 
MHz, CDCl3): δ 5.07 (m, 1H), 2.04 – 1.82 (m, 2H), 1.65 (s, 3H), 1.57 (s, 3H), 1.49 – 1.35 (m, 
1H), 1.35 – 1.16 (m, 14H), 1.13 – 0.98 (m, 2H), 0.91 (m, 3H), 0.83 (m, 3H). 13C NMR (126 
MHz, CDCl3): δ 130.84, 130.82, 125.12, 125.11, 82.73, 82.70, 41.04, 40.27, 37.29, 37.26, 
31.62, 31.02, 25.71, 25.58, 25.54, 24.74, 24.71, 24.70, 24.66, 19.75, 19.33, 17.64, 17.62, 16.11, 
15.39. 11B NMR (128 MHz, CDCl3): δ 34.28. IR (thin film): ν 2957, 2914, 1460, 1370, 1314, 
1144, 861, 688 cm-1. HRMS (EI) (m/z): [M+] calculated for C17H33BO2, 280.2574 found, 
280.2579. 
4,4,5,5-tetramethyl-2-(1-(2-methylenecyclohexyl)propan-2-yl)-1,3,2-dioxaborolane (2-30)  
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 1-allyl-2-methylenecyclohexane (41 mg, 0.3 mmol) and 
MeOH (19 mg, 0.6 mmol) by following the general procedure. The crude residue was purified 
via flash chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product 
observed as a single isomer (66 mg, 0.25 mmol, 83% yield). 1H NMR (500 MHz, CDCl3): δ 
4.63 (s, 1H), 4.58 (d, J = 7.6, 1.5 Hz, 1H), 2.22 (m, 1H), 2.17 – 2.08 (m, 1H), 2.04 – 1.95 (m, 
1H), 1.80 (dt, J = 13.4, 7.9 Hz, 1H), 1.76 – 1.62 (m, 2H), 1.58 – 1.34 (m, 5H), 1.31 – 1.18 (m, 
14H), 1.11 – 1.00 (m, 1H), 0.99 – 0.93 (m, 3H). 13C NMR (126 MHz, CDCl3): δ 105.96, 
105.74, 82.73, 42.08, 41.99, 35.59, 35.38, 34.44, 34.41, 33.78, 33.52, 28.85, 28.84, 24.75, 24.75, 
24.71, 24.68, 23.87, 15.96, 15.78. 11B NMR (128 MHz, CDCl3): δ 34.48. IR (thin film): ν 
2976, 2926, 2854, 1462, 1370, 1312, 1144, 859, 688 cm-1. HRMS (EI) (m/z): [M+] calculated 
for C16H29BO2, 264.2261 found, 264.2274.  
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2-(6-(Benzyloxy)hexan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-31)  
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), ((hex-5-enyloxy)methyl)benzene (57 mg, 0.3 mmol)  and 
MeOH (19 mg, 0.6 mmol) by following the general procedure. The crude residue was purified 
via flash chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product 
as a 92:8 mixture of regioisomers (79 mg, 0.25 mmol, 83% yield). 1H NMR (500 MHz, CDCl3): 
δ 7.39 – 7.33 (m, 4H), 7.33 – 7.25 (m, 1H), 4.51 (s, 2H), 3.48 (t, J = 6.7 Hz, 2H), 1.64 (m, 2H), 
1.55 – 1.44 (m, 1H), 1.44 – 1.35 (m, 2H), 1.35 – 1.20 (m, 14H), 1.07 – 0.94 (m, 4H). 13C NMR 
(126 MHz, CDCl3): δ 138.75, 128.27, 127.54, 127.37, 82.77, 72.76, 70.50, 32.99, 29.95, 25.49, 
24.73, 24.70, 15.44. 11B NMR (128 MHz, CDCl3): δ 34.34. IR (thin film): ν 2930, 2856, 1455, 
1370, 1213, 1143, 1103, 732 cm-1. HRMS (EI) (m/z): [M+] calculated for C19H31BO3, 318.2366, 
found, 318.2370. 
tert-Butyldimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentyloxy)silane (2-32)  
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), tert-butyldimethyl(pent-4-enyloxy)silane (60 mg, 0.3 mmol)  
and MeOH (19 mg, 0.6 mmol) by following the general procedure. The crude residue was 
purified via flash chromatography (100% hexanes to 5% EtOAc in hexanes) to afford the desired 
product as a 90:10 mixture of regioisomers (91 mg, 0.28 mmol, 92% yield). 1H NMR (500 
MHz, CDCl3): δ 3.61 – 3.51 (m, 2H), 1.55 – 1.46 (m, 2H), 1.46 – 1.37 (m, 1H), 1.31 – 1.24 (m, 
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1H), 1.20 (m, 12H), 1.01 – 0.91 (m, 4H), 0.86 (m, 9H), 0.01 (m, 6H). 13C NMR (126 MHz, 
CDCl3): δ 82.78, 63.60, 32.27, 29.26, 25.99, 24.75, 24.71, 18.38, 15.53, -5.24. 11B NMR (128 
MHz, CDCl3): δ 33.95. IR (thin film): ν 2929, 2858, 1462, 1386, 1314, 1251, 1145, 1096, 833, 
773 cm-1. HRMS (EI) (m/z): [M+H+] calculated for C17H38BO3Si, 329.2678 found, 329.2680. 
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-1-ol (2-33)  
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 5-hexen-1-ol (30 mg, 0.3 mmol) and MeOH (19 mg, 0.6 
mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 20% EtOAc in hexanes) to afford the desired product 
observed as a single isomer (64 mg, 0.28 mmol, 93% yield). 1H NMR (500 MHz, CDCl3): δ 
3.63 (t, J = 6.5 Hz, 2H), 1.56 (quint, J = 6.9 Hz, 2H), 1.49 – 1.26 (m, 6H), 1.23 (s, 12H), 1.06 – 
0.88 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 82.86, 62.83, 32.77, 32.61, 24.91, 24.74, 24.69, 
15.46. 11B NMR (128 MHz, CDCl3): δ 34.11. IR (thin film): ν 3362, 2977, 2928, 2872, 1462, 
1370, 1313, 1143, 858 cm-1. HRMS (EI) (m/z): [M+H+] calculated for C12H25BO3, 229.1970 
found, 229.1970. 
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)hexyl pivalate (2-34)  
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), hex-5-enyl pivalate (55 mg, 0.3 mmol) and MeOH (19 mg, 
0.6 mmol) by following the general procedure. The crude residue was purified via flash 
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chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 96:4 
mixture of regioisomers (73 mg, 0.23 mmol, 78% yield). 1H NMR (500 MHz, CDCl3): δ 4.09 – 
3.97 (m, 2H), 1.66 – 1.55 (m, 2H), 1.51 – 1.41 (m, 1H), 1.39 – 1.27 (m, 3H), 1.23 (s, 12H), 1.18 
(s, 9H), 1.03 – 0.93 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 178.62, 82.82, 64.50, 38.70, 
32.81, 28.86, 27.20, 25.27, 24.74, 24.70, 15.43. 11B NMR (128 MHz, CDCl3): δ 34.35. IR (thin 
film): ν 2975, 2932, 2871, 1727, 1370, 1315, 1284, 1144, 859 cm-1. HRMS (EI) (m/z): [M+H+] 
calculated for C17H34BO4, 313.2545 found, 313.2546. 
2-(4-(2-Bromophenyl)butan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-35) 
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 4-(2-bromophenyl)-1-butene (63 mg, 0.3 mmol) and MeOH 
(19 mg, 0.6 mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 
90:10 mixture of regioisomers (94 mg, 0.28 mmol, 92% yield). 1H NMR (500 MHz, CDCl3): δ 
7.48 (d, J = 7.8 Hz, 1H), 7.24 – 7.15 (m, 2H), 7.00 (dt, J = 8.3, 4.1 Hz, 1H), 2.79 – 2.67 (m, 2H), 
1.79 – 1.67 (m, 1H), 1.62 – 1.52 (m, 1H), 1.24 (s, 12H), 1.13 – 0.99 (m, 4H). 13C NMR (126 
MHz, CDCl3): δ 142.29, 132.64, 130.31, 127.28, 127.24, 124.37, 82.94, 35.54, 33.55, 24.83, 
24.78, 15.41 11B NMR (128 MHz, CDCl3): δ 34.29. IR (thin film): ν 2976, 1469, 1369, 1315, 
1142, 747, 411 cm-1. HRMS (EI) (m/z): [M+] calculated for C16H24BBrO2, 338.1053 found, 
338.1051. 
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4,4,5,5-Tetramethyl-2-(1-phenylpropan-2-yl)-1,3,2-dioxaborolane (2-36) 
 
Following a modified procedure 1.5 mL of acetonitrile was added to a solid mixture of IPrCuCl 
(14.6 mg, 0.03 mmol), KO-t-Bu (50 mg 0.45 mmol), and B2pin2 (152 mg, 0.6 mmol). 
Allylbenzene (35 mg, 0.3 mmol) and MeOH (19 mg 0.6 mmol) were immediately added to the 
mixture by syringe. The reaction mixture was allowed to stir at rt for 2 h and was then filtered 
through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo, and 
the crude residue was purified via flash chromatography on silica gel to afford the desired 
product. The crude residue was purified via flash chromatography (100% hexanes to 4% EtOAc 
in hexanes) to afford the desired product as a 95:5 mixture of regioisomers (72 mg, 0.29 mmol, 
98% yield). 1H NMR (500 MHz, CDCl3): δ 7.28 – 7.13 (m, 5H), 2.82 (dd, J = 13.6, 7.5 Hz, 
1H), 2.55 (dd, J = 13.6, 8.4 Hz, 1H), 1.38 (m, 1H), 1.19 (m, 12H), 0.98 (d, J = 7.4 Hz, 3H). 13C 
NMR (126 MHz CDCl3): δ 142.28, 128.86, 127.96, 125.51, 82.94, 38.94, 24.69, 24.67, 15.17. 
The spectral data matched the literature.26 
Trimethyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)silane (2-37) 
 
Following a modified procedure 1.5 mL of acetonitrile was added to a solid mixture of IPrCuCl 
(14.6 mg, 0.03 mmol), KO-t-Bu (50 mg 0.45 mmol), and B2pin2 (152 mg, 0.6 mmol). 
Allyltrimethylsilane (34 mg, 0.3 mmol) and MeOH (19 mg 0.6 mmol) were immediately added 
to the mixture by syringe. The reaction mixture was allowed to stir at rt for 2 h and was then 
filtered through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in 
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vacuo, and the crude residue was purified via flash chromatography on silica gel to afford the 
desired product. The crude residue was purified via flash chromatography (100% hexanes to 4% 
EtOAc in hexanes) to afford the desired product as a single regioisomers (52 mg, 0.23 mmol, 
77% yield). 1H NMR (500 MHz, CDCl3): δ 1.21 (s, 12H), 1.10 – 1.04 (m, 1H), 0.99 (d, J = 7.2 
Hz, 3H), 0.77 (dd, J = 14.6, 7.4 Hz, 1H), 0.40 (dd, J = 14.6, 6.9 Hz, 1H), -0.04 (s, 9H). 13C NMR 
(126 MHz, CDCl3): δ 82.78, 24.78, 24.76, 19.88, 19.35, -0.86. 11B NMR (128 MHz, CDCl3): δ 
34.36. IR (thin film): ν 2952, 1459, 1378, 1315, 1246, 1226, 1144, 834, 689 cm-1. HRMS (EI) 
(m/z): [M-CH3+] calculated for C11H23BO2Si, 227.1639 found, 227.1637. 
1-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-1H-indole (2-38) 
 
The title compound was prepared from IPrCuCl (29.2 mg, 0.06 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 1-allyl-1H-indole (47 mg, 0.3 mmol) and MeOH (19 mg, 0.6 
mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 94:6 
mixture of regioisomers (48 mg, 0.17 mmol, 56% yield). 1H NMR (500 MHz, CDCl3): δ 7.61 
(d, J = 7.9, 1.1 Hz, 1H), 7.39 (d, J = 8.3 Hz, 1H), 7.22 – 7.12 (m, 2H), 7.07 (td, J = 7.5, 7.0, 1.0 
Hz, 1H), 6.46 (d, J = 3.0 Hz, 1H), 4.31 (dd, J = 14.1, 6.7 Hz, 1H), 4.00 (dd, J = 14.1, 9.1 Hz, 
1H), 1.77 – 1.63 (m, 1H), 1.23 – 1.17 (m, 14H), 0.94 (d, J = 7.4 Hz, 3H). 13C NMR (126 MHz, 
CDCl3): δ 136.13, 128.46, 128.24, 121.03, 120.69, 118.96, 109.75, 100.53, 83.40, 48.98, 24.72, 
24.68, 13.30. 11B NMR (128 MHz, CDCl3): δ 33.35. IR (thin film): ν 2975, 2931, 2873, 1512, 
1462, 1371, 1317, 1216, 1142, 966, 853, 714 cm-1. HRMS (EI) (m/z): [M+H+] calculated for 
C17H25BNO2, 286.1973 found, 286.1975. 
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1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-1H-indole 
 
The title compound was synthesized according to a literature procedure for use as an authentic 
standard for the analysis of 2-38.71 1H NMR (500 MHz, CDCl3): δ 7.62 (d, J = 7.8 Hz, 1H), 
7.39 (d, J = 8.0 Hz, 1H), 7.23 – 7.16 (m, 1H), 7.14 – 7.04 (m, 2H), 4.12 (t, J = 7.3, 5.5 Hz, 2H), 
2.00 – 1.88 (m, 2H), 1.25 (s, 13H), 0.80 (t, J = 7.7 Hz, 2H). 13C NMR (126 MHz, CDCl3): δ 
135.95, 128.52, 127.94, 121.16, 120.81, 119.05, 109.51, 100.70, 83.17, 48.28, 24.90, 24.84. IR 
(thin film): ν 2976, 1463, 1370, 1314, 1219, 1142, 967, 845, 737 cm-1. HRMS (EI) (m/z): 
[M+H+] calculated for C17H25BNO2, 286.1973 found, 286.1976. 
1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butyl)-1H-indole (2-39)  
 
The title compound was prepared from IPrCuCl (21.9 mg, 0.045 mmol), KO-t-Bu (50 mg, 0.45 
mmol), B2pin2 (152 mg, 0.6 mmol), 1-(but-3-enyl)-1H-indole (51 mg, 0.3 mmol) and MeOH (19 
mg, 0.6 mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 94:6 
mixture of regioisomers (71 mg, 0.24 mmol, 79% yield). 1H NMR (500 MHz, CDCl3): δ 7.63 
(d, J = 7.8 Hz, 1H), 7.42 (d, J = 8.2 Hz, 1H), 7.24 – 7.18 (m, 1H), 7.14 – 7.06 (m, 2H), 6.50 – 
6.47 (m, 1H), 4.22 – 4.09 (m, 2H), 2.05 – 1.95 (m, 1H), 1.87 – 1.77 (m, 1H), 1.28 (s, 12H), 1.12 
– 1.00 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 135.94, 128.52, 127.80, 121.14, 120.81, 
119.03, 109.50, 100.72, 83.15, 45.78, 33.67, 24.83, 24.77, 15.46. 11B NMR (128 MHz, CDCl3): 
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δ 34.37. IR (thin film): ν 2975, 2871, 1463, 1387, 1369, 1315, 1142, 737 cm-1. HRMS (EI) 
(m/z): [M+H+] calculated for C18H27BNO2, 300.2129 found, 300.2131. 
6.2.4 Synthesis of Trifluoroborate Salts 
General Procedure for Synthesis of Trifluoroborate Salts46,177 
Acetone (0.5 M) was added to the boronic ester (1.0 equiv) and cooled in an ice bath. KHF2 (3.0 
equiv) and deionized water (1.5 M) were added. The reaction was capped with a septum, and a 
nitrogen line was inserted. The ice bath was removed, and the reaction was allowed to stir at rt. 
After 30 min the reaction mixture was concentrated. The pinacol and water were azeotroped with 
toluene, and the residual solvent was removed on high vacuum. The crude material was extracted 
with hot acetone (4x20 mL) and filtered. The mixture was concentrated to < 1 mL and copious 
amounts of hexanes were added. The mixture was sonicated for ~2 min, and the suspension was 
placed in the freezer (-20 °C) overnight. The resulting white crystalline solid was collected via 
vacuum filtration washing with hexanes. 
Potassium (4-phenylbutan-2-yl)trifluoroborate 
 
Following the general procedure, KHF2 (618 mg, 8.70 mmol) and deionized H2O (1.9 mL) were 
added to acetone (5.8 mL) and 4,4,5,5-tetramethyl-2-(4-phenylbutan-2-yl)-1,3,2-dioxaborolane 
(780 mg, 2.90 mmol). The white solid was precipitated from 200 mL of hexanes affording the 
desired product (495 mg, 2.06 mmol, 71 % yield). 1H NMR (500 MHz, Acetone-d6): δ 7.22 – 
7.12 (m, 4H), 7.09 – 7.03 (m, 1H), 2.71 – 2.62 (m, 1H), 2.58 – 2.47 (m, 1H), 1.77 – 1.66 (m, 
1H), 1.36 – 1.23 (m, 1H), 0.82 (d, J = 7.2 Hz, 3H), 0.32 (s, 1H). 13C NMR (126 MHz, Acetone-
d6): δ 145.79, 128.92, 128.42, 125.31, 36.93, 36.16, 16.16. The spectral data matched the 
literature.50 
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Potassium trifluoro(6-hydroxyhexan-2-yl)borate 
 
Following the general procedure, KHF2 (351 mg, 4.5 mmol) and deionized H2O (1.0 mL) were 
added to acetone (3.0 mL) and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-1-ol (342 
mg, 1.5 mmol). The white solid was precipitated from 150 mL of hexanes affording the desired 
product (217 mg, 1.04 mmol, 70 % yield).  1H NMR (500 MHz, Acetone-d6): δ 3.50 (q, J = 6.2 
Hz, 2H), 3.23 (t, J = 5.4 Hz, 1H), 1.50 – 1.38 (m, 4H), 1.31 – 1.20 (m, 1H), 1.06 – 0.94 (m, 1H), 
0.74 (d, J = 7.6 Hz, 3H), 0.26 (s, 1H). 13C NMR (126 MHz, Acetone-d6): δ 62.98, 34.74, 34.37, 
26.01, 16.39. 11B NMR (128 MHz, Acetone-d6): δ 5.50. 19F NMR (377 MHz, Acetone-d6): δ -
147.33. IR (KBr pellet): ν 3594, 3430, 2934, 2853, 1459, 1276, 1087, 1067, 1003, 904 cm-1. 
HRMS (EI) (m/z): [M-K-] calculated for C6H13BF3O, 169.1017 found, 169.1016. 
Potassium trifluoro(6-(pivaloyloxy)hexan-2-yl)borate 
 
Following the general procedure, KHF2 (169 mg, 2.16 mmol) and deionized H2O (0.5 mL) were 
added to acetone (1.4 mL) and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexyl pivalate 
(225 mg, 0.72 mmol). The white solid was precipitated from 150 mL of hexanes affording the 
desired product (144 mg, 0.49 mmol, 69 % yield). 1H NMR (500 MHz, Acetone-d6): δ 4.01 
(t, J = 6.8 Hz, 2H), 1.64 – 1.48 (m, 2H), 1.48 – 1.41 (m, 2H), 1.32 – 1.25 (m, 1H), 1.16 (s, 9H), 
1.07 – 0.99 (m, 1H), 0.75 (d, J = 7.2 Hz, 3H), 0.26 (s, 1H). 13C NMR (126 MHz, Acetone-d6): δ 
178.28, 65.23, 39.14, 33.95, 27.45, 25.85, 25.21, 16.19. 11B NMR (128 MHz, Acetone-d6): δ 
5.52. 19F NMR (377 MHz, Acetone-d6): δ -147.39. IR (KBr pellet): ν 3432, 2970, 2938, 2868, 
1720, 1480, 1463, 1290, 1179 cm-1.  HRMS (EI) (m/z): [M-K-] calculated for C11H21BF3O2 
253.1592 found, 253.1595.  
HO
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Potassium (4-(1H-indol-1-yl)butan-2-yl)trifluoroborate  
 
Following the general procedure, KHF2 (234 mg, 3.0 mmol) and deionized H2O (0.67 mL) were 
added to acetone (2.0 mL) and 17 (300 mg, 1.0 mmol). The white solid was precipitated from 
150 mL of hexanes affording the desired product (182 mg, 0.65 mmol, 65 % yield). 1H NMR 
(500 MHz, Acetone-d6): δ 7.55 – 7.47 (m, 1H), 7.43 (d, J = 8.3 Hz, 1H), 7.24 (d, J = 3.2, 1.1 Hz, 
1H), 7.08 (ddt, J = 8.3, 6.9, 1.2 Hz, 1H), 6.95 (ddt, J = 9.1, 7.8, 1.6 Hz, 1H), 6.36 – 6.33 (m, 1H), 
4.28 – 4.13 (m, 2H), 1.95 – 1.81 (m, 1H), 1.61 – 1.51 (m, 1H), 0.85 (d, J = 7.2 Hz, 3H), 0.37 (s, 
1H). 13C NMR (126 MHz, Acetone-d6): δ 137.30, 129.89, 129.31, 121.73, 121.47, 119.60, 
110.84, 100.92, 47.30, 35.80, 16.89. 11B NMR (128 MHz, Acetone-d6): δ 5.09. 19F NMR (377 
MHz, Acetone-d6): δ -146.71. IR (KBr plate): ν 3621, 3052, 2933, 2868, 1890, 1612, 1464, 751 
cm-1. HRMS (EI) (m/z): [M-K-] calculated for C12H14BF3N, 240.1177 found, 2410.1179. 
6.2.5 Photocatalytic Cross-coupling 
General Procedure for Photocatalytic Cross-Couplings46 
Following the Molander procedure, to a thin threaded culture tube, NiCl2·dme (2.2 mg, 0.01 
mmol) and 4,4’-di-tert-2,2’-bipyridine (2.7 mg, 0.01 mmol) were added under N2. THF (0.4 mL, 
0.5 M) was added and vial was heated with a heat gun until the solids were fully dissolved. The 
reaction mixture was concentrated in vacuo leaving behind a blue/green solid. The aryl bromide 
(0.2 mmol), potassium trifluoroborate salt (0.3 mmol), Ir[dFCF3ppy]2(bpy)PF648 (5.0 mg, 0.005 
mmol) and Cs2CO3 (98 mg, 0.3 mmol) were added. The reaction vial was sealed with a septum 
and purged with N2 four times. 4.0 mL (0.05 M) 1,4-dioxane (freeze, pumped, thawed three 
times) were added. The reaction was stirred ~4 cm away from two 23 W compact fluorescent 
N BF3K
 99 
(CFL) light bulbs while a fan was blown across to keep constant temperature. After ~22 h the 
reaction was filtered through a Celite plug with 20 mL EtOAc. The solvent was removed in 
vacuo, and the crude residue was purified via flash chromatography on silica gel to afford the 
desired product. 
4-(4-Phenylbutan-2-yl)biphenyl (2-52) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), 4-bromobiphenyl (47 mg, 0.2 mmol), potassium (4-
phenylbutan-2-yl)trifluoroborate (72 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 
mmol), and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via 
column chromatography (5% EtOAc in hexanes) to afford the desired product (54 mg, 0.190 
mmol, 95% yield).  1H NMR (500 MHz, CDCl3): δ 7.66 – 7.60 (m, 2H), 7.60 – 7.53 (m, 2H), 
7.50 – 7.42 (m, 2H), 7.37 – 7.32 (m, 1H), 7.32 – 7.25 (m, 4H), 7.22 – 7.15 (m, 3H), 2.84 – 2.75 
(m, 1H), 2.61 – 2.55 (m, 2H), 2.05 – 1.89 (m, 2H), 1.34 (d, J = 7.4 Hz, 3H), 1.29 – 1.25 (m, 1H). 
13C NMR (126 MHz, CDCl3): δ 146.41, 142.48, 141.10, 138.87, 128.69, 128.37, 128.26, 
127.47, 127.11, 126.98, 126.97, 125.65, 39.94, 39.15, 33.93, 22.48. IR (thin film): ν 3025, 
29.21, 1601, 1485, 1452, 836, 763, 731, 695 cm-1. HRMS (EI) (m/z): [M+] calculated for 
C22H22, 286.1722 found, 286.1727. 
  
Ph
Ph
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2-Fluoro-5-(4-phenylbutan-2-yl)pyridine (2-53) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), 5-bromo-2-fluoropyridine (35 mg, 0.2 mmol), potassium (4-
phenylbutan-2-yl)trifluoroborate (72 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 
mmol), and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via 
column chromatography (5% EtOAc in hexanes) to afford the desired product (43 mg, 0.189 
mmol, 95% yield).  1H NMR (500 MHz, CDCl3): δ 8.03 (s, 1H), 7.61 (td, J = 8.1, 2.5 Hz, 1H), 
7.31 – 7.23 (m, 2H), 7.23 – 7.15 (m, 1H), 7.15 – 7.08 (m, 2H), 6.88 (dd, J = 8.4, 2.9 Hz, 1H), 
2.82 – 2.71 (m, 1H), 2.57 – 2.47 (m, 2H), 2.01 – 1.84 (m, 2H), 1.29 (d, J = 7.0 Hz, 3H). 13C 
NMR (126 MHz, CDCl3): δ 162.32 (d, J = 236.8 Hz), 146.29 (d, J = 14.2 Hz), 141.65, 139.84 
(d, J = 4.9 Hz), 139.33 (d, J = 7.6 Hz), 128.38, 128.26, 125.89, 109.23 (d, J = 37.2 Hz), 39.61 , 
36.06 , 33.64 , 22.23. IR (thin film): ν 3026, 2921, 1594, 1481, 1454, 1400, 1249, 831, 731, 698 
cm-1. HRMS (EI) (m/z): [M+H+] calculated for C15H16FN, 230.1340 found, 230.1337. 
4-(4-Phenylbutan-2-yl)benzonitrile (2-54) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), 4-bromobenzonitrile (36 mg, 0.2 mmol), potassium (4-
phenylbutan-2-yl)trifluoroborate (72 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 
Ph
N
F
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mmol), and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via 
column chromatography (5% EtOAc in hexanes) to afford the desired product (26 mg, 0.112 
mmol, 56% yield. 1H NMR (500 MHz, CDCl3): δ 7.64 – 7.58 (m, 2H), 7.35 – 7.25 (m, 4H), 
7.21 – 7.15 (m, 1H), 7.14 – 7.07 (m, 2H), 2.83 – 2.73 (m, 1H), 2.57 – 2.42 (m, 2H), 1.97 – 1.87 
(m, 2H), 1.28 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 152.91, 141.73, 132.31, 
128.37, 128.26, 127.90, 125.88, 119.08, 109.86, 39.65, 39.46, 33.69, 21.99. IR (thin film): ν 
3027, 2924, 2226, 1606, 1495, 1454, 1032, 1018, 836, 748, 698 cm-1. HRMS (EI) (m/z): [M+] 
calculated for C17H17N, 235.1361 found, 235.1361. 
N-(4-(4-phenylbutane-2-yl)phenyl)acetamide (2-55) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), N-(4-bromophenyl)acetamide (43 mg, 0.2 mmol), potassium (4-
phenylbutan-2-yl)trifluoroborate (72 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 
mmol), and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via 
column chromatography (5% EtOAc in hexanes) to afford the desired product (28 mg, 0.106 
mmol, 53% yield. 1H NMR (500 MHz, CDCl3):  δ 7.45 – 7.40 (m, 2H), 7.28 – 7.23 (m, 2H), 
7.19 – 7.09 (m, 5H), 2.76 – 2.63 (m, 1H), 2.58 – 2.42 (m, 2H), 2.17 (s, 3H), 1.92 – 1.83 (m, 2H), 
1.31 – 1.20 (m, 4H). 13C NMR (126 MHz, CDCl3):  δ 168.12, 143.38, 142.45, 135.69, 128.33, 
128.25, 127.54, 125.62, 120.06, 39.93, 38.94, 33.85, 24.57, 22.54. IR (thin film): ν 3296, 2922, 
1660, 1602, 1537, 1514, 1412, 1370, 1318, 1264, 836 cm-1. HRMS (EI) (m/z): [M+] calculated 
for C18H22NO, 268.1696 found, 268.1694. 
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5-(Biphenyl-4-yl)hexan-1-ol (2-56) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), 4-bromobiphenyl (35 mg, 0.2 mmol), potassium trifluoro(6-
hydroxyhexan-2-yl)borate (62 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 mmol), 
and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via column 
chromatography (10% EtOAc in hexanes) to afford the desired product (31 mg, 0.122 mmol, 
60% yield).  1H NMR (500 MHz, CDCl3): δ 7.60 (d, J = 10.0 Hz, 2H), 7.53 (d, J = 7.9 Hz, 2H), 
7.43 (t, J = 7.6 Hz, 2H), 7.36 – 7.30 (m, 1H), 7.27 – 7.24 (m, 2H), 3.61 (t, J = 6.7 Hz, 2H), 2.75 
(sextet, J = 7.0 Hz, 1H), 1.68 – 1.60 (m, 2H), 1.60 – 1.53 (m, 2H), 1.41 – 1.31 (m, 1H), 1.29 
(d, J = 6.9 Hz, 4H), 1.27 – 1.18 (m, 1H). 13C NMR (126 MHz, CDCl3): δ 146.70, 141.09, 
138.77, 128.66, 127.36, 127.04, 126.96, 126.94, 62.93, 39.61, 38.17, 32.85, 23.91, 22.29. IR 
(thin film): ν 3341, 2925, 1485, 1452, 1408, 1312, 1073, 1039, 1007, 836 cm-1. HRMS (EI) 
(m/z): [M+] calculated for C18H22O, 254.1671 found, 254.1666. 
5-(Biphenyl-4-yl)hexyl pivalate (2-57) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), 4-bromobiphenyl (35 mg, 0.2 mmol), potassium trifluoro(6-
Ph
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(pivaloyloxy)hexan-2-yl)borate (88 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 
mmol), and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via 
column chromatography (5% EtOAc in hexanes) to afford the desired product (58 mg, 0.173 
mmol, 86% yield). 1H NMR (500 MHz, CDCl3): δ 7.62 – 7.56 (m, 2H), 7.55 – 7.50 (m, 2H), 
7.47 – 7.40 (m, 2H), 7.35 – 7.30 (m, 1H), 7.28 – 7.23 (m, 2H), 4.03 (t, J = 6.6 Hz, 2H), 2.78 – 
2.68 (m, 1H), 1.71 – 1.54 (m, 4H), 1.39 – 1.26 (m, 5H), 1.16 (s, 9H). 13C NMR (126 MHz, 
CDCl3): δ 178.54, 146.54, 141.13, 138.83, 128.66, 127.34, 127.05, 126.97, 126.94, 64.14, 39.48, 
38.69, 37.87, 28.64, 27.15, 23.96, 22.29. IR (thin film): ν 2958, 1725, 1485, 1283, 1152, 837, 
765, 732, 696 cm-1. HRMS (EI) (m/z): [M+H+] calculated for C23H31O2, 339.2319 found, 
339.2316. 
1-(3-(Biphenyl-4-yl)butyl)-1H-indole (2-58) 
 
The general procedure was followed using NiCl2·dme (2.2 mg, 0.01 mmol), 4,4’-di-tert-2,2’-
bipyridine (2.7 mg, 0.01 mmol), 4-bromobiphenyl (35 mg, 0.2 mmol), potassium (4-(1H-indol-1-
yl)butan-2-yl)trifluoroborate (88 mg, 0.3 mmol), Ir[dFCF3ppy]2(bpy)PF6 (5.0 mg, 0.005 mmol), 
and Cs2CO3 (98 mg, 0.3 mmol) in 4 mL 1,4-dioxane. The crude residue was purified via column 
chromatography (1% EtOAc in hexanes) to afford the desired product (43 mg, 0.131 mmol, 65% 
yield). 1H NMR (500 MHz, CDCl3): δ 7.66 – 7.56 (m, 5H), 7.46 (td, J = 7.8, 2.0 Hz, 2H), 7.36 
(dd, J = 8.3, 6.3 Hz, 1H), 7.29 (dd, J = 8.2, 1.9 Hz, 2H), 7.24 (d, J = 8.5 Hz, 1H), 7.21 – 7.16 (m, 
1H), 7.13 – 7.09 (m, 1H), 7.06 – 7.03 (m, 1H), 6.51 – 6.46 (m, 1H), 4.11 – 3.97 (m, 2H), 2.82 – 
2.72 (m, 1H), 2.27 – 2.12 (m, 2H), 1.32 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 
N
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145.09, 140.91, 139.35, 135.82, 128.75, 128.60, 127.68, 127.46, 127.37, 127.13, 127.00, 121.30, 
120.93, 119.20, 109.36, 100.97, 44.57, 38.04, 37.11, 22.87. IR (thin film): ν 2956, 2157, 1510, 
1485, 1462, 1315, 1262, 1007, 763, 731 cm-1. HRMS (EI) (m/z): [M+H+] calculated for 
C24H23N, 326.1903 found, 326.1900. 
6.2.6 Enantioselectivity Investigation 
0.2 M Solvent was added to a solid mixture of CuCl (10 mol %), Ligand (12 mol %), and KO-t-
Bu (1.5 equiv) under N2. The reaction was allowed to stir at rt for 10 minutes. B2pin2 (2.0 equiv) 
was added under N2 and the reaction was allowed to stir for an additional 30 minutes at rt. 4-
Phenyl-1-butene (1.0 equiv) and MeOH (2.0 equiv) were added to the mixture by syringe. The 
reaction mixture was allowed to stir at rt for 2 h and was then filtered through silica gel, eluting 
with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo. The crude residue was 
purified via flash chromatography (100% hexanes- 96:4 hexanes: EtOAc) Following literature 
precedent, conversion of the secondary alkylborane to the secondary alcohol was performed for 
enantioselectivity determination.26  
  
 105 
Reaction using ligand 2-59 
 
The general procedure was followed using CuCl (2.0 mg, 0.02 mmol), 2-59 (11.6 mg, 0.024 
mmol), KO-t-Bu (34 mg, 0.3 mmol), B2pin2 (102 mg, 0.4 mmol), 4-phenyl-1-butene (26 mg, 0.2 
mmol), MeOH (13 mg, 0.4 mmol) and 1.5 mL of acetonitrile. The crude residue was purified via 
flash chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as 
an 86:14 mixture of regioisomers (29 mg, 0.11 mmol, 56% yield). The enantioselectivity was 
determined by SFC analysis: OD-H column, 3 mL/min, 20% i-PrOH, 120 bar, 40 °C, 24% ee. 
Racemic 
 
Table 6-1: Racemic SFC Trace for 4-Phenyl-2-butanol 3 Minute Run 
  
N N
PhPh iPr
iPr
iPrSO3
2-59
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Reaction with ligand 2-59 
 
Table 6-2: SFC Trace for Reaction with Ligand 2-59 
Reaction at room temperature with ligand 2-60 
 
The general procedure was followed using CuCl (2.0 mg, 0.02 mmol), 2-60 (15.2 mg, 0.024 
mmol), KO-t-Bu (34 mg, 0.3 mmol), B2pin2 (102 mg, 0.4 mmol), 4-phenyl-1-butene (26 mg, 0.2 
mmol), MeOH (13 mg, 0.4 mmol) and 1.0 mL of tetrahydrofuran. The crude residue was purified 
via flash chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product 
as a 70:30 mixture of regioisomers (50.0 mg, 0.19 mmol, 96% yield). The enantioselectivity was 
determined by HPLC analysis: OD-H column, 0.75 mL/min, 10% i-PrOH 15% ee. 
N N
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Racemic 
 
 
Table 6-3: Racemic SFC Trace for 4-Phenyl-2-butanol 
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Reaction at room temperature with ligand 2-60 
 
 
Table 6-4: HPLC Trace for Reaction with Ligand 2-60 at Room Temperature 
Reaction at -35 °C with ligand 2-60 
 
The general procedure was followed using CuCl (2.0 mg, 0.02 mmol), 2-60 (15.2 mg, 0.024 
mmol), KO-t-Bu (34 mg, 0.3 mmol), B2pin2 (102 mg, 0.4 mmol) and 1.0 mL of tetrahydrofuran. 
The reaction was cooled to -35 °C before, 4-phenyl-1-butene (26 mg, 0.2 mmol), MeOH (13 mg, 
0.4 mmol) were added. The crude residue was purified via flash chromatography (100% hexanes 
to 4% EtOAc in hexanes) to afford the desired product as a 70:30 mixture of regioisomers (17.1 
N N
PhPh
SO3
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mg, 0.066 mmol, 33% yield). The enantioselectivity was determined by HPLC analysis: OD-H 
column, 0.75 mL/min, 10% i-PrOH, 13% ee. 
 
 
Table 6-5: HPLC Trace for Reaction with Ligand 2-60 at -35 °C 
Reaction using ligand 2-61 
 
The general procedure was followed using CuCl (2.0 mg, 0.02 mmol), 2-61 (15.0 mg, 0.024 
mmol), KO-t-Bu (34 mg, 0.3 mmol), B2pin2 (102 mg, 0.4 mmol), 4-phenyl-1-butene (26 mg, 0.2 
mmol), MeOH (13 mg, 0.4 mmol) and 1.5 mL of acetonitrile. The crude residue was purified via 
flash chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as 
N N
PhPh iPr
iPr
iPr
iPr BF4
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a >98:2 mixture of regioisomers (44 mg, 0.17 mmol, 85% yield). The enantioselectivity was 
determined by SFC analysis: OD-H column, 3 mL/min, 20% i-PrOH, 120 bar, 40 °C, 8% ee. 
 
 
Table 6-6 SFC Trace for Reaction with Ligand 2-61 
Reaction using catalyst 2-62 in tetrahydrofuran 
 
The general procedure was followed using 2-62 (3.6 mg, 0.005 mmol), KO-t-Bu (16.8 mg, 0.15 
mmol), B2pin2 (51 mg, 0.2 mmol), 4-phenyl-1-butene (13 mg, 0.1 mmol), MeOH (6.4 mg, 
0.42mmol) and 0.5 mL of tetrahydrofuran. The crude residue was a mixture of regioisomers 
>98:2 and was directly oxidized (6.1 mg, 0.04 mmol, 41% yield). The enantioselectivity was 
determined by SFC analysis: OD-H column, 3 mL/min, 5% i-PrOH, 120 bar, 40 °C, 5% ee. 
N N
PhPh iPr
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Racemic 
 
 
Table 6-7: Racemic SFC Trace for 4-Phenyl-2-butanol 10 Minute Run 
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Reaction using catalyst 2-62 in tetrahydrofuran 
 
 
Table 6-8: Reaction Using Catalyst 2-62 in Tetrahydrofuran 
Reaction using catalyst 2-62 in toluene 
 
The general procedure was followed using 2-62 (3.6 mg, 0.005 mmol), KO-t-Bu (16.8 mg, 0.15 
mmol), B2pin2 (51 mg, 0.2 mmol), 4-phenyl-1-butene (13 mg, 0.1 mmol), MeOH (6.4 mg, 
0.42mmol) and 0.5 mL of toluene. The crude residue was a mixture of isomers >98:2 that was 
directly oxidized (7.6 mg, 0.05 mmol, 51% yield). The enantioselectivity was determined by 
SFC analysis: OD-H column, 3 mL/min, 5% i-PrOH, 120 bar, 40 °C, 7% ee. 
N N
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Table 6-9: Reaction Using Catalyst 2-62 in Toluene 
Reaction using catalyst 2-62 in acetonitrile 
 
The general procedure was followed using 2-62 (3.6 mg, 0.005 mmol), KO-t-Bu (16.8 mg, 0.15 
mmol), B2pin2 (51 mg, 0.2 mmol), 4-phenyl-1-butene (13 mg, 0.1 mmol), MeOH (6.4 mg, 
0.42mmol) and 0.5 mL of acetonitrile. The crude residue was a mixture of isomers 95:5 that 
were directly oxidized (7.6 mg, 0.05 mmol, 51% yield). The enantioselectivity was determined 
by SFC analysis: OD-H column, 3 mL/min, 5% i-PrOH, 120 bar, 40 °C, 2% ee. 
N N
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Table 6-10: Reaction Using Catalyst 2-62 in Tetrahydrofuran 
6.2.7 Hydroboration of 1,2-Disubstituted Olefins 
6.2.7.1 GC-FID Calibration Curves 
Solutions containing a constant amount of internal standard, tridecane, (0.200 mmol) and varying 
amounts of 2-27 (0.0485, 0.0970, 0.1455, 0.1940 mmol) were prepared in ethyl acetate. Each 
sample was analyzed by GC-FID and the response factor (F) was calculated via a linear 
regression to calculate the slope (F) of equation 1. Equation 2 was used to determine the amount 
of desired product.  
area of 2-27
mmol of 2-27=F
area of standard
mmol of standard
   (𝑒𝑞𝑢𝑎𝑡𝑖𝑜𝑛 1)  
mmol of 2-27=
mmol of standard (area of 2-27)
F (area of standard)
  (𝑒𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2) 
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mmol 2-27 area 2-27 area IS mmol IS 
0.0485 13729811 53246861 0.2 
0.0970 22790204 44791016 0.2 
0.1455 47609265 62355222 0.2 
0.1940 63872472 61831334 0.2 
Table 6-11: Calibration Curve for 2-27 
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6.2.7.2 Tables of Reaction Screens for Hydroboration of Internal Olefins 
Table 6-12 summarized the hydroboration of trans-2-octene with nickel and palladium catalysts 
and a variety of N-heterocyclic carbenes. 
 
Entry [M] Ligand Solvent temp a:b:c:d Yield(GCFID) 
1 Ni(cod)2 IPr·HCl THF rt - 
 2 Ni(cod)2 IMes·HCl THF rt - 
 3 Ni(cod)2 ICy·HBF4 THF rt - 
 4 Ni(cod)2 DMIPr·HCl THF rt - 
 5 Pd2(dba)3 IPr·HCl THF rt - 
 6 Pd2(dba)3 IMes·HCl THF rt - 
 7 Pd2(dba)3 ICy·HBF4 THF rt - 
 8 Pd2(dba)3 DMIPr·HCl THF rt - 
 9 Pd(OAc)2 IPr·HCl Toluene 100 °C 100:0:0:0 trace 
10 Pd(OAc)2 IMes·HCl Toluene 100 °C 100:0:0:0 trace 
11 Pd(OAc)2 DMIPr·HCl Toluene 100 °C - 
 12 Pd(OAc)2 ICy·HBF4 Toluene 100 °C - 
 13 Pd(OAc)2 IPrBAC·HCl Toluene 100 °C 39:37:24:0 9%:8%:5%:0% 
14 Pd(OAc)2 IPr*OMe Toluene 100 °C - 
 15 Pd(OAc)2 iprNHC·HCl Toluene 100 °C 55:24:20:1 7%:3%:2%:<1% 
16 Pd(OAc)2 BMIMCl Toluene 100 °C 19:39:40:3 11%:23%:24%:2% 
17 Pd(OAc)2 MeNHC·HCl Toluene 100 °C -   
Table 6-12 Hydroboration of Internal Olefins with Nickel and Palladium 
  
HBpin
Bpin
2-27
a
b
c d
+
2-63
[M] (10 mol %)
Ligand (12 mol %)
KO-t-Bu or nBuLi (12 mol %)
Solvent, temp
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Table 6-13 summarizes the hydroboration of trans-2-octene with an iron catalyst in several 
solvents. 
 
Entry Ligand Solvent temp a:b:c:d 
1 A Cyclohexane 60 °C 100:0:0:0 
2 A THF 60 °C 100:0:0:0 
3 A Toluene 60 °C 100:0:0:0 
4 A CH3CN 60 °C - 
5 Xantphos Cyclohexane 60 °C 100:0:0:0 
6 Xantphos THF 60 °C 100:0:0:0 
7 Xantphos Toluene 60 °C 100:0:0:0 
8 Xantphos CH3CN 60 °C - 
Table 6-13 Hydroboration of Internal Olefins with Iron 
 
Table 6-14 summarizes the hydroboration of trans-2-octene with cobalt and LiBHEt3. 
 
Entry Ligand Solvent temp a:b:c:d 
xx 
LiBHEt3 
1 A Toluene 60 °C 100:0:0:0 20 mol % 
2 A Toluene 60 °C 100:0:0:0 10 mol % 
3 A Toluene 60 °C 100:0:0:0 5 mol % 
4 A Toluene 60 °C - - 
5 XantPhos THF 60 °C 100:0:0:0 20 mol % 
6 XantPhos THF 60 °C 100:0:0:0 10 mol % 
7 XantPhos THF 60 °C ND 5 mol % 
8 XantPhos THF 60 °C - - 
Table 6-14 Hydroboration of Internal Olefins with Cobalt and Additive 
  
HBpin
Bpin
2-27
a
b
c d
+
2-63
Fe(OAc)2 (10 mol %)
Ligand (12 mol %)
LiBHEt3 (30 mol %)
Solvent, temp
N NH
Ph
P
A
HBpin
Bpin
2-27
a
b
c d
+
2-63
CoI2 (10 mol %)
Ligand (12 mol %)
LiBHEt3 (xx mol %)
Solvent, temp
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Table 6-15 summarizes hydroboration of trans-2-octene with cobalt and no additive in a variety 
of solvents. 
 
Entry Ligand Solvent temp a:b:c:d Note 
1 A Cyclohexane 60 °C 100:0:0:0 
 2 A THF 60 °C 100:0:0:0 
 3 A Toluene 60 °C 100:0:0:0 55% isolated 
4 A CH3CN 60 °C - 
 5 Xantphos Cyclohexane 60 °C 100:0:0:0 
 6 Xantphos THF 60 °C ND product unable to analyze 
7 Xantphos Toluene 60 °C ND product unable to analyze 
8 Xantphos CH3CN 60 °C -   
Table 6-15 Hydroboration of Internal Olefin with Cobalt and No Additive 
  
CoI2 (10 mol %)
Ligand (12 mol %)HBpin
solvent, temp
Bpin
2-27
a
b
c d
+
2-63
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Table 6-16 summarizes the hydroboration of trans-2-octene with palladium and phosphine 
ligands. 
 
Entry [Pd] Ligand Solvent temp a:b:c:d Notes 
1 Pd(OAc)2 XantPhos THF 60 °C - 
 2 Pd(OAc)2 S-Phos THF 60 °C 100:0:0:0 
 3 Pd(OAc)2 A THF 60 °C - 
 4 Pd(OAc)2 S-Phos Toluene 100 °C 100:0:0:0 
 5 Pd(OAc)2 Trinapth Toluene 100 °C - 
 6 Pd(OAc)2 Ru-Phos Toluene 100 °C 100:0:0:0 
 7 Pd(OAc)2 TTMPP Toluene 100 °C - 
 8 Pd(OAc)2 BrettPhos Toluene 100 °C - 
 9 Pd(OAc)2 Xantphos Toluene 100 °C 100:0:0:0 trace isomers  
10 Pd(OAc)2 rac-BINAP Toluene 100 °C 100:0:0:0 trace isomers  
11 Pd(OAc)2 DPEPhos Toluene 100 °C 100:0:0:0 
 
12 Pd(OAc)2 
(S)-DTBM-
SEGPHOS Toluene 100 °C 100:0:0:0 
 13 Pd(OAc)2 PhDavePhos Toluene 100 °C 100:0:0:0 trace isomers  
14 Pd(OAc)2 DiPhos Toluene 100 °C 100:0:0:0 trace isomers  
15 Pd(OAc)2 BiPhos Toluene 100 °C - trace isomer  
16 Pd2(dba)3 S-Phos Toluene 100 °C - 
 17 Pd2(dba)3 Trinapth Toluene 100 °C - 
 18 Pd2(dba)3 Ru-Phos Toluene 100 °C - 
 19 Pd2(dba)3 TTMPP Toluene 100 °C - 
 20 Pd2(dba)3 BrettPhos Toluene 100 °C -   
Table 6-16 Hydroboration of Internal Olefins with Palladium and Phosphine Ligands 
  
[Pd] (10 mol %)
Ligand (12 mol %)HBpin
solvent, temp
Bpin
2-27
a
b
c d
+
2-63
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Table 6-17 summarizes the failed hydroboration reactions of trans-2-octene with copper 
catalysts. 
 
 
Entry [Cu] Ligand Solvent temp 
1 IPrCuCl - nhexane rt 
2 IMesCuCl - nhexane rt 
3 ICyCuCl - nhexane rt 
4 CuCl BIPHEP nhexane rt 
5 CuCl BIPHEP THF rt 
6 CuCl BIPHEP Toluene rt 
7 CuCl A nhexane rt 
8 CuCl A THF rt 
9 CuCl A Toluene rt 
10 CuCl A nhexane 60 °C 
11 CuCl A THF 60 °C 
12 CuCl A Toluene 60 °C 
13 CuCl A CH3CN 60 °C 
14 CuCl XantPhos nhexane rt 
15 CuCl XantPhos THF rt 
16 CuCl XantPhos Toluene rt 
17 CuCl XantPhos nhexane 60 °C 
18 CuCl XantPhos THF 60 °C 
19 CuCl XantPhos Toluene 60 °C 
20 CuCl XantPhos MeCN 60 °C 
Table 6-17 Hydroboration of Internal Olefins with Copper 
  
[Cu] (10 mol %)
Ligand (12 mol %)
KO-t-Bu (20 mol %)
Solvent, temp
HBpin
Bpin
2-27
a
b
c d
+
2-63
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6.2.8 Synthesis of Tertiary Alkylboranes 
General procedures for copper-catalyzed hydroboration of trisubstituted olefins: 
1.5 mL of dichloromethane was added to a solid mixture of IPrCuCl (0.03 mmol) and NaO-t-Bu 
(0.3 mmol) under N2. The reaction was allowed to stir at rt for 10 minutes. B2pin2 (0.6 mmol) 
was added under N2 and the reaction was allowed to stir for an additional 30 minutes at rt. The 
alkene (0.3 mmol) and MeOH (0.6 mmol) were added to the mixture by syringe. The reaction 
mixture was allowed to stir at rt for 2 h and was then filtered through silica gel, eluting with 50% 
v/v EtOAc/hexanes. The solvent was removed in vacuo, and the crude residue was purified via 
flash chromatography on silica gel to afford the desired product. 
4,4,5,5-tetramethyl-2-(2-methyl-4-phenylbutan-2-yl)-1,3,2-dioxaborolane (2-68) 
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), NaO-t-Bu (29 mg, 0.3 
mmol), B2pin2 (152 mg, 0.6 mmol), (3-methylbut-3-enyl)benzene (44 mg, 0.3 mmol) and MeOH 
(19 mg, 0.6 mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 91:9 
mixture of regioisomers (72 mg, 0.26 mmol, 87% yield). 1H NMR (500 MHz, CDCl3): δ 7.34 – 
7.24 (m, 2H), 7.22 – 7.14 (m, 3H), 2.61 – 2.54 (m, 2H), 1.63 – 1.56 (m, 2H), 1.27 (s, 12H), 1.02 
(s, 6H). 13C NMR (126 MHz, CDCl3): δ 143.63, 128.31, 128.19, 125.42, 82.96, 43.50, 33.06, 
24.76, 24.74. 11B NMR (128 MHz, CDCl3): δ 34.80. IR (thin film): ν 2937, 2861, 1474, 1388, 
1365, 1306, 1134, 854, 693 cm-1. HRMS (EI) (m/z): [M+H+] calculated for C17H27BO2, 
274.2104 found, 274.2110. 
  
Ph
Bpin
2-68
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4,4,5,5-tetramethyl-2-(3-methyl-1-phenylpentan-3-yl)-1,3,2-dioxaborolane (2-71) 
 
The title compound was prepared from IPrCuCl (14.6 mg, 0.03 mmol), NaO-t-Bu (29 mg, 0.3 
mmol), B2pin2 (152 mg, 0.6 mmol), (3-methylenepentyl)benzene (48 mg, 0.3 mmol) and MeOH 
(19 mg, 0.6 mmol) by following the general procedure. The crude residue was purified via flash 
chromatography (100% hexanes to 4% EtOAc in hexanes) to afford the desired product as a 93:7 
mixture of regioisomers (51 mg, 0.26 mmol, 59% yield). 1H NMR (700 MHz, CDCl3): δ 7.28 – 
7.25 (m, 2H), 7.20 – 7.18 (m, 2H), 7.16 (td, J = 7.2, 1.4 Hz, 1H), 2.58 (td, J = 13.0, 5.0 Hz, 1H), 
2.52 (td, J = 13.0, 4.7 Hz, 1H), 1.71 (td, J = 13.0, 4.7 Hz, 1H), 1.56 – 1.45 (m, 2H), 1.33 – 1.23 
(m, 13H), 0.98 (s, 3H), 0.88 (t, J = 7.5 Hz, 3H). 13C NMR (176 MHz, CDCl3): δ 143.76, 128.32, 
128.20, 125.42, 82.98, 41.35, 32.43, 31.38, 24.90, 24.84, 20.83, 10.05. 11B NMR (128 MHz, 
CDCl3): δ 34.49. IR (thin film): ν 2974, 2931, 1456, 1370, 1306, 1260, 1138, 852, 698 cm-1. 
HRMS (EI) (m/z): [M+H+] calculated for C18H20BO2, 289.2333 found, 289.2335. 
6.3 Chapter 4 Experimental 
6.3.1 Synthesis of 2-Hydroxy Mannose 4-28 
α/β-D-Mannose pentaacetate 
 
D-(+)-mannose (5.0 g, 27.8 mmol) and I2 (247 mg, 0.973 mmol) were added to a flask and 
backfilled with N2 before being cooled to 0 °C. Ac2O (25 mL, 1.1 M) was added via syringe. The 
reaction was allowed to stir overnight gradually warming to room temperature. 50 mL Na2S2O3 
Ph
Bpin
2-71
D-(+)-mannose
I2 (0.035 equiv)
Ac2O, 0 °C-rtO
HO
HO
HO
OH
OH
O
AcO
AcO
AcO
OAc
OAc
 123 
was added. The reaction was extracted 3x50 mL CH2Cl2. The combined organic layers were 
dried over MgSO4 and filtered. The solvent was removed in vacuo and the crude material was 
used without further purification. 
(2R,3R,4S,5S,6R)-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate (4-
23) 
 
α/β-D-Mannose pentaacetate (10.8 g, 27.8 mmol) was dissolved in CH2Cl2 (28 mL, 1.0 M). HBr 
(20 mL, 83.4 mmol, 33% weight in AcOH) was carefully added. The flask was capped with a 
septum and a balloon. The reaction was allowed to stir at room temperature for 4 h. The reaction 
was poured over ice. After ~5 minutes, the reaction was diluted with 200 mL CH2Cl2. Saturated 
NaHCO3 was carefully added until gas formation ceased. The reaction continued to stir for 30 
minutes. The layers were separated. The aqueous layer was washed 2x200 mL CH2Cl2. The 
combined organic layers were washed 2x200 mL saturated NaHCO3, dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the crude material was used without further 
purification. 
(3aS,5R,6R,7S,7aS)-5-(acetoxymethyl)-2-ethoxy-2-methyltetrahydro-3aH-[1,3]dioxolo[4,5-
b]pyran-6,7-diyl diacetate (4-24) 
 
CH2Cl2 (140 mL, 0.2 M) was added via syringe to a stirring solution of 4-23 (11.4 g, 27.8 mmol) 
and tetrabutyl ammonium bromide (2.2 g 6.7 mmol). Distilled 2,6-lutidine (6.1 mL, 52.8 mmol) 
O
AcO
AcO
AcO
OAc
Br4-23
 HBr (3.0 equiv)
CH2Cl2, rtO
AcO
AcO
AcO
OAc
OAc
4-24
80% over 3 steps
O
AcO
AcO
AcO
O
O
OEt
O
AcO
AcO
AcO
OAc
Br
2,6-lutidine (1.9 equiv)
EtOH (1.6 equiv)
Bu4NBr (0.24 equiv)
CH2Cl2, reflux4-23
 124 
and dry ethanol (2.6 mL, 44.5 mmol) were added via syringe. The reaction was heated to reflux 
and allowed to stir overnight. The reaction was cooled to room temperature and diluted with 200 
mL CH2Cl2. The reaction was washed 2x200 mL water, 1x200 mL saturated NaHCO3, dried 
over MgSO4, and filtered. The solvent was removed in vacuo and the crude residue was 
recrystallized from CH2Cl2/pentanes affording a white crystalline solid (8.35 g, 22.2 mmol, 
80%). 1H NMR (700 MHz, CDCl3): δ 5.30 (d, J = 2.5 Hz, 1H), 5.03 (t, J = 9.7 Hz, 1H), 4.96 
(dd, J = 9.9, 3.9 Hz, 1H), 4.35 (dd, J = 4.0, 2.5 Hz, 1H), 4.00 (dd, J = 12.2, 4.7 Hz, 1H), 3.89 
(dd, J = 12.2, 2.6 Hz, 1H), 3.53 – 3.48 (m, 1H), 3.37 – 3.22 (m, 2H), 1.87 (s, 3H), 1.83 (s, 3H), 
1.81 (s, 3H), 1.49 (s, 3H), 0.93 (t, J = 7.1 Hz, 3H). 13C NMR (176 MHz, CDCl3): δ 169.98, 
169.72, 168.93, 123.76, 96.89, 76.25, 70.61, 70.16, 65.17, 61.77, 57.36, 24.53, 20.18, 20.14, 
20.12, 14.56. HRMS (ESI) (m/z): [M+Na+] calculated for NaC16H24O10, 399.1262 found, 
399.1261. 
(3aS,5R,6R,7S,7aS)-6,7-bis(benzyloxy)-5-(benzyloxymethyl)-2-ethoxy-2-methyltetrahydro-
3aH-[1,3]dioxolo[4,5-b]pyran (4-25) 
 
4-24 (10.4 g, 27.6 mmol) was added to a flask and dissolved in MeOH (276 mL, 0.1 M). NaOMe 
(746 mg, 13.8 mmol, 95%) was added. The reaction was allowed to stir until full conversion via 
TLC. The solvent was removed in vacuo. Bu4NI (1.02 g, 2.76 mmol) was added and the flask 
was backfilled with N2. DMF (138 mL, 0.2 M) and BnBr (16.4 mL, 138 mmol) were added via 
syringe. The flask was cooled to 0 °C. NaH (3.2 g, 88.3 mmol, 95%) was added slowly under a 
stream of N2. The reaction was allowed to stir for 4 h gradually warming to room temperature. 
4-24
i) NaOMe (0.5 equiv)
 MeOH, rt
4-25
59%
O
AcO
AcO
AcO
O
O
OEt
O
BnO
BnO
BnO
O
O
OEt
ii) BnBr (5.0 equiv)
NaH (3.2 equiv)
Bu4NI (0.1 equiv)
DMF, 0 °C-rt
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20 mL MeOH was added to quench the reaction. 200 mL NaHCO3 was added and the reaction 
was allowed to stir an additional 30 minutes at room temperature. The reaction was extracted 
3x200 mL Et2O. The combined organic layers were washed 5x200 mL brine, dried over MgSO4 
and filtered. The solvent was removed in vacuo. The crude residue was purified via flash 
chromatography (80:20-70:30 hexanes: EtOAc) then recrystallized from 
dichloromethane/pentanes to afford the desired product (8.51 g, 16.3 mmol, 59%). 1H NMR 
(700 MHz, CDCl3): δ 7.42 – 7.37 (m, 2H), 7.35 – 7.25 (m, 10H), 7.25 – 7.23 (m, 2H), 5.33 (d, J 
= 2.5 Hz, 1H), 4.90 (d, J = 10.8 Hz, 1H), 4.81 – 4.74 (m, 2H), 4.62 (d, J = 1.9 Hz, 1H), 4.60 (d, J 
= 3.3 Hz, 1H), 4.56 (s, 1H), 4.54 (s, 1H), 4.38 (dd, J = 4.0, 2.6 Hz, 1H), 3.92 (t, J = 9.3 Hz, 1H), 
3.77 – 3.68 (m, 3H), 3.61 – 3.51 (m, 2H), 3.42 (ddd, J = 9.5, 4.6, 2.2 Hz, 1H), 1.75 (s, 3H), 1.22 
(t, J = 7.0 Hz, 3H). 13C NMR (176 MHz, CDCl3): δ 138.33, 137.95, 128.57, 128.47, 128.37, 
128.13, 128.11, 128.05, 127.83, 127.60, 127.57, 123.81, 97.59, 79.13, 76.98, 75.31, 74.34, 74.26, 
73.44, 72.46, 69.12, 58.02, 24.82, 15.34. HRMS (ESI) (m/z): [M+NH4+] calculated for 
C31H40NO7, 538.2799 found, 538.2794. 
(2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-2H-
pyran-3-yl acetate (4-26) 
 
4-25 (1.0 g, 1.92 mmol) and 2-iodophenol (1.1 g, 4.99 mmol) were added to a flask before being 
backfilled 2xN2. CH2Cl2 (13 mL, 0.15 M) and distilled Et3N (0.27 mL, 1.92 mmol) were added 
via syringe. The reaction was allowed to stir at room temperature for 20 minutes before being 
cooled to 0 °C. BF3·OEt2 (1.2 mL, 9.6 mmol) was added dropwise via syringe. The reaction was 
2-iodophenol (2.6 equiv)
Et3N (1.0 equiv)
BF3·OEt2 (5.0 equiv)
CH2Cl2, 0 °C-rt
O
BnO
BnO
BnO
OAc
O
I4-26
73%
4-25
O
BnO
BnO
BnO
O
O
OEt
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allowed to stir gradually warming to room temperature. After full conversion via mass 
spectroscopy Et3N was added to quench the reaction. The solvent was removed in vacuo. The 
reaction was filtered through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was 
removed in vacuo. The crude material was purified via flash chromatography, Biotage (100% 
hexanes-80:20 hexanes: EtOAc) to afford product that was used without further purification (988 
mg, 1.42 mmol, 73%). 1H NMR (700 MHz, CDCl3): δ 7.75 (dd, J = 7.8, 1.4 Hz, 1H), 7.40 (d, J 
= 7.4 Hz, 2H), 7.35 – 7.24 (m, 12H), 7.19 (d, J = 7.2 Hz, 2H), 7.13 (d, J = 8.2 Hz, 1H), 6.77 (t, J 
= 7.6 Hz, 1H), 5.59 (d, J = 11.9 Hz, 2H), 4.92 (d, J = 10.8 Hz, 1H), 4.80 (d, J = 11.4 Hz, 1H), 
4.67 (dd, J = 18.4, 11.7 Hz, 2H), 4.53 (d, J = 10.7 Hz, 1H), 4.45 (d, J = 12.0 Hz, 1H), 4.34 (dd, J 
= 9.5, 3.2 Hz, 1H), 4.06 (t, J = 9.7 Hz, 1H), 3.92 – 3.88 (m, 1H), 3.81 (dd, J = 11.0, 4.2 Hz, 1H), 
3.66 (dd, J = 11.0, 1.8 Hz, 1H), 2.21 (s, 3H). 13C NMR (176 MHz, CDCl3): δ 170.44, 154.87, 
139.45, 138.39, 138.14, 137.82, 129.62, 128.56, 128.43, 128.39, 128.37, 128.36, 127.94, 127.82, 
127.72, 127.67, 124.29, 114.96, 96.73, 87.15, 77.51, 75.27, 74.06, 73.41, 72.61, 72.12, 68.78, 
68.61, 21.18. HRMS (ESI) (m/z): [M+Na+] calculated for NaC35H35IO7, 717.1320 found, 
717.1313. 
(2R,3S,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-ol (4-27) 
 
4-26 (1.72 g, 2.49 mmol) was added to a flask and dissolved in MeOH (25 mL, 0.1 M). NaOMe 
(471 mg, 8.72 mmol, 95%) was added to the reaction. The reaction was allowed to stir at room 
temperature until full conversion of starting material was seen by TLC.  The reaction was diluted 
NaOMe (3.5 equiv)
MeOH, rt
O
BnO
BnO
BnO
OH
O
I4-27
70%
O
BnO
BnO
BnO
OAc
O
I4-26
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with 100 mL sat. NH4Cl and acidified to pH=3 with 2 M HCl. The reaction was extracted 3x75 
mL EtOAc. The combined organic layers were dried over Na2SO4 and filtered. The solvent was 
removed in vacuo. The reaction was purified via flash chromatography, Biotage (95:5-70:30 
hexanes: EtOAc) to afford the desired product (1.10 g, 1.69 mmol, 70%). 1H NMR (700 MHz, 
CDCl3):  δ 7.71 – 7.66 (m, 1H), 7.37 (dd, J = 7.4, 1.9 Hz, 2H), 7.31 (t, J = 7.6, 1.9 Hz, 2H), 7.28 
– 7.18 (m, 9H), 7.17 – 7.13 (m, 4H), 6.71 (t, J = 7.5 Hz, 1H), 5.57 (s, 1H), 4.82 (d, J = 10.4 Hz, 
1H), 4.77 – 4.70 (m, 3H), 4.56 (d, J = 11.7 Hz, 1H), 4.51 (d, J = 10.1 Hz, 1H), 4.40 (d, J = 11.5 
Hz, 1H), 4.21 – 4.18 (m, 1H), 4.18 – 4.13 (m, 1H), 3.96 (t, J = 9.2 Hz, 1H), 3.85 – 3.79 (m, 1H), 
3.71 (dt, J = 11.0, 3.0 Hz, 1H), 3.59 (d, J = 10.6 Hz, 1H). 13C NMR (176 MHz, CDCl3): δ 
155.02, 139.34, 138.34, 138.17, 137.83, 129.65, 128.68, 128.40, 128.34, 128.27, 128.13, 127.98, 
127.88, 127.75, 127.61, 124.12, 115.28, 98.30, 87.26, 79.54, 75.21, 74.01, 73.39, 72.44, 72.29, 
68.70, 68.51. HRMS (ESI) (m/z): [M+Na+] calculated for NaC33H33IO6, 675.1214 found, 
675.1209. 
(2R,3S,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-ol (4-28) 
 
Following a modified procedure,166 4-27 (1.1 g, 1.69 mmol), para-methoxyphenylacetylene (780 
mg, 5.90 mmol), Pd(PPh3)2Cl2 (119 mg, 0.169 mmol), CuI (161 mg, 0.845 mmol), and PPh3 
(222 mg, 0.845 mmol) were added to a 2-neck round bottom flask with reflux condenser before 
being back filled 2xN2. DMF (28 mL, 0.06 M) and distilled iPr2NH (47 mL, 0.036 M) were 
added via syringe. The reaction was heated to 70 °C and allowed to stir overnight. The reaction 
OMe
PPh3 (0.5 equiv)
CuI (0.5 equiv)
Pd(PPh3)2Cl2 (0.1 equiv)
iPr2NH, DMF, 70 °C
O
BnO
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O
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was cooled to room temperature and 60 mL saturated NH4Cl was added. The reaction was 
extracted 3x60 mL EtOAc. The combined organic layers were washed 2x60 mL H2O, 5x 60 mL 
brine, dried over Na2SO4 and filtered. The solvent was removed in vacuo. The reaction was 
filtered through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in 
vacuo. The reaction was purified via flash chromatography, Biotage (97:3-70:30 hexanes: 
EtOAc) to afford the desired product (909 mg, 1.38 mmol, 82%). 1H NMR (700 MHz, CDCl3): 
δ 7.55 (d, J = 8.3 Hz, 3H), 7.40 – 7.28 (m, 14H), 7.26 (t, J = 8.1 Hz, 3H), 7.07 (t, J = 7.4 Hz, 
1H), 6.73 (d, J = 8.4 Hz, 2H), 5.88 (s, 1H), 4.93 (d, J = 10.8 Hz, 1H), 4.78 – 4.70 (m, 2H), 4.68 
(d, J = 12.0 Hz, 1H), 4.62 (d, J = 10.8 Hz, 1H), 4.48 (d, J = 12.0 Hz, 1H), 4.40 (s, 1H), 4.34 (dd, 
J = 9.3, 3.2 Hz, 1H), 4.25 (dd, J = 10.3, 2.7 Hz, 2H), 4.12 (t, J = 9.6 Hz, 1H), 3.87 (dd, J = 11.1, 
4.3 Hz, 1H), 3.78 (s, 3H), 3.72 (dd, J = 11.2, 1.9 Hz, 1H), 3.00 (s, 1H). 13C NMR (176 MHz, 
CDCl3): δ 159.52, 156.14, 138.46, 138.09, 137.95, 132.97, 132.93, 129.31, 128.43, 128.22, 
127.87, 127.84, 127.81, 127.79, 127.70, 127.50, 127.48, 122.43, 115.81, 115.37, 114.73, 113.91, 
97.90, 93.76, 84.03, 80.41, 75.03, 74.07, 73.17, 72.26, 72.12, 68.60, 68.29, 55.19. HRMS (ESI) 
(m/z): [M+NH4+] calculated for C42H37NO7, 674.3112 found, 674.3104. 
6.3.2 Synthesis of 2-Hydroxy Glucose Sugar 4-36 and 4-38 
(2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate 
 
β-D-glucose pentaacetate (10.8 g, 27.8 mmol) was dissolved in CH2Cl2 (28 mL, 1.0 M). HBr (20 
mL, 83.4 mmol, 33% weight in AcOH) was carefully added. The flask was capped with a septum 
and a balloon. The reaction was allowed to stir at room temperature for 4 h. The reaction was 
O
AcO
AcO
AcO
OAcAcO
glucose pentaacetate
 HBr (3.0 equiv)
CH2Cl2, rt O
AcO
AcO
AcO
BrAcO
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poured over ice. After ~5 minutes, the reaction was diluted with 200 mL CH2Cl2. Saturated 
NaHCO3 was carefully added until gas formation ceased. The reaction continued to stir for 30 
minutes. The layers were separated. The aqueous layer was washed 2x200 mL CH2Cl2. The 
combined organic layers were washed 2x200 mL saturated NaHCO3, dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the crude material was used without further 
purification. 
(3aR,5R,6R,7S,7aR)-5-(acetoxymethyl)-2-ethoxy-2-methyltetrahydro-3aH-[1,3]dioxolo[4,5-
b]pyran-6,7-diyl diacetate (4-31) 
 
CH2Cl2 (140 mL, 0.2 M) was added via syringe to a stirring solution of (2R,3R,4S,5R,6R)-2-
(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate (11.4 g, 27.8 mmol) and 
tetrabutyl ammonium bromide (2.2 g 6.7 mmol). Distilled 2,6-lutidine (6.1 mL, 52.8 mmol) and 
dry ethanol (2.6 mL, 44.5 mmol) were added via syringe. The reaction was heated to reflux and 
allowed to stir overnight. The reaction was cooled to room temperature and diluted with 200 mL 
CH2Cl2. The reaction was washed 2x200 mL water, 1x200 mL saturated NaHCO3, dried over 
MgSO4, and filtered. The solvent was removed in vacuo and the crude residue was recrystallized 
from CH2Cl2/pentanes affording a white crystalline solid that was used without further 
purification (7.03 g, 18.7 mmol, 68%). 1H NMR (700 MHz, CDCl3):  δ 5.70 (d, J = 5.2 Hz, 1H), 
5.17 (t, J = 2.8 Hz, 1H), 4.92 – 4.83 (m, 1H), 4.34 – 4.28 (m, 1H), 4.22 – 4.14 (m, 2H), 3.95 – 
3.91 (m, 1H), 3.55 – 3.47 (m, 2H), 2.09 (s, 3H), 2.08 (s, 3H), 2.07 (s, 3H), 1.70 (s, 2H), 1.16 (t, J 
= 7.1 Hz, 3H). 13C NMR (176 MHz, CDCl3): δ 170.67, 169.64, 169.16, 121.24, 96.88, 73.04, 
O
AcO
AcO
AcO
BrAcO
2,6-lutidine (1.9 equiv)
EtOH (1.6 equiv)
Bu4NBr (0.24 equiv)
CH2Cl2, reflux
O
AcO
AcO
AcO
O O
OEt4-31
68% over 2 steps
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70.12, 68.21, 66.92, 63.06, 59.16, 20.79, 20.78, 20.75, 20.74, 15.26. HRMS (ESI) (m/z): 
[M+Na+] calculated for NaC16H24O10, 399.1262 found, 399.1266. 
(3aR,5R,6R,7S,7aR)-6,7-bis(benzyloxy)-5-(benzyloxymethyl)-2-ethoxy-2-methyltetrahydro-
3aH-[1,3]dioxolo[4,5-b]pyran (4-32) 
 
4-31 (7.0 g, 18.6 mmol) was added to a flask and dissolved in MeOH (186 mL, 0.1 M). NaOMe 
(502 mg, 9.3 mmol, 95%) was added. The reaction was allowed to stir until full conversion via 
TLC. The solvent was removed in vacuo. Bu4NI (687 mg, 1.86 mmol) was added and the flask 
was backfilled with N2. DMF (93 mL, 0.2 M) and BnBr (11.0 mL, 93.0 mmol) were added via 
syringe. The flask was cooled to 0 °C. NaH (2.2 g, 59.5 mmol, 95%) was added slowly under a 
stream of N2. The reaction was allowed to stir for 4 h gradually warming to room temperature. 
15 mL MeOH was added to quench the reaction. 200 mL NaHCO3 was added and the reaction 
was allowed to stir an additional 30 minutes at room temperature. The reaction was extracted 
3x150 mL Et2O. The combined organic layers were washed 5x200 mL brine, dried over MgSO4 
and filtered. The solvent was removed in vacuo. The crude residue was purified via flash 
chromatography (80:20-hexanes: EtOAc) to afford the desired product that was used without 
further purification (9.2 g, 17.7 mmol, 95%). 1H NMR (500 MHz, CDCl3): δ 7.41 – 7.24 (m, 
13H), 7.18 (dd, J = 7.4, 2.2 Hz, 2H), 5.77 (d, J = 5.2 Hz, 1H), 4.73 – 4.69 (m, 1H), 4.59 (dd, J = 
12.0, 9.0 Hz, 4H), 4.53 – 4.48 (m, 2H), 4.43 – 4.39 (m, 2H), 3.88 (t, J = 4.0 Hz, 1H), 3.79 (dt, J 
= 9.5, 3.1 Hz, 1H), 3.71 (dd, J = 9.5, 4.6 Hz, 1H), 3.66 (t, J = 3.7 Hz, 2H), 3.59 – 3.50 (m, 2H), 
1.67 (d, J = 2.3 Hz, 3H), 1.20 (t, J = 7.1 Hz, 4H). 13C NMR (126 MHz, CDCl3): δ 138.19, 
O
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 MeOH, rt
ii) BnBr (5.0 equiv)
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138.03, 137.83, 129.10, 128.87, 128.52, 128.49, 128.47, 128.42, 128.41, 128.10, 128.08, 127.96, 
127.92, 127.85, 127.80, 127.72, 127.67, 121.05, 97.87, 78.93, 75.89, 75.01, 73.49, 73.03, 72.00, 
70.57, 69.22, 58.77, 21.95, 15.43. HRMS (ESI) (m/z): [M+Na+] calculated for NaC31H36O7, 
543.2353 found, 543.2350. 
(2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-yl acetate (4-33) 
 
4-32 (1.0 g, 1.92 mmol) and 2-iodophenol (1.1 g, 4.99 mmol) were added to a flask before being 
backfilled 2xN2. CH2Cl2 (13 mL, 0.15 M) and distilled Et3N (0.27 mL, 1.92 mmol) were added 
via syringe. The reaction was allowed to stir at room temperature for 20 minutes before being 
cooled to 0 °C. BF3·OEt2 (1.2 mL, 9.6 mmol) was added dropwise via syringe. The reaction was 
allowed to stir gradually warming to room temperature overnight. Et3N was added to quench the 
reaction. The solvent was removed in vacuo. The reaction was filtered through silica gel, eluting 
with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo. The crude material was 
purified via flash chromatography, Biotage (97:3 hexanes: EtOAc-70:30 hexanes: EtOAc) 
followed by recrystallization from CH2Cl2/pentane to afford the desired product (320 mg, 0.49 
mmol, 26%). 1H NMR (700 MHz, CDCl3):  7.73 (dd, J = 7.8, 1.5 Hz, 1H), 7.34 – 7.25 (m, 
12H), 7.20 (d, J = 7.5 Hz, 3H), 7.10 (d, J = 8.2 Hz, 1H), 6.76 (t, J = 7.5 Hz, 1H), 5.37 (t, J = 8.5 
Hz, 1H), 4.90 (d, J = 7.9 Hz, 1H), 4.81 (dd, J = 11.1, 4.7 Hz, 2H), 4.70 (d, J = 11.4 Hz, 1H), 4.61 
– 4.56 (m, 2H), 4.53 (d, J = 12.0 Hz, 1H), 3.82 – 3.71 (m, 4H), 3.71 – 3.63 (m, 2H), 2.01 (s, 3H). 
13C NMR (176 MHz, CDCl3): δ 169.45, 156.47, 139.55, 138.10, 138.07, 137.81, 129.64, 
2-iodophenol (2.6 equiv)
Et3N (1.0 equiv)
BF3·OEt2 (5.0 equiv)
CH2Cl2, 0 °C-rt
overnight
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128.57, 128.55, 128.46, 128.13, 128.05, 128.03, 127.91, 127.77, 127.73, 124.55, 116.01, 100.09, 
86.86, 82.88, 77.88, 75.69, 75.21, 75.18, 73.64, 72.38, 68.83, 21.60. HRMS (ESI) (m/z): 
[M+Na+] calculated for NaC35H35IO7, 717.1320 found, 717.1310. 
(2R,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-yl acetate (4-34) 
 
4-32 (7.9 g, 15.2 mmol) and 2-iodophenol (6.7 g, 430.4 mmol) were added to a flask before 
being backfilled 2xN2. CH2Cl2 (100 mL, 0.15 M) and distilled Et3N (1.34 mL, 9.6 mmol) were 
added via syringe. The reaction was allowed to stir at room temperature for 20 minutes before 
being cooled to 0 °C. BF3·OEt2 (14.9 mL, 120 mmol) was added dropwise via syringe. The 
reaction was allowed to stir gradually warming to room temperature for several days. Et3N was 
added to quench the reaction. The solvent was removed in vacuo. The reaction was filtered 
through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo. The 
crude material was purified via flash chromatography (97:3 hexanes-70:30 hexanes: EtOAc) to 
afford the desired product that was used with out further purification (1.76 mg, 2.53 mmol, 
17%). 
(2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-ol (4-35) 
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4-33 (320 mg, 0.46 mmol) was added to a flask and dissolved in MeOH (4.6 mL, 0.1 M) and 
THF (1.0 mL). NaOMe (87 mg, 1.61 mmol, 95%) was added to the reaction. The reaction was 
allowed to stir at room temperature until full conversion of starting material was seen by TLC.  
The reaction was diluted with 10 mL sat. NH4Cl and acidified to pH=3 with 2 M HCl. The 
reaction was extracted 3x10 mL CH2Cl2. The combined organic layers were dried over MgSO4 
and filtered. The solvent was removed in vacuo. The crude material was purified recrystallization 
from CH2Cl2/pentanes (184 mg, 0.28 mmol, 61%). 1H NMR (700 MHz, CDCl3):  δ 7.77 (d, J = 
7.9 Hz, 1H), 7.42 (d, J = 7.5 Hz, 2H), 7.38 – 7.27 (m, 10H), 7.26 (d, J = 6.6 Hz, 1H), 7.24 – 7.19 
(m, 3H), 6.83 (t, J = 7.5 Hz, 1H), 5.05 (d, J = 11.2 Hz, 1H), 4.89 (dd, J = 22.3, 11.0 Hz, 2H), 
4.80 (d, J = 7.7 Hz, 1H), 4.66 – 4.55 (m, 3H), 3.98 (t, J = 8.2 Hz, 1H), 3.83 (d, J = 10.7 Hz, 1H), 
3.76 – 3.64 (m, 5H), 2.82 – 2.78 (m, 1H). 13C NMR (176 MHz, CDCl3): δ 156.28, 139.16, 
138.63, 138.15, 138.07, 129.95, 128.51, 128.46, 128.40, 128.08, 128.07, 127.92, 127.80, 127.73, 
124.94, 116.85, 103.00, 87.76, 84.01, 75.64, 75.32, 75.22, 74.93, 73.60, 68.97. HRMS (ESI) 
(m/z): [M+Na+] calculated for NaC33H33IO7, 675.1214 found, 675.1204. 
(2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-ol (4-36) 
 
Following a modified procedure,166 4-35 (503 mg, 0.77 mmol), para-methoxyphenylacetylene 
(357 mg, 2.7 mmol), Pd(PPh3)2Cl2 (54 mg, 0.0.077 mmol), CuI (73 mg, 0.385 mmol), and PPh3 
(101 mg, 0.385 mmol) were added to a 2-neck round bottom flask with reflux condenser before 
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being back filled 2xN2. DMF (13 mL, 0.06 M) and distilled iPr2NH (21 mL, 0.036 M) were 
added via syringe. The reaction was heated to 70 °C and allowed to stir overnight. The reaction 
was cooled to room temperature and 50 mL saturated NH4Cl was added. The reaction was 
extracted 3x30 mL EtOAc. The combined organic layers were washed 2x50 mL H2O, 5x 50 mL 
brine, dried over Na2SO4 and filtered. The solvent was removed in vacuo. The reaction was 
filtered through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in 
vacuo. The reaction was purified via flash chromatography, Biotage (100% hexanes-80:20 
hexanes: EtOAc) to afford the desired product (281 mg, 0.43 mmol, 56%). 1H NMR (700 MHz, 
CDCl3):  δ 7.49 (d, J = 8.0 Hz, 3H), 7.41 (d, J = 7.5 Hz, 2H), 7.36 – 7.24 (m, 13H), 7.21 (d, J = 
7.3 Hz, 2H), 7.09 – 7.05 (m, 1H), 6.89 (d, J = 8.4 Hz, 2H), 5.04 (d, J = 11.2 Hz, 1H), 4.89 (d, J = 
10.8 Hz, 1H), 4.85 (d, J = 11.3 Hz, 1H), 4.82 (d, J = 7.8 Hz, 1H), 4.63 (d, J = 12.1 Hz, 1H), 4.58 
(dd, J = 13.8, 11.5 Hz, 2H), 3.94 (t, J = 8.0 Hz, 1H), 3.82 (d, J = 18.2 Hz, 4H), 3.75 (dd, J = 
11.0, 5.2 Hz, 1H), 3.71 (dd, J = 10.7, 6.2 Hz, 2H), 3.66 – 3.61 (m, 1H), 2.99 (s, 1H). (176 MHz, 
CDCl3):  δ 159.87, 157.56, 138.74, 138.24, 138.15, 133.18, 132.98, 129.58, 128.47, 128.45, 
128.43, 128.09, 128.05, 127.86, 127.79, 127.71, 127.68, 123.53, 118.13, 115.17, 115.16, 114.17, 
103.17, 94.32, 84.18, 84.00, 75.65, 75.20, 75.18, 75.08, 73.57, 68.95, 55.41, 17.16, 17.13, 13.12. 
HRMS (ESI) (m/z): [M+Na+] calculated for NaC42H40O7, 679.2666 found, 679.2662. 
(2R,3R,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-ol (4-37) 
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4-34 (1.76 g, 2.53 mmol) was added to a flask and dissolved in MeOH (25 mL, 0.1 M) and THF 
(2.0 mL). NaOMe (479 mg, 8.87 mmol, 95%) was added to the reaction. The reaction was 
allowed to stir at room temperature until full conversion of reaction was seen by TLC.  The 
reaction was diluted with 50 mL sat. NH4Cl and acidified to pH=3 with 2 M HCl. The reaction 
was extracted 3x30 mL EtOAc. The combined organic layers were dried over MgSO4 and 
filtered. The solvent was removed in vacuo. The crude material was purified via flash 
chromatography, Biotage (95:5-70:30 hexanes:EtOAc) to afford the desired product (975 mg, 
1.50 mmol, 59%). 1H NMR (700 MHz, CDCl3): δ 7.73 (dd, J = 7.8, 1.5 Hz, 1H), 7.43 (d, J = 
7.2 Hz, 2H), 7.34 (dd, J = 8.2, 6.8 Hz, 2H), 7.32 – 7.19 (m, 8H), 7.19 – 7.15 (m, 2H), 6.79 (td, J 
= 7.5, 1.6 Hz, 1H), 5.54 (d, J = 3.7 Hz, 1H), 5.03 (d, J = 11.2 Hz, 1H), 4.92 (d, J = 11.1 Hz, 1H), 
4.88 (d, J = 10.8 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 10.7 Hz, 1H), 4.46 (d, J = 12.0 
Hz, 1H), 4.04 (t, J = 9.2 Hz, 1H), 3.91 (ddd, J = 10.1, 3.8, 2.1 Hz, 1H), 3.84 (td, J = 10.0, 3.7 Hz, 
1H), 3.79 – 3.75 (m, 2H), 3.64 (dd, J = 10.8, 2.0 Hz, 1H), 2.30 (d, J = 10.7 Hz, 1H). 13C NMR 
(176 MHz, CDCl3):  δ 155.30, 139.13, 138.57, 138.18, 137.84, 129.95, 128.53, 128.52, 128.46, 
128.46, 128.39, 127.97, 127.94, 127.92, 127.85, 127.83, 127.82, 124.51, 115.46, 99.40, 87.48, 
82.84, 75.47, 75.19, 73.55, 73.17, 71.74, 68.35. HRMS (ESI) (m/z): [M+Na+] calculated for 
NaC33H33IO6, 675.1214 found, 675.1206. 
(2R,3R,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-ol (4-37) 
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Following a modified procedure166, 4-36 (900 mg, 1.38 mmol), para-methoxyphenylacetylene 
(638 mg, 4.83 mmol), Pd(PPh3)2Cl2 (97 mg, 0.138 mmol), CuI (131 mg, 0.690 mmol), and PPh3 
(181 mg, 0.690 mmol) were added to a 2-neck round bottom flask with reflux condenser before 
being back filled 2xN2. DMF (23 mL, 0.06 M) and distilled iPr2NH (38 mL, 0.036 M) were 
added via syringe. The reaction was heated to 70 °C and allowed to stir overnight. The reaction 
was cooled to room temperature and 100 mL saturated NH4Cl was added. The reaction was 
extracted 3x50 mL EtOAc. The combined organic layers were washed 2x50 mL H2O, 5x 50 mL 
brine, dried over Na2SO4 and filtered. The solvent was removed in vacuo. The reaction was 
filtered through silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in 
vacuo. The reaction was purified via flash chromatography, Biotage (95:5-70:30 hexanes: 
EtOAc) to afford the desired product (546 mg, 0.83 mmol, 60%). 1H NMR (700 MHz, CDCl3):  
δ 7.50 (t, J = 9.0 Hz, 3H), 7.36 (d, J = 7.8 Hz, 2H), 7.34 – 7.25 (m, 13H), 7.18 – 7.14 (m, 2H), 
7.07 (ddt, J = 8.0, 5.5, 2.2 Hz, 1H), 6.77 – 6.72 (m, 2H), 5.65 – 5.57 (m, 1H), 4.97 (d, J = 11.0 
Hz, 1H), 4.87 (d, J = 10.6 Hz, 1H), 4.81 (d, J = 11.1 Hz, 1H), 4.64 (dd, J = 12.0, 1.5 Hz, 1H), 
4.54 (d, J = 10.7 Hz, 1H), 4.48 (dd, J = 12.0, 1.6 Hz, 1H), 4.18 (d, J = 9.5 Hz, 1H), 4.07 (td, J = 
9.2, 1.6 Hz, 1H), 3.96 – 3.89 (m, 1H), 3.82 – 3.76 (m, 2H), 3.75 (d, J = 1.6 Hz, 3H), 3.70 (d, J = 
10.8 Hz, 1H), 2.68 (d, J = 10.5 Hz, 1H). 13C NMR (176 MHz, CDCl3): δ 159.85, 157.11, 
138.82, 138.35, 137.93, 133.12, 132.81, 129.68, 128.44, 128.39, 127.95, 127.89, 127.77, 127.70, 
127.66, 123.19, 116.84, 115.11, 115.03, 114.11, 99.74, 94.44, 83.97, 77.04, 75.67, 75.10, 73.52, 
73.35, 71.70, 68.45, 55.35. HRMS (ESI) (m/z): [M+NH4+] calculated for C42H44NO7, 674.3112 
found, 674.3060. 
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6.3.3 Synthesis of Sugar Silane from 2-Hydroxy Sugars 
General Procedure: 
Dry CH2Cl2 (0.2 M) was added to the prospective 2-hydroxy sugar (1.0 equiv.) under N2. The 
reaction was cooled to 0 °C. Freshly distilled Et3N (2.0 equiv.) was added dropwise via syringe. 
After ~5 minutes distilled R2Si(H)Cl (1.3 equiv.) was added dropwise via syringe. The reaction 
was allowed to stir at 0 °C for 4 hours. Sat. NaHCO3 was added. The reaction was extracted 
3xCH2Cl2. The combined organic layers were washed 1xH2O, 1xbrine, dried over MgSO4 and 
filtered. The solvent was removed in vacuo. The material was either used as was or purified. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-21) 
 
The title compound was prepared from 4-28 (2.85 g, 4.34 mmol), iPr2Si(H)Cl (0.96 mL, 5.64 
mmol), Et3N (1.2 mL, 8.68 mmol) in 22 mL CH2Cl2 by following the general procedure. The 
crude residue was purified via flash chromatography, Biotage (100% hexanes-90:10 hexanes: 
EtOAc) to afford the desired product as a white solid (2.85 g, 3.70 mmol, 85%).  1H NMR (700 
MHz, CDCl3): δ 7.49 – 7.44 (m, 3H), 7.33 – 7.30 (m, 2H), 7.30 – 7.22 (m, 12H), 7.16 (dd, J = 
7.2, 2.4 Hz, 2H), 7.01 (td, J = 7.4, 1.2 Hz, 1H), 6.68 – 6.62 (m, 2H), 5.67 (d, J = 2.0 Hz, 1H), 
4.85 (d, J = 10.8 Hz, 1H), 4.75 (d, J = 11.4 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 11.4 
Hz, 1H), 4.52 (d, J = 10.7 Hz, 1H), 4.45 (t, J = 2.4 Hz, 1H), 4.43 (d, J = 12.0 Hz, 1H), 4.35 (s, 
4-21
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1H), 4.26 (dd, J = 8.7, 2.7 Hz, 1H), 4.12 – 4.06 (m, 2H), 3.80 (dd, J = 11.1, 4.1 Hz, 1H), 3.73 (s, 
3H), 3.69 (dd, J = 11.1, 1.6 Hz, 1H), 1.12 – 1.08 (m, 1H), 1.06 – 1.00 (m, 14H). 13C NMR (176 
MHz, CDCl3): δ 159.62, 156.42, 138.69, 138.64, 138.55, 133.13, 133.06, 129.36, 128.29, 
128.24, 128.23, 128.11, 127.69, 127.65, 127.63, 127.54, 127.42, 127.39, 122.39, 115.84, 115.56, 
114.76, 113.99, 98.75, 93.75, 84.15, 81.07, 75.09, 74.23, 73.07, 73.04, 72.55, 71.64, 69.06, 
55.35, 17.56, 17.55, 17.53, 17.42, 12.81, 12.76. HRMS (ESI) (m/z): [M+NH4+] calculated for 
C48H58NO7Si, 788.3977 found, 788.3973. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)dimethylsilane (4-29) 
 
The title compound was prepared from 4-28 (1.06 mg, 1.61 mmol), Me2Si(H)Cl (0.27 mL, 2.42 
mmol), Et3N (0.45 mL, 3.22 mmol) in 8 mL CH2Cl2 by following the general procedure. The 
crude yellow viscous oil was used as was (970 mg, 1.36 mmol, 84%). 1H NMR (700 MHz, 
CDCl3): δ 7.44 (t, J = 8.9 Hz, 4H), 7.31 – 7.25 (m, 9H), 7.24 – 7.21 (m, 5H), 7.18 (d, J = 8.3 Hz, 
1H), 7.14 – 7.11 (m, 2H), 6.99 (t, J = 7.4 Hz, 1H), 6.64 (d, J = 8.3 Hz, 2H), 5.63 (s, 1H), 4.83 (d, 
J = 10.7 Hz, 1H), 4.79 – 4.76 (m, 1H), 4.71 (d, J = 11.4 Hz, 1H), 4.62 (d, J = 12.1 Hz, 1H), 4.57 
(d, J = 11.4 Hz, 1H), 4.50 (d, J = 10.7 Hz, 1H), 4.40 (d, J = 12.0 Hz, 2H), 4.21 (dd, J = 8.9, 2.8 
Hz, 1H), 4.07 (dd, J = 10.0, 4.0 Hz, 1H), 3.78 (dd, J = 11.2, 4.3 Hz, 1H), 3.72 – 3.69 (m, 3H), 
3.66 (d, J = 11.4 Hz, 1H), 0.25 (d, J = 2.7 Hz, 3H), 0.21 (d, J = 2.8 Hz, 3H). 13C NMR (176 
MHz, CDCl3): δ 159.64, 156.43, 138.67, 138.47, 133.11, 133.08, 133.05, 129.39, 128.62, 
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128.37, 128.33, 128.30, 128.28, 128.01, 127.96, 127.85, 127.82, 127.73, 127.66, 127.59, 127.54, 
127.48, 122.43, 115.89, 115.53, 114.74, 114.02, 114.00, 98.85, 93.77, 84.14, 80.84, 75.06, 74.31, 
73.20, 73.05, 72.81, 71.16, 68.97, 55.35, -0.42, -0.54. HRMS (ESI) (m/z): [M+Na+] calculated 
for NaC44H46O7Si, 737.2905 found, 737.2895. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisobutylsilane (4-30) 
 
The title compound was prepared from 4-28 (342 mg, 0.52 mmol), iBu2Si(H)Cl (0.34 mL, 0.68 
mmol), Et3N (0.15 mL, 1.04 mmol) in 3 mL CH2Cl2 by following the general procedure. The 
crude residue was purified via flash chromatography, Biotage (97:3-70:30 hexanes: EtOAc) to 
afford the desired product as a colorless viscous oil (197 mg, 0.25 mmol, 47%). 1H NMR (700 
MHz, CDCl3):  δ 7.47 (t, J = 7.6 Hz, 3H), 7.33 (d, J = 6.7 Hz, 2H), 7.30 – 7.24 (m, 12H), 7.22 
(d, J = 8.3 Hz, 1H), 7.17 (dd, J = 7.3, 2.2 Hz, 2H), 7.02 (td, J = 7.5, 1.1 Hz, 1H), 6.69 – 6.65 (m, 
2H), 5.65 (d, J = 2.0 Hz, 1H), 4.86 (d, J = 10.7 Hz, 1H), 4.77 (p, J = 2.6 Hz, 1H), 4.74 (d, J = 
11.4 Hz, 1H), 4.61 (dd, J = 17.8, 11.7 Hz, 2H), 4.53 (d, J = 10.7 Hz, 1H), 4.45 – 4.40 (m, 2H), 
4.27 – 4.24 (m, 1H), 4.09 – 4.07 (m, 2H), 3.79 (dd, J = 11.1, 3.9 Hz, 1H), 3.74 (s, 3H), 3.71 – 
3.67 (m, 1H), 1.87 (dhept, J = 20.2, 6.7 Hz, 2H), 0.97 – 0.91 (m, 12H), 0.79 (dddd, J = 21.1, 
14.9, 6.8, 2.7 Hz, 2H), 0.72 (ddd, J = 14.8, 7.3, 2.6 Hz, 1H), 0.63 (ddd, J = 14.9, 7.5, 2.3 Hz, 
1H). 13C NMR (176 MHz, CDCl3): δ 159.62, 156.39, 138.68, 138.58, 138.51, 133.12, 133.05, 
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129.37, 128.30, 128.27, 128.25, 128.09, 127.73, 127.70, 127.56, 127.46, 127.42, 122.36, 115.78, 
115.55, 114.73, 113.99, 98.71, 93.75, 84.15, 80.93, 75.07, 74.33, 73.11, 73.01, 72.71, 71.46, 
69.01, 55.34, 26.21, 26.11, 25.98, 25.83, 25.54, 25.19, 24.55, 24.45. HRMS (ESI) (m/z): 
[M+NH4+] calculated for C50H62NO7Si, 816.4290 found, 816.4285.  
((2S,3R,4R,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl) 
ethynyl)phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-22) 
 
The title compound was prepared from 4-35 (280 mg, 0.43 mmol), iPr2Si(H)Cl (96 µL, 0.85 
mmol), Et3N (119 µL, 0.56 mmol) in 2.2 mL CH2Cl2 by following the general procedure. The 
crude residue was purified via flash chromatography, Biotage (100% hexanes-80:20 hexanes: 
EtOAc) to afford the desired product as light yellow viscous oil (191 mg, 0.25 mmol, 57%). 1H 
NMR (700 MHz, CDCl3): δ 7.50 (d, J = 7.4 Hz, 1H), 7.49 – 7.46 (m, 2H), 7.37 (d, J = 7.9 Hz, 
2H), 7.34 – 7.30 (m, 2H), 7.29 – 7.23 (m, 10H), 7.17 – 7.14 (m, 2H), 7.00 – 6.96 (m, 2H), 6.84 
(d, J = 8.7 Hz, 2H), 5.14 (td, J = 7.3, 1.4 Hz, 1H), 4.98 (d, J = 11.1 Hz, 1H), 4.87 (d, J = 11.1 Hz, 
1H), 4.80 (d, J = 10.8 Hz, 1H), 4.56 (d, J = 10.9 Hz, 1H), 4.54 – 4.45 (m, 3H), 4.07 (t, J = 7.3 
Hz, 1H), 3.82 (s, 3H), 3.76 (d, J = 10.1 Hz, 1H), 3.71 – 3.69 (m, 2H), 3.67 – 3.64 (m, 2H), 1.11 
(m, 2H), 0.94 (t, J = 6.9 Hz, 9H), 0.88 (dd, J = 7.4, 1.4 Hz, 3H). 13C NMR (176 MHz, CDCl3): 
δ 159.49, 156.79, 138.68, 138.22, 138.13, 133.79, 133.13, 129.10, 128.46, 128.35, 127.95, 
127.82, 127.79, 127.70, 127.57, 127.54, 121.84, 116.16, 114.24, 114.11, 113.87, 99.80, 93.60, 
86.27, 84.97, 77.83, 76.45, 75.70, 75.55, 75.01, 73.56, 68.86, 55.38, 17.61, 17.52, 17.37, 17.32, 
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12.65, 12.22. HRMS (ESI) (m/z): [M+NH4+] calculated for C48H58NO7Si, 788.3977 found, 
788.3968. 
((2R,3R,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-39) 
 
The title compound was prepared from 4-38 (546 mg, 0.83 mmol), iPr2Si(H)Cl (184 µL, 1.66 
mmol), Et3N (234 µL, 0.56 mmol) in 4.2 mL CH2Cl2 by following the general procedure. The 
crude residue was purified via flash chromatography, Biotage (100% hexanes-80:20 hexanes: 
EtOAc) to afford the desired product as a colorless viscous oil (447 mg, 6.29 mmol, 70%). 1H 
NMR (700 MHz, CDCl3): δ 7.51 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 7.6 Hz, 1H), 7.35 (d, J = 8.0 
Hz, 2H), 7.33 – 7.22 (m, 12H), 7.19 (d, J = 8.4 Hz, 1H), 7.09 – 7.05 (m, 2H), 6.99 (t, J = 7.4 Hz, 
1H), 6.65 (d, J = 8.0 Hz, 2H), 5.74 (d, J = 3.3 Hz, 1H), 4.99 (d, J = 11.1 Hz, 1H), 4.81 (dd, J = 
13.6, 11.2 Hz, 2H), 4.61 (d, J = 12.0 Hz, 1H), 4.48 (d, J = 10.7 Hz, 1H), 4.41 (d, J = 12.1 Hz, 
1H), 4.33 (s, 1H), 4.30 (td, J = 9.3, 1.4 Hz, 1H), 4.16 (dd, J = 10.1, 2.5 Hz, 1H), 4.06 (dd, J = 
9.5, 3.0 Hz, 1H), 3.85 – 3.79 (m, 1H), 3.76 (dd, J = 11.0, 2.9 Hz, 1H), 3.73 (s, 3H), 3.59 (d, J = 
10.9 Hz, 1H), 1.05 – 0.94 (m, 14H). 13C NMR (176 MHz, CDCl3): δ 159.48, 157.12, 139.07, 
138.50, 137.93, 133.14, 132.87, 129.21, 128.40, 128.33, 128.30, 128.06, 127.87, 127.74, 127.71, 
127.56, 127.44, 121.92, 115.93, 114.75, 114.40, 113.87, 97.12, 93.93, 84.51, 77.50, 75.84, 75.41, 
75.07, 73.45, 71.49, 68.32, 55.33, 17.42, 17.39, 17.37, 17.26, 17.20, 17.03, 12.86, 12.27. HRMS 
(ESI) (m/z): [M+NH4+] calculated for C48H58NO7Si, 788.3977 found, 788.3969. 
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6.3.4 Tethering Alcohols to Sugar Silanes 
General Procedure: 
Dry toluene (0.1 M) was added via syringe to the respective sugar silane (1.1 equiv.) and alcohol 
(1.0 equiv.) under N2. B(C6F5)3 (4 mol %) in minimal toluene was added via syringe. The 
reaction was allowed to stir at room temperature for 3-5 hours. B(C6F5)3 (4 mol %) in minimal 
toluene was added via syringe. The reaction was allowed to stir at room temperature overnight. 
The reaction was directly purified via flash chromatography, Biotage. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy) 
dimethylsilane (4-40) 
 
The title compound was prepared from 4-29 (79 mg, 0.11 mmol), (-)-menthol (16 mg, 0.1 
mmol), B(C6F5)3 (4.0 mg, 0.008 mmol) in 1.5 mL toluene by following the general procedure. 
The reaction was directly purified via flash chromatography, Biotage (100% hexanes-90:10 
hexanes: EtOAc) to afford the desired product as a colorless viscous oil (53 mg,  0.061 mmol, 
60%). 1H NMR (700 MHz, CDCl3): δ 7.46 – 7.42 (m, 3H), 7.29 – 7.17 (m, 16H), 7.14 (dd, J = 
7.3, 2.3 Hz, 2H), 6.98 (td, J = 7.5, 1.1 Hz, 1H), 6.62 (d, J = 8.7 Hz, 2H), 5.66 (d, J = 2.0 Hz, 1H), 
4.84 (d, J = 10.7 Hz, 1H), 4.69 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 11.9 Hz, 1H), 4.57 (d, J = 11.5 
Hz, 1H), 4.53 (d, J = 10.7 Hz, 1H), 4.48 (t, J = 2.5 Hz, 1H), 4.42 (d, J = 11.9 Hz, 1H), 4.22 (dd, J 
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= 9.3, 2.9 Hz, 1H), 4.09 (ddd, J = 9.9, 5.0, 1.8 Hz, 1H), 4.04 (t, J = 9.6 Hz, 1H), 3.79 (dd, J = 
11.3, 4.8 Hz, 1H), 3.70 (s, 3H), 3.68 (dd, J = 11.4, 1.8 Hz, 1H), 3.53 (td, J = 10.4, 4.3 Hz, 1H), 
2.11 (pd, J = 7.0, 2.6 Hz, 1H), 1.99 – 1.94 (m, 1H), 1.60 – 1.55 (m, 1H), 1.56 – 1.49 (m, 1H), 
1.33 – 1.26 (m, 1H), 1.10 (ddt, J = 12.8, 10.0, 3.1 Hz, 1H), 1.02 (td, J = 12.2, 10.7 Hz, 1H), 0.86 
(dt, J = 13.2, 2.9 Hz, 1H), 0.82 (d, J = 6.5 Hz, 3H), 0.78 (d, J = 7.1 Hz, 3H), 0.68 (d, J = 6.9 Hz, 
3H), 0.16 (s, 3H), 0.13 (s, 3H). 13C NMR (176 MHz, CDCl3): δ 159.62, 156.58, 138.76, 138.70, 
138.61, 133.13, 133.03, 129.37, 128.31, 128.30, 128.27, 127.99, 127.76, 127.66, 127.52, 127.46, 
127.41, 122.28, 115.63, 114.74, 113.99, 99.01, 93.70, 84.24, 80.55, 75.04, 74.66, 73.20, 73.12, 
72.81, 72.73, 69.48, 69.21, 55.35, 50.00, 45.49, 34.59, 31.73, 25.47, 22.94, 22.33, 21.20, 15.96, -
1.28, -1.35. HRMS (ESI) (m/z): [M+NH4+] calculated for C54H68NO8Si, 886.4709 found, 
886.4707. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropyl((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)silane (4-40) 
 
The title compound was prepared from 4-21 (85 mg, 0.11 mmol), (-)-menthol (16 mg, 0.1 
mmol), B(C6F5)3 (4.0 mg, 0.008 mmol) in 1.5 mL toluene by following the general procedure. 
The reaction was directly purified via flash chromatography, Biotage (97:3-85:15 hexanes: 
EtOAc) to afford the desired product as a colorless viscous oil (78 mg,  0.085 mmol, 85%). 1H 
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NMR (700 MHz, CDCl3): δ 7.51 – 7.45 (m, 3H), 7.32 – 7.22 (m, 17H), 7.19 (dd, J = 7.3, 2.2 
Hz, 2H), 7.01 (td, J = 7.4, 1.1 Hz, 1H), 6.68 – 6.59 (m, 2H), 5.70 (d, J = 2.0 Hz, 1H), 4.88 (d, J = 
10.8 Hz, 1H), 4.74 (d, J = 11.5 Hz, 1H), 4.64 (t, J = 2.4 Hz, 1H), 4.63 – 4.57 (m, 4H), 4.46 (d, J 
= 12.0 Hz, 1H), 4.28 (dd, J = 8.9, 2.7 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.80 (dd, J = 11.2, 4.6 Hz, 
1H), 3.74 – 3.70 (m, 4H), 3.68 (td, J = 10.3, 4.2 Hz, 1H), 2.28 (pd, J = 7.0, 2.6 Hz, 1H), 2.06 
(dtd, J = 12.0, 3.8, 1.9 Hz, 1H), 1.59 (dq, J = 12.4, 3.0 Hz, 1H), 1.55 (dq, J = 13.1, 3.3 Hz, 1H), 
1.36 – 1.28 (m, 1H), 1.17 – 0.99 (m, 14H), 0.91 – 0.87 (m, 1H), 0.84 (d, J = 6.5 Hz, 3H), 0.80 (d, 
J = 7.1 Hz, 3H), 0.73 (d, J = 6.9 Hz, 3H). 13C NMR (176 MHz, CDCl3): δ 159.57, 156.76, 
138.85, 138.75, 138.68, 133.12, 132.97, 129.34, 128.29, 128.21, 128.16, 128.08, 127.58, 127.54, 
127.50, 127.31, 127.29, 122.19, 115.66, 115.53, 114.78, 113.95, 99.19, 93.66, 84.29, 80.76, 
75.04, 74.66, 73.23, 73.04, 72.94, 72.81, 69.69, 69.33, 55.33, 50.44, 45.90, 34.56, 31.73, 25.22, 
22.70, 22.33, 21.31, 17.80, 17.75, 17.72, 15.88, 13.68, 13.45. HRMS (ESI) (m/z): [M+NH4+] 
calculated for C58H76NO8Si, 942.5335 found, 942.5336. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisobutyl((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)silane (4-42) 
 
The title compound was prepared from 4-30 (67 mg, 0.084 mmol), (-)-menthol (12 mg, 0.076 
mmol), B(C6F5)3 (3.1 mg, 0.006 mmol) in 1.2 mL toluene by following the general procedure. 
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The reaction was directly purified via flash chromatography, Biotage (100% hexanes-80:20 
hexanes: EtOAc) to afford the desired product as a colorless viscous oil (52 mg,  0.055 mmol, 
65%). 1H NMR (700 MHz, CDCl3): δ 7.49 (dd, J = 7.6, 5.5 Hz, 3H), 7.32 (d, J = 7.5 Hz, 2H), 
7.31 – 7.25 (m, 12H), 7.22 (d, J = 8.3 Hz, 1H), 7.20 – 7.18 (m, 2H), 7.02 (t, J = 7.5 Hz, 1H), 6.67 
(d, J = 8.4 Hz, 2H), 5.71 (d, J = 2.1 Hz, 1H), 4.88 (d, J = 10.7 Hz, 1H), 4.72 (d, J = 11.5 Hz, 1H), 
4.66 – 4.61 (m, 2H), 4.61 – 4.56 (m, 2H), 4.46 (d, J = 12.0 Hz, 1H), 4.27 (dd, J = 9.3, 2.7 Hz, 
1H), 4.14 (dd, J = 10.2, 4.6 Hz, 1H), 4.09 (t, J = 9.6 Hz, 1H), 3.81 (dd, J = 11.4, 4.9 Hz, 1H), 
3.74 (s, 3H), 3.73 – 3.69 (m, 1H), 3.61 (td, J = 10.4, 4.2 Hz, 1H), 2.22 (pd, J = 7.1, 2.2 Hz, 1H), 
2.05 (d, J = 12.1 Hz, 1H), 1.96 (hept, J = 6.7 Hz, 1H), 1.87 (hept, J = 6.7 Hz, 1H), 1.59 (ddd, J = 
31.7, 14.5, 3.7 Hz, 3H), 1.37 – 1.30 (m, 1H), 1.16 – 1.10 (m, 1H), 1.10 – 1.04 (m, 1H), 1.00 (dd, 
J = 11.2, 6.6 Hz, 6H), 0.91 (d, J = 6.5 Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H), 
0.82 (d, J = 7.2 Hz, 3H), 0.78 (dd, J = 12.8, 3.2 Hz, 1H), 0.73 (d, J = 6.9 Hz, 3H), 0.66 (m, 4H). 
13C NMR (176 MHz, CDCl3): δ 159.58, 156.70, 138.81, 138.73, 138.68, 133.13, 132.97, 
129.34, 128.30, 128.24, 128.20, 128.09, 127.63, 127.53, 127.50, 127.34, 127.31, 122.19, 115.65, 
115.48, 114.73, 113.97, 99.00, 93.69, 84.28, 80.63, 75.06, 74.70, 73.24, 73.01, 72.82, 72.68, 
69.46, 69.29, 55.32, 50.23, 45.76, 34.54, 31.75, 26.58, 26.47, 26.40, 26.27, 25.16, 25.14, 25.06, 
24.02, 23.94, 22.70, 22.34, 21.30, 15.85. HRMS (ESI) (m/z): [M+NH4+] calculated for 
C60H80NO8Si, 970.5648 found, 970.5640. 
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((2R,3R,4R,5R,6S)-4,5-bis(benzyloxy)-2-(benzyloxymethyl)-6-methoxytetrahydro-2H-
pyran-3-yloxy)((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-
methoxyphenyl)ethynyl)phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-44) 
 
The title compound was prepared from 4-21 (85 mg, 0.11 mmol), (2R,3R,4S,5R,6S)-4,5-
bis(benzyloxy)-2-(benzyloxymethyl)-6-methoxytetrahydro-2H-pyran-3-ol159 (46 mg, 0.1 mmol), 
B(C6F5)3 (4.0 mg, 0.008 mmol) in 1.5 mL toluene by following the general procedure. The 
reaction was directly purified via flash chromatography, Biotage (97:3-70:3- hexanes: EtOAc) to 
afford the desired product as a colorless viscous oil (39 mg,  0.032 mmol, 32%). 1H NMR (700 
MHz, CDCl3): δ 7.47 (dd, J = 7.8, 1.7 Hz, 1H), 7.46 – 7.43 (m, 2H), 7.32 – 7.15 (m, 30H), 7.12 
(dd, J = 6.6, 3.0 Hz, 2H), 6.99 (td, J = 7.3, 1.4 Hz, 1H), 6.60 – 6.56 (m, 2H), 5.72 (d, J = 1.9 Hz, 
1H), 5.12 (d, J = 11.6 Hz, 1H), 4.82 (d, J = 10.7 Hz, 1H), 4.69 (d, J = 11.6 Hz, 1H), 4.61 – 4.55 
(m, 4H), 4.52 – 4.44 (m, 6H), 4.37 (d, J = 12.0 Hz, 1H), 4.23 (dd, J = 9.3, 2.8 Hz, 1H), 4.10 
(ddd, J = 10.1, 4.9, 1.7 Hz, 1H), 4.05 (dd, J = 11.4, 7.9 Hz, 1H), 3.92 (t, J = 9.0 Hz, 1H), 3.82 – 
3.76 (m, 4H), 3.75 – 3.72 (m, 1H), 3.71 (s, 3H), 3.64 (dd, J = 11.2, 1.8 Hz, 1H), 3.46 (dd, J = 
9.5, 3.6 Hz, 1H), 3.35 (s, 3H), 1.05 (dt, J = 19.2, 6.6 Hz, 2H), 0.99 (s, 9H), 0.98 – 0.95 (m, 3H). 
13C NMR (176 MHz, CDCl3): δ 159.56, 156.25, 139.42, 138.85, 138.69, 138.48, 138.36, 
138.11, 133.14, 133.12, 133.04, 129.43, 128.69, 128.46, 128.31, 128.24, 128.22, 128.19, 128.15, 
128.10, 128.04, 127.91, 127.76, 127.65, 127.62, 127.58, 127.47, 127.44, 127.41, 127.39, 127.36, 
127.20, 127.05, 126.97, 122.22, 115.58, 115.31, 114.71, 114.07, 113.94, 98.40, 97.62, 93.74, 
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84.29, 81.49, 80.99, 80.81, 74.98, 74.51, 74.50, 73.38, 73.05, 72.94, 72.84, 72.60, 71.46, 71.24, 
69.89, 69.83, 69.22, 55.33, 55.23, 17.77, 17.73, 17.72, 17.56, 12.89, 12.78. HRMS (ESI) (m/z): 
[M+NH4+] calculated for C76H88NO13Si, 1250.6019 found, 1250.6020. 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropyl(((2R,3R,4S,5S,6R)-3,4,5-tris(benzyloxy) 
-6-methoxytetrahydro-2H-pyran-2-yl)methoxy)silane (4-46) 
 
The title compound was prepared from 4-21 (85 mg, 0.11 mmol), ((2R,3R,4S,5S,6R)-3,4,5-
tris(benzyloxy)-6-methoxytetrahydro-2H-pyran-2-yl)178 (46 mg, 0.1 mmol), B(C6F5)3 (8.0 mg, 
0.016 mmol) in 1.5 mL toluene by following a modified general procedure. The reaction was 
directly purified via flash chromatography, Biotage (100% hexanes-70:30 hexanes: EtOAc) to 
afford the desired product as a colorless viscous oil (96 mg,  0.078 mmol, 77%). 1H NMR (700 
MHz, CDCl3): δ 7.44 (dd, J = 7.7, 5.6 Hz, 3H), 7.37 – 7.20 (m, 29H), 7.19 – 7.14 (m, 3H), 6.93 
(t, J = 7.5 Hz, 1H), 6.64 (d, J = 8.5 Hz, 2H), 5.75 (d, J = 2.0 Hz, 1H), 4.90 (d, J = 10.8 Hz, 1H), 
4.86 (d, J = 10.8 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.75 (d, J = 10.8 Hz, 1H), 4.73 – 4.69 (m, 
2H), 4.62 (d, J = 11.6 Hz, 1H), 4.60 (d, J = 3.3 Hz, 1H), 4.58 (d, J = 4.4 Hz, 1H), 4.55 (d, J = 
10.7 Hz, 1H), 4.47 (d, J = 3.3 Hz, 1H), 4.44 (dd, J = 12.7, 11.1 Hz, 3H), 4.28 (dd, J = 9.4, 2.6 
Hz, 1H), 4.12 (t, J = 9.6 Hz, 1H), 4.04 (ddd, J = 10.0, 4.8, 1.7 Hz, 1H), 4.00 (dd, J = 11.2, 1.8 
Hz, 1H), 3.95 – 3.89 (m, 2H), 3.79 (dd, J = 11.3, 4.7 Hz, 1H), 3.72 (s, 3H), 3.68 (dd, J = 11.3, 
1.8 Hz, 1H), 3.63 (dd, J = 10.3, 4.5 Hz, 1H), 3.47 (t, J = 9.5 Hz, 1H), 3.29 (dd, J = 9.6, 3.5 Hz, 
O
BnO
BnO
BnO
O
O
OMe
Si
iPr iPr
O
O
BnO BnO
OMe
4-46
BnO
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1H), 3.21 (s, 3H), 1.06 (dq, J = 11.6, 5.8, 4.7 Hz, 14H). 13C NMR (176 MHz, CDCl3):  δ 
159.63, 156.48, 138.85, 138.82, 138.68, 138.61, 138.41, 138.33, 133.07, 133.05, 129.44, 128.49, 
128.47, 128.44, 128.42, 128.35, 128.30, 128.28, 128.23, 128.16, 128.11, 127.95, 127.92, 127.78, 
127.75, 127.66, 127.56, 127.54, 127.40, 127.35, 121.96, 115.57, 114.95, 114.20, 114.01, 98.47, 
97.48, 93.79, 84.33, 82.07, 80.85, 80.75, 77.76, 75.88, 75.14, 75.09, 74.50, 73.09, 73.02, 72.94, 
72.74, 71.41, 69.48, 69.19, 62.53, 55.34, 54.87, 17.54, 17.48, 17.46, 12.75, 12.72, 1.11. HRMS 
(ESI) (m/z): [M+K+] calculated for KC76H84O13Si, 1271.5313 found, 1271.5305. 
((2R,3R,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropyl((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)silane (4-48) 
 
The title compound was prepared from 4-39 (85 mg, 0.11 mmol), (-)-menthol (16 mg, 0.1 
mmol), B(C6F5)3 (4.0 mg, 0.008 mmol) in 1.5 mL toluene by following the general procedure. 
The reaction was directly purified via flash chromatography, Biotage (100% hexanes-80:20 
hexanes: EtOAc) to afford the desired product as a colorless viscous oil (81 mg,  0.087 mmol, 
87%).1H NMR (700 MHz, CDCl3): δ 7.57 – 7.52 (m, 2H), 7.47 (dd, J = 7.7, 1.8 Hz, 1H), 7.36 
(d, J = 8.1 Hz, 2H), 7.34 – 7.20 (m, 13H), 7.07 (dd, J = 5.3, 2.6 Hz, 2H), 6.98 (t, J = 7.4 Hz, 1H), 
6.70 – 6.64 (m, 2H), 5.84 (d, J = 7.2 Hz, 1H), 5.03 (d, J = 11.3 Hz, 1H), 4.81 (dd, J = 11.0, 9.1 
Hz, 2H), 4.61 (dd, J = 12.1, 1.6 Hz, 1H), 4.50 (d, J = 10.6 Hz, 1H), 4.42 (dd, J = 12.1, 1.6 Hz, 
O
BnO
BnO
BnO
O O
OMe
(iPr)2Si
O iPr
4-48
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1H), 4.33 (td, J = 9.3, 1.6 Hz, 1H), 4.22 (dt, J = 9.6, 2.4 Hz, 1H), 4.12 (ddd, J = 10.3, 3.6, 1.9 Hz, 
1H), 3.81 – 3.76 (m, 2H), 3.74 (d, J = 1.7 Hz, 3H), 3.60 (dd, J = 11.1, 2.1 Hz, 1H), 3.53 (td, J = 
10.3, 4.1 Hz, 1H), 2.28 – 2.23 (m, 1H), 2.09 – 2.05 (m, 1H), 1.57 – 1.50 (m, 2H), 1.13 – 1.02 (m, 
11H), 1.03 – 0.99 (m, 3H), 0.98 (d, J = 6.4 Hz, 2H), 0.96 – 0.89 (m, 1H), 0.84 (dd, J = 7.1, 1.6 
Hz, 3H), 0.83 – 0.78 (m, 4H), 0.79 – 0.73 (m, 1H), 0.69 (dd, J = 6.9, 1.6 Hz, 3H). 13C NMR (176 
MHz, CDCl3): δ 159.44, 156.92, 139.28, 138.52, 138.01, 133.16, 132.77, 129.08, 128.37, 
128.27, 128.23, 127.99, 127.87, 127.67, 127.52, 127.49, 127.26, 121.61, 116.04, 114.50, 114.08, 
113.83, 97.17, 93.90, 84.56, 82.97, 77.77, 75.79, 75.03, 73.63, 73.34, 73.29, 71.33, 68.50, 55.32, 
50.47, 45.49, 34.52, 31.66, 25.14, 22.68, 22.24, 21.43, 17.87, 17.74, 17.59, 17.42, 15.87, 13.67, 
13.54. HRMS (ESI) (m/z): [M+NH4+] calculated for C58H76NO8Si, 942.5335 found, 942.5331. 
6.3.5 Aglycone Delivery 
General Procedure: 
CH2Cl2 (0.02 M) was added to the respective tethered sugar silane (1.0 equiv.) under N2. The 
reaction was cooled to -40 °C. A slurry of N-iodosuccinimide (1.3 equiv) and 2,6-DTBMP (2.0 
equiv.) in minimal CH2Cl2 was added via syringe. The reaction was allowed to stir ~5 minutes 
before TMSOTf (1.2 equiv.) was added via syringe. The reaction as allowed to stir 20 minutes 
before being warmed to 0 °C. The reaction was allowed to stir at 0 °C for 7-8 hours before being 
quenched with Bu4NF (5.0 equiv.) The reaction was allowed to stir at room temperature 
overnight. Saturated Na2S2O3 and NH4Cl were added. The reaction was extracted 3x5 mL 
CH2Cl. The combined organic layers were dried over MgSO4 and filtered. The solvent was 
removed in vacuo. The crude residue was purified via flash chromatography, Biotage. 
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(2R,3S,4R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)tetrahydro-2H-pyran-3-ol (4-11) 
 
The title compound was prepared from 4-40 (52 mg, 0.060 mmol), NIS (17.5 mg, 0.078 mmol), 
TMSOTf (13 µL, 0.072 mmol), 2,6-DTBMP (25 mg, 0.12 mmol) in 3.0 mL CH2Cl2 by following 
the general procedure. The crude residue was purified via flash chromatography, Biotage (97:3-
70:30 hexanes: EtOAc) to give the desired product as a white solid (12 mg, 0.021 mmol, 34%). 
The spectral data matched the literature.161 
(2R,3S,4R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)tetrahydro-2H-pyran-3-ol (4-11) 
 
The title compound was prepared from 4-41 (63 mg, 0.068 mmol), NIS (32.5 mg, 0.089 mmol), 
TMSOTf (14 µL, 0.082 mmol), 2,6-DTBMP (28 mg, 0.14 mmol) in 3.4 mL CH2Cl2 by following 
the general procedure. The crude residue was purified via flash chromatography, Biotage (97:3-
4-40
O
BnO
BnO
BnO
O
O
OMe
Si O NIS (1.3 equiv)
TMSOTf (1.2 equiv)
4-11
2,6-DTBMP (2.0 equiv)
CH2Cl2, -40 °C- 0 °C
(Bu4NF work up)
O
BnO
BnO
BnO
OH
O
34%
4-41
O
BnO
BnO
BnO
O
O
OMe
Si
iPr iPr
O NIS (1.3 equiv)
TMSOTf (1.2 equiv)
4-11
2,6-DTBMP (2.0 equiv)
CH2Cl2, -40 °C- 0 °C
(Bu4NF work up)
O
BnO
BnO
BnO
OH
O
45%
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70:30 hexanes: EtOAc) to give the desired product as a white solid (18 mg, 0.030 mmol, 44%). 
The spectral data matched the literature.161 
(2R,3S,4R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)tetrahydro-2H-pyran-3-ol (4-11) 
 
The title compound was prepared from 4-41 (52 mg, 0.055 mmol), NIS (16.0 mg, 0.071 mmol), 
TMSOTf (12 µL, 0.066 mmol), 2,6-DTBMP (23 mg, 0.11 mmol) in 2.8 mL CH2Cl2 by following 
the general procedure. The crude residue was purified via flash chromatography, Biotage (100% 
hexanes-80:20 hexanes: EtOAc) to give the desired product as a white solid (18 mg, 0.030 mmol, 
56%). The spectral data matched the literature.161 
(2S,3R,4R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)tetrahydro-2H-pyran-3-ol (4-49) 
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The title compound was prepared from 4-48 (80 mg, 0.086 mmol), NIS (25.3 mg, 0.11 mmol), 
TMSOTf (19 µL, 0.10 mmol), 2,6-DTBMP (35 mg, 0.17 mmol) in 4.3 mL CH2Cl2 by following 
the general procedure. The crude residue was purified via flash chromatography, Biotage (100% 
hexanes-80:20 hexanes: EtOAc) to give the desired product as a white solid (26 mg, 0.044 mmol, 
51%). The spectral data matched the literature.161 
6.3.6 Asymmetric Hydrosilylation of Ketones 
General Procedure: 
Dry THF (0.2 M) was added to a solid mixture of Ni(cod)2 (0.10 equiv.), Ligand (0.11 equiv.), 
KO-t-Bu (0.12 equiv.) under N2. The reaction was allowed to premix at room temperature for 20 
minutes. Silane (2.0 equiv.) was added to the reaction under N2. The reaction was allowed to stir 
at room temperature for 5 minutes before acetophenone (1.0 equiv.) was added under N2. The 
reaction was allowed to stir at room temperature for 7-9 hours and was then filtered through 
silica gel, eluting with 50% v/v EtOAc/hexanes. The solvent was removed in vacuo. Dry THF 
(0.2 M) was added to the crude residue via under N2. Bu4NF (2.0 equiv) was added dropwise via 
syringe to the reaction. The reaction was allowed to stir at room temperature over night. The 
reaction was quenched with NH4Cl and extracted 3x Et2O. The combined organic layers were 
dried over MgSO4 and filtered. The solvent was removed in vacuo and the crude residue was 
purified via flash chromatography, Biotage (100% hexanes-80:20 hexanes: EtOAc). The 
enantioselectivity was determined by SFC analysis: OD-H column, 3 mL/min, 5% i-PrOH, 120 
bar, 40 °C. 
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Racemic: 
 
 
Table 6-18: Racemic SFC Trace for 4-53 
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Reaction using ligand A 
 
The general procedure was followed using Ni(cod)2 (5.5 mg, 0.02 mmol), Ligand A (15.1 mg, 
0.022 mmol), KO-t-Bu (2.7 mg, 0.024 mmol), Et3SiH (64 µL, 0.4 mmol), acetophenone (23 µL, 
0.2 mmol) and 1.0 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (3.5 mg, 0.029 
mmol, 14%, 13% ee).   
 
 
Table 6-19: SFC Trace for Reaction with Ligand A 
  
N N
PhPh iPr
BF4
iPr
iPr iPr
A
iPr iPr
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Reaction using ligand B 
 
The general procedure was followed using Ni(cod)2 (5.5 mg, 0.02 mmol), Ligand B (16.4 mg, 
0.022 mmol), KO-t-Bu (2.7 mg, 0.024 mmol), Et3SiH (64 µL, 0.4 mmol), acetophenone (23 µL, 
0.2 mmol) and 1.0 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (17.0 mg, 0.129 
mmol, 70%, 23% ee). 
 
 
Table 6-20: SFC Trace for Reaction with Ligand B 
  
N N
PhPh
OMeMeO
tBu
tBu
tBu
tBuBF4
B
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Reaction using ligand C at room temperature 
 
The general procedure was followed using Ni(cod)2 (2.8 mg, 0.01 mmol), Ligand C (7.7 mg, 
0.011 mmol), KO-t-Bu (1.3 mg, 0.012 mmol), tBuMe2SiH (33 µL, 0.2 mmol), acetophenone (12 
µL, 0.1 mmol) and 0.5 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (1.1 mg, 0.009 
mmol, 9%, 55% ee). 
 
 
Table 6-21:  SFC Trace for Reaction with Ligand C 
  
N N
PhPh iPr
BF4
iPr
tBu
tBu
iPrMeO
C
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Reaction using ligand C at 0 °C 
 
A modified general procedure was followed using Ni(cod)2 (2.8 mg, 0.01 mmol), Ligand C (7.7 
mg, 0.011 mmol), KO-t-Bu (1.3 mg, 0.012 mmol), tBuMe2SiH (33 µL, 0.2 mmol), acetophenone 
(12 µL, 0.1 mmol) and 0.5 mL of THF. The reaction was cooled to 0 °C before acetophenone 
was added. The reaction was run at 0 °C until the reaction was filtered through a plug of silica. 
The crude residue was purified via flash chromatography, Biotage (100% hexanes-80:20 
hexanes: EtOAc) to afford the desired product (2.4 mg, 0.020 mmol, 20%, 63% ee). 
 
 
Table 6-22: SFC Trace for Reaction with Ligand D at 0 °C 
N N
PhPh iPr
BF4
iPr
tBu
tBu
iPrMeO
C
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Reaction using ligand D and tBuMe2SiH 
 
The general procedure was followed using Ni(cod)2 (2.8 mg, 0.01 mmol), Ligand D (8.0 mg, 
0.011 mmol), KO-t-Bu (1.3 mg, 0.012 mmol), tBuMe2SiH (33 µL, 0.2 mmol), acetophenone (12 
µL, 0.1 mmol) and 0.5 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (5.9 mg, 0.048 
mmol, 48%, 56% ee). 
 
 
Table 6-23: SFC Trace for Reaction with Ligand D and tBuMe2Si 
  
N N
PhPh iPr
BF4 iPr
tBu
tBu
iPr
D
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Reaction using ligand D and PhMe2SiH 
 
The general procedure was followed using Ni(cod)2 (2.8 mg, 0.01 mmol), Ligand D (8.0 mg, 
0.011 mmol), KO-t-Bu (1.3 mg, 0.012 mmol), PhMe2SiH (31 µL, 0.2 mmol), acetophenone (12 
µL, 0.1 mmol) and 0.5 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (5.3 mg, 0.043 
mmol, 43%, 56% ee). 
 
 
Table 6-24: SFC Trace for Reaction with Ligand D and PhMe2Si 
  
N N
PhPh iPr
BF4 iPr
tBu
tBu
iPr
D
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Reaction using ligand E 
 
The general procedure was followed using Ni(cod)2 (2.8 mg, 0.01 mmol), Ligand E (8.1 mg, 
0.011 mmol), KO-t-Bu (1.3 mg, 0.012 mmol), Bn3SiH (60 mg, 0.2 mmol), acetophenone (12 µL, 
0.1 mmol) and 0.5 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (2.3 mg, 0.019 
mmol, 19%, 53% ee). 
 
 
Table 6-25: SFC Trace for Reaction with Ligand E 
  
N N
PhPh iPr
BF4
iPr
Ph
Ph
iPr
E
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Reaction using ligand F 
 
The general procedure was followed using Ni(cod)2 (2.8 mg, 0.01 mmol), Ligand F (7.5 mg, 
0.011 mmol), KO-t-Bu (1.3 mg, 0.012 mmol), Et3SiH (32 µL, 0.2 mmol), acetophenone (12 µL, 
0.1 mmol) and 0.5 mL of THF. The crude residue was purified via flash chromatography, 
Biotage (100% hexanes-80:20 hexanes: EtOAc) to afford the desired product (0.9 mg, 0.007 
mmol, 7%, 14% ee). 
 
 
Table 6-26: SFC Trace for Reaction with Ligand F 
6.4 NMR Spectra 
  
N N
Ph
Ph
Ph iPr
BF4
iPr
iPr
Ph
F
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1-Allyl-2-methylenecyclohexane 
 
 
Figure 6-1:  Spectra for 1-Allyl-2-methylenecyclohexane  
	





	







	



















	

	



















	






















































	

	

	

		

		

	












	

 163 
hex-5-enyl pivalate  
 
 
Figure 6-2: Spectra for Hex-5-enyl Pivalate  
	




	


































	












































	

	




	

	

	

	


 164 
1-(but-3-enyl)-1H-indole 
 
 
Figure 6-3: Spectra for 1-(But-3-enyl)-1H-indole  
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4,4,5,5-tetramethyl-2-(4-phenylbutan-2-yl)-1,3,2-dioxaborolane (2-1) 
 
 
Figure 6-4: Spectra for Compound 2-1  
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4,4,5,5-tetramethyl-2-(octan-2-yl)-1,3,2-dioxaborolane (2-27) 
 
 
Figure 6-5: Spectra for Compound 2-27  

	







































 167 
2-(1-cyclohexylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-28) 
 
 
Figure 6-6: Spectra for Compound 2-28  
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2-(4,8-dimethylnon-7-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-29) 
 
 
Figure 6-7: Spectra for Compound 2--29  
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4,4,5,5-tetramethyl-2-(1-(2-methylenecyclohexyl)propan-2-yl)-1,3,2-dioxaborolane (2-30) 
 
 
Figure 6-8: Spectra for Compound 2-30  
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2-(6-(benzyloxy)hexan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-31) 
 
 
Figure 6-9: Spectra for Compound 2-32  
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tert-butyldimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentyloxy)silane (2-32) 
 
 
Figure 6-10: Spectra for Compound 2-32  
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5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-1-ol (2-33) 
 
 
Figure 6-11: Spectra for Compound 2-33  
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5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexyl pivalate (2-34) 
 
 
Figure 6-12: Spectra for Compound 2-34  
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2-(4-(2-bromophenyl)butan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-35) 
 
 
Figure 6-13: Spectra for Compound 2-35  
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4,4,5,5-tetramethyl-2-(1-phenylpropan-2-yl)-1,3,2-dioxaborolane (2-36) 
 
 
Figure 6-14: Spectra for Compound 2-36  
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trimethyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)silane (2-37) 
 
 
Figure 6-15: Spectra for Compound 2-37  
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1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-1H-indole (2-38) 
 
 
Figure 6-16: Spectra for Compound 2-38  
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1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-1H-indole 
 
 
Figure 6-17: Spectra for 1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl_propyl)-1H-indole  
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1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl)-1H-indole (2-39) 
 
 
Figure 6-18: Spectra for Compound 2-39   
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Potassium (4-phenylbutan-2-yl)trifluoroborate 
 
 
Figure 6-19: Spectra for Potassium (4-Phenylbutan-2-yl)trifluroborate  
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Potassium trifluoro(6-hydroxyhexan-2-yl)borate  
 
 
Figure 6-20: Spectra for Potassium (6-hydroxyhexan-2-yl)trifluroborate  
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Potassium trifluoro(6-(pivaloyloxy)hexan-2-yl)borate  
 
 
Figure 6-21: Spectra for Potassium (6-(pivaloyloxy)hexan2-yl)trifluroborate  
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Potassium (4-(1H-indol-1-yl)butan-2-yl)trifluoroborate  
 
 
Figure 6-22: Spectra for Potassium (4-(1H-indol-1-yl)butan-2-yl)trifluroborate   
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4-(4-phenylbutan-2-yl)biphenyl (2-52) 
 
 
Figure 6-23: Spectra for 2-52  
	













	












	











	














	




		

	






	

	


	

	

	

	

	
	
	

	

	

	

	

	

	

	

	

	

	

	

	

	

	
	
	
	
	

	

	

	

 185 
2-fluoro-5-(4-phenylbutan-2-yl)pyridine (2-53) 
 
 
Figure 6-24: Spectra for 2-53  
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4-(4-Phenylbutan-2-yl)benzonitrile (2-54) 
 
 
Figure 6-25: Spectra for 2-54  
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N-(4-(4-phenylbutane-2-yl)phenyl)acetamide (2-55) 
 
 
Figure 6-26: Spectra for 2-55  
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5-(biphenyl-4-yl)hexan-1-ol (2-56) 
 
 
Figure 6-27: Spectra for 2-56  
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5-(biphenyl-4-yl)hexyl pivalate (2-57) 
 
 
Figure 6-28: Spectra for 2-57  
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 190 
1-(3-(biphenyl-4-yl)butyl)-1H-indole (2-58) 
 
 
Figure 6-29: Spectra for 2-58 
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 191 
4,4,5,5-tetramethyl-2-(2-methyl-4-phenylbutan-2-yl)-1,3,2-dioxaborolane (2-68) 
 
 
Figure 6-30: Spectra for 2-68  
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 192 
4,4,5,5-tetramethyl-2-(3-methyl-1-phenylpentan-3-yl)-1,3,2-dioxaborolane (2-71) 
 
 
Figure 6-31: Spectra for 2-71  
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193 
(3aS,5R,6R,7S,7aS)-5-(acetoxymethyl)-2-ethoxy-2-methyltetrahydro-3aH-[1,3]dioxolo[4,5-
b]pyran-6,7-diyl diacetate (4-24) 
 
 
Figure 6-32: Spectra for 4-24  
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194 
(3aS,5R,6R,7S,7aS)-6,7-bis(benzyloxy)-5-(benzyloxymethyl)-2-ethoxy-2-methyltetrahydro-
3aH-[1,3]dioxolo[4,5-b]pyran (4-25) 
 
 
Figure 6-33: Spectra for 4-25  
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195 
(2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-2H-
pyran-3-yl acetate (4-26) 
 
 
Figure 6-34: Spectra for 4-26  
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196 
(2R,3S,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-ol (4-27) 
 
 
Figure 6-35: Spectra for 4-27 
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197 
(2R,3S,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-ol (4-28) 
 
 
Figure 6-36: Spectra for 4-28  
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198 
(3aR,5R,6R,7S,7aR)-5-(acetoxymethyl)-2-ethoxy-2-methyltetrahydro-3aH-[1,3]dioxolo[4,5-
b]pyran-6,7-diyl diacetate (4-31) 
 
 
Figure 6-37: Spectra for 4-31  
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199 
(3aR,5R,6R,7S,7aR)-6,7-bis(benzyloxy)-5-(benzyloxymethyl)-2-ethoxy-2-methyltetrahydro-
3aH-[1,3]dioxolo[4,5-b]pyran (4-32) 
 
 
Figure 6-38: Spectra for 4-32 
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200 
(2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-yl acetate (4-33) 
 
 
Figure 6-39: Spectra for 4-33  
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201 
(2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-ol (4-35) 
 
 
Figure 6-40: Spectra for 4-35  
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202 
(2S,3R,4S,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-ol (4-36) 
 
 
Figure 6-41: Spectra for 4-36  
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203 
(2R,3R,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-iodophenoxy)tetrahydro-
2H-pyran-3-ol (4-37) 
 
 
Figure 6-42: Spectra for 4-37  
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204 
(2R,3R,4R,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-ol (4-38) 
 
 
Figure 6-43: Spectra for 4-38  
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205 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-21) 
 
 
Figure 6-44: Spectra for 4-21  
		
















	














	



	
















































	

	

	

























	





	

	







	

	





	
	

	

	

	

	

	

	
	
	

	

	

	

	

	

	

	

	

	

	

	

	
	
	
	
	


	


	

	

	

	

	

	

	

	
	
	
	
	
	










	












	







































	


	







	















	

























	


	


	


	













	


	


	









 
 
206 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)dimethylsilane (4-29) 
 
 
Figure 6-45: Spectra for 4-29  
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207 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisobutylsilane (4-30) 
 
 
Figure 6-46: Spectra for 4-30  
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208 
((2S,3R,4R,5R,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl) 
ethynyl)phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-22) 
 
 
Figure 6-47: Spectra for 4-22  
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209 
((2R,3R,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-39) 
 
 
Figure 6-48: Spectra for 4-39  
		




























	










	


























	






	

	
















	

	

	

	

	

		











	

	





	














	







	















	

	






	

	
	
	
	
	


	


	

	

	

	

	

	

	

	

	
	
	


	


	

	

	

	

	

	

	

	

	
	
	

	

	
	










	






	























	
















	




	













	




























	

	


	


	


	







	








	











	
 
 
210 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy) 
dimethylsilane (4-40) 
 
 
Figure 6-49: Spectra for 4-40 
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211 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropyl((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)silane (4-41) 
 
 
Figure 6-50: Spectra for 4-41  
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212 
((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisobutyl((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyloxy)silane (4-42) 
 
 
Figure 6-51: Spectra for 4-42  
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213 
((2R,3R,4R,5R,6S)-4,5-bis(benzyloxy)-2-(benzyloxymethyl)-6-methoxytetrahydro-2H-
pyran-3-yloxy)((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-
methoxyphenyl)ethynyl)phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropylsilane (4-44) 
 
 
Figure 6-52: Spectra for 4-44  
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((2R,3S,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-methoxyphenyl)ethynyl) 
phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropyl(((2R,3R,4S,5S,6R)-3,4,5-tris(benzyloxy) 
-6-methoxytetrahydro-2H-pyran-2-yl)methoxy)silane (4-46) 
 
 
Figure 6-53: Spectra for 4-46  
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 ((2R,3R,4S,5S,6R)-4,5-bis(benzyloxy)-6-(benzyloxymethyl)-2-(2-((4-
methoxyphenyl)ethynyl) phenoxy)tetrahydro-2H-pyran-3-yloxy)diisopropyl((1R,2S,5R)-2-
isopropyl-5-methylcyclohexyloxy)silane (4-48) 
 
 
Figure 6-54: Spectra for 4-48 
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